Philips Medical Systems North America MX40SH14 INTELLIVUE MX40 1.4 GHz PATIENT WORN DEVICE User Manual MX40 IFU 453564242441

Download:
Mirror Download [FCC.gov]
Document ID	1516312
Application ID	ZiNU3MQBBalUcMha3Xi94g==
Document Description	Users Manual
Short Term Confidential	No
Permanent Confidential	No
Supercede	No
Document Type	User Manual
Display Format	Adobe Acrobat PDF - pdf
Filesize	188.99kB (2362344 bits)
Date Submitted	2011-08-03 00:00:00
Date Available	2011-08-03 00:00:00
Creation Date	2011-07-12 15:40:27
Producing Software	Microsoft® Word 2010
Document Lastmod	2011-07-20 10:55:36
Document Title	MX40 IFU - 453564242441
Document Creator	Microsoft® Word 2010

op
ft
ra
IntelliVue MX40
Instructions for Use
Notice
Proprietary Information
This document contains proprietary information, which is protected by
copyright.
Copyright
Copyright © 2011 Koninklijke Philips Electronics N.V. All rights reserved.
Reproduction in whole or in part is prohibited without the prior written
consent of the copyright holder. Philips Medical Systems Nederland B.V.
reserves the right to make changes in specifications and/or to discontinue any
products at any time without notice or obligation and will not be liable for any
consequences resulting from the use of this publication.
op
OxiCliq ® and OxiMax ® are registered trademarks of Nellcor Incorporated.
Duracell ® is a registered trademark of Procter & Gamble Incorporated.
STERRAD ® is a registered trademark of Advanced Sterilization Products.
GORE-TEX ® is a registered trademark of W.L. Gore & Assoc.Incorporated
Manufacturer
ft
Tone modulation is licensed under US patent 4,653,498 from Nellcor Puritan
Bennett Incorporated.
ra
Philips Medical Systems
3000 Minuteman Road
Andover, MA 01810-1099
(978) 687-1501
Printed in USA
Document number
453 564 242 441
Warranty
The information contained in this document is subject to change without
notice. Philips Medical Systems makes no warranty of any kind with regard to
this material, including, but not limited to, the implied warranties or
merchantability and fitness for a particular purpose. Philips Medical Systems
shall not be liable for errors contained herein or for incidental or consequential
damages in connection with the furnishing, performance, or use of this
material.
ii
FCC
This device complies with Part 15 and/or Part 95 of the FCC Rules. Operation
is subject to the following two conditions: (1) these devices may not cause
harmful interference, and (2) these devices must accept any interference
received, including interference that may cause undesired operation.
Changes and modifications not expressly approved by Philips Medical
Systems can void your authority to operate this equipment under Federal
Communications Commissions rules
Printing History
op
New editions of this document will incorporate all material updated since the
previous edition. Update packages may be issued between editions and
contain replacement and additional pages to be merged by a revision date at
the bottom of the page. Note that pages which are rearranged due to changes
on a previous page are not considered revised.
ft
The documentation printing date and part number indicate its current edition.
The printing date changes when a new edition is printed. (Minor corrections
and updates which are incorporated at reprint do not cause the date to
change.) The document part number changes when extensive technical
changes are incorporated.
First Edition
June 2011
ra
Document Conventions
In this guide:
Warnings
Warning
A Warning alerts you to a potential serious outcome, adverse event or safety
hazard. Failure to observe a warning may result in death or serious injury to
the user or patient.
iii
Cautions
Caution
A Caution alerts you to where special care is necessary for the safe and
effective use of the product. Failure to observe a caution may result in minor
or moderate personal injury or damage to the product or other property, and
possibly in a remote risk of more serious injury.
Notes
ra
ft
op
A Note contains additional information on the product's usage.
iv
Contents
1. Introducing the IntelliVue MX40
1-1
MX40 Features-------------------------------------------------------------------------- 1-2
MX40 Models ---------------------------------------------------------------------------- 1-3
MX40 Compatibility -------------------------------------------------------------------- 1-4
2. Product Safety
2-1
General Safety -------------------------------------------------------------------------- 2-2
Safety Symbols & Other Marks ----------------------------------------------------- 2-4
ra
ft
op
3. Basic Operation
3-1
Controls, Indicators and Connectors ---------------------------------------------- 3-2
MX40 Controls and Indicators -------------------------------------------------- 3-2
Operating and Navigating ------------------------------------------------------------ 3-7
Power-On Self Test --------------------------------------------------------------- 3-7
Navigating --------------------------------------------------------------------------- 3-7
Selecting Display Elements ----------------------------------------------------- 3-8
Locking the Display---------------------------------------------------------------- 3-8
Measurement Area ---------------------------------------------------------------- 3-8
Measurement Area Display Configurations --------------------------------- 3-8
Connecting/Disconnecting the Patient Cable ------------------------------ 3-9
Understanding Settings -------------------------------------------------------------- 3-10
Changing Measurement Settings --------------------------------------------- 3-10
ECG Settings at the MX40 ----------------------------------------------------- 3-10
Waveform Settings at the MX40 ---------------------------------------------- 3-11
Battery Information -------------------------------------------------------------------- 3-12
Battery Safety Information ------------------------------------------------------ 3-12
Lithium-ion Rechargeable Battery Care ------------------------------------ 3-13
Inserting/Removing Batteries -------------------------------------------------- 3-14
Inserting Batteries ---------------------------------------------------------------- 3-15
Removing the Batteries --------------------------------------------------------- 3-16
Battery Charge Status ----------------------------------------------------------- 3-17
Pouch Use------------------------------------------------------------------------------- 3-19
Securing the Pouch -------------------------------------------------------------- 3-19
Showering -------------------------------------------------------------------------- 3-21
Telemetry Mode Use ----------------------------------------------------------------- 3-23
Monitoring Mode Use----------------------------------------------------------------- 3-24
Briefing the Patient -------------------------------------------------------------------- 3-25
4. Alarms
4-1
Alarms Overview ----------------------------------------------------------------------- 4-2
Visual Alarm Indicators ----------------------------------------------------------- 4-3
Audible Alarm Indicators when in Monitoring Mode ---------------------- 4-5
Acknowledging Alarms ----------------------------------------------------------- 4-6
Contents - 1
Pausing or Switching Off Alarms----------------------------------------------- 4-6
Alarm Limits ------------------------------------------------------------------------- 4-7
Reviewing Alarms ------------------------------------------------------------------ 4-8
Latching Alarms -------------------------------------------------------------------- 4-8
Alarm Latching Behavior --------------------------------------------------------- 4-9
Alarm Behavior at Power On---------------------------------------------------- 4-9
Physiologic Alarms ------------------------------------------------------------------- 4-10
Technical Alarms (INOPs) --------------------------------------------------------- 4-14
ra
ft
op
5. ECG and Arrhythmia Monitoring
5-1
ECG Safety Information--------------------------------------------------------------- 5-2
For Paced Patients ---------------------------------------------------------------- 5-3
Measuring ECG ------------------------------------------------------------------------- 5-5
Connecting and Positioning ECG Electrodes ----------------------------------- 5-6
Selecting the Primary and Secondary ECG Leads ---------------------------- 5-7
Checking Paced Status --------------------------------------------------------------- 5-8
Understanding the ECG Display---------------------------------------------------- 5-9
Monitoring Paced Patients --------------------------------------------------------- 5-10
Avoiding Pace Pulse Repolarization Tails --------------------------------- 5-10
Changing the Size of the ECG Wave ------------------------------------------- 5-11
Selecting Positions of Va and Vb Chest Leads ------------------------------- 5-12
Choosing EASI or Standard Lead Placement--------------------------------- 5-13
ECG Configuration ------------------------------------------------------------------- 5-14
ECG Leads Monitored--------------------------------------------------------------- 5-15
Reconstructed Leads ---------------------------------------------------------------- 5-17
3-Wire Placement -------------------------------------------------------------------- 5-18
5-Wire Placement (Standard Mode) --------------------------------------------- 5-19
5-Wire Placement (EASI Mode) -------------------------------------------------- 5-20
6-Wire Placement -------------------------------------------------------------------- 5-21
Chest Electrode Placement -------------------------------------------------------- 5-22
Monitoring during Leads Off ------------------------------------------------------- 5-23
ECG Fallback --------------------------------------------------------------------- 5-23
Relearning ------------------------------------------------------------------------- 5-23
ST/AR Arrhythmia Monitoring ----------------------------------------------------- 5-25
ST/AR Arrhythmia Algorithm -------------------------------------------------- 5-25
How the ST/AR Algorithm Works -------------------------------------------- 5-25
ECG and Arrhythmia Alarm Overview -------------------------------------- 5-26
Using ECG Alarms--------------------------------------------------------------- 5-27
Learning ---------------------------------------------------------------------------- 5-29
Initiating Arrhythmia Relearning Manually --------------------------------- 5-31
ST/AR ST Analysis Algorithm ----------------------------------------------------- 5-32
Intended Use ---------------------------------------------------------------------- 5-32
The Measurement --------------------------------------------------------------- 5-33
Algorithm Processing ----------------------------------------------------------- 5-33
Displayed ST Data --------------------------------------------------------------- 5-34
Contents - 2
EASI ST Analysis ----------------------------------------------------------------- 5-34
Turning ST Monitoring On/Off ------------------------------------------------- 5-34
QT Interval Monitoring --------------------------------------------------------------- 5-35
Intended Use ----------------------------------------------------------------------- 5-36
How the QT Analysis Algorithm Works ------------------------------------- 5-36
6. Monitoring Pulse Rate
6-1
Pulse Rate Measurement ------------------------------------------------------------ 6-2
Displaying the Pulse Rate Measurement at the MX40 ----------------------- 6-3
ft
op
7. SpO2 Monitoring
7-1
SpO2 Safety Information -------------------------------------------------------------- 7-2
SpO2 Information for the User -------------------------------------------------- 7-3
Pulse Oximetry Measurement ------------------------------------------------------ 7-5
SpO2 Sensors ----------------------------------------------------------------------- 7-6
Selecting an SpO2 Sensor ------------------------------------------------------- 7-6
Sensor Application Safety Information --------------------------------------- 7-7
Applying the Sensor --------------------------------------------------------------- 7-8
Connecting SpO2 Cables -------------------------------------------------------- 7-8
Tone Modulation Indication ----------------------------------------------------- 7-8
Signal Quality Indicator ----------------------------------------------------------- 7-8
Measuring SpO2-------------------------------------------------------------------- 7-9
Understanding SpO2 Alarms --------------------------------------------------- 7-10
ra
8. Monitoring with other Assigned Devices
8-1
Assigning Devices ---------------------------------------------------------------------- 8-2
Device Assignment at the Information Center ----------------------------- 8-2
Device Assignment at the MX40 ----------------------------------------------- 8-2
Device Assignment at the Patient Monitor ---------------------------------- 8-3
Controls Available when Assigned to IntelliVue Cableless Measurements8-5
Controls Available when Assigned to IntelliVue Patient Monitors --------- 8-6
MX40 Display when Wirelessly Connected to a Patient Monitor ---------- 8-7
9. Monitoring with the MX40 at the Information Center
9-1
MX40 Controls in the Patient Window -------------------------------------------- 9-2
Locating the MX40 (Find Device) -------------------------------------------------- 9-4
Viewing Device Location and Location History (optional) ------------------- 9-5
Using the Device Location Client (optional) ------------------------------------- 9-6
Patient Configurable Settings in Telemetry Setup ----------------------------- 9-7
Unit Configurable Settings ---------------------------------------------------------- 9-11
10. Operating with Information Center Release L or M
10-1
Display ----------------------------------------------------------------------------------- 10-2
Alarms ------------------------------------------------------------------------------------ 10-3
11. Trends (Optional)
11-1
Viewing Vital Trend Information --------------------------------------------------- 11-2
Contents - 3
12. Maintenance
Cleaning--------------------------------------------------------------------------------Cleaning Materials for the MX40 --------------------------------------------Label Assignment for Replacement MX40 ------------------------------------Re-assigning an Equipment Label -----------------------------------------Charging Lithium-ion Rechargeable Batteries -------------------------------Battery Power Indicators ------------------------------------------------------Battery Lifetime Management -----------------------------------------------Battery Disposal ------------------------------------------------------------------
12-1
12-2
12-2
12-5
12-5
12-7
12-7
12-8
12-9
ra
ft
op
13. Safety Standards & Specifications
13-1
Regulatory Information -------------------------------------------------------------- 13-2
Software Hazard Prevention -------------------------------------------------- 13-2
AC Power Source ---------------------------------------------------------------- 13-2
Industrie Canada Compliance (Canada)----------------------------------- 13-2
Safety Standards ----------------------------------------------------------------- 13-2
Intended Use Statement ------------------------------------------------------- 13-3
Indications for Use --------------------------------------------------------------- 13-3
Intended Uses of MX40 -------------------------------------------------------- 13-4
Authorized EU Representative ----------------------------------------------- 13-4
Patient Population --------------------------------------------------------------- 13-4
Rx ------------------------------------------------------------------------------------ 13-4
Essential Performance --------------------------------------------------------- 13-5
Electromagnetic Compatibility----------------------------------------------------- 13-6
Reducing Electromagnetic Interference ------------------------------------ 13-7
Restrictions for Use-------------------------------------------------------------- 13-7
Electromagnetic Compatibility (EMC) Specifications ------------------- 13-7
Electromagnetic Emissions---------------------------------------------------- 13-8
Electromagnetic Immunity ----------------------------------------------------- 13-8
Recommended Separation Distance --------------------------------------- 13-9
Battery Specifications -------------------------------------------------------------- 13-12
Lithium-ion Battery Charge Time ------------------------------------------------ 13-14
Physical Specifications ------------------------------------------------------------- 13-15
MX40 1.4 GHz Radio --------------------------------------------------------------- 13-16
MX40 2.4 GHz Radio --------------------------------------------------------------- 13-17
MX40 Short-Range Radio --------------------------------------------------------- 13-19
Environmental Specifications ----------------------------------------------------- 13-20
Measurement Specifications ----------------------------------------------------- 13-21
ECG -------------------------------------------------------------------------------- 13-21
ECG Performance Disclosure/Specifications ---------------------------- 13-22
FAST SpO2 ----------------------------------------------------------------------- 13-24
SpO2 Sensor Accuracy -------------------------------------------------------- 13-26
A. Accessories
A-1
MX40 Accessories --------------------------------------------------------------------- A-2
Contents - 4
Pouches ------------------------------------------------------------------------------ A-2
Miscellaneous----------------------------------------------------------------------- A-2
ECG Accessories----------------------------------------------------------------------- A-3
Electrodes --------------------------------------------------------------------------- A-3
Leadsets and Patient Cables --------------------------------------------------- A-3
SpO2 Accessories ---------------------------------------------------------------------- A-5
Philips/Nellcor Disposable Sensors ------------------------------------------- A-5
Philips Reusable Sensors ------------------------------------------------------- A-5
Adapter Cables --------------------------------------------------------------------- A-6
B. Default Settings
B-1
Alarm Default Settings ---------------------------------------------------------------- B-2
ECG, Arrhythmia, ST and QT Default Settings --------------------------------- B-3
Configuration Default Settings at the MX40 ------------------------------------- B-5
D-1
ra
ft
D. Sales and Support Offices
op
C-1
C. MX40 2.4GHz WLAN Radio
ISM Radio ---------------------------------------------------------------------------- C-1
Contents - 5
op
ft
ra
Contents - 6
1.
Introducing the IntelliVue
MX40
This section introduces the IntelliVue MX40 wearable monitor.
MX40 Features ........................................................................................... 1-2
MX40 Models ............................................................................................. 1-3
ra
ft
op
MX40 Compatibility .................................................................................. 1-4
Introducing the IntelliVue MX40
1-1
MX40 Features
Easy for clinicians to use and comfortable for patients to wear.
2.8" color, touch sensitive display.
Smart, multi-measurement cable system available for use with reusable
and single-patient use supplies.
FAST SpO2 (continuous, or manual measurement).
EASI or standard ECG selectable in one device.
6-lead with two V-leads for diagnosing multiple cardiac abnormalities,
including wide-QRS complex tachycardias and acute myocardial
ischemia/infarction.
op
Local measurement trend/alarm history.
Local alarming for measurements (requires IntelliVue Information
Center Release N or later).
Integrated Smart-hopping radio.
ft
Integrated Short-Range Radio (SRR).
Communication with IntelliVue Patient Monitors and Cableless
Measurements via Short-Range Radio connection (MP5/MP5T/MP5SC,
MP2 and X2 monitors only).
ra
Powered by three AA batteries or rechargeable lithium-ion battery
pack.
Audio feedback for out-of-range and lost device.
Battery gauge on device and at Information Center.
Alarm suspend and resume from standby at device and Information
Center.
Pouch with clear front that closes securely.
Note — Unlike a traditional bedside monitor which operates on AC power,
the MX40 is powered by battery and provides time-limited screen display
and local alarming.
1-2
Introducing the IntelliVue MX40
MX40 Models
ra
ft
op
The MX40 is available in three models (ECG only, ECG and FAST SpO2, or
ECG and SpO2 Ready (for future upgrade).
Introducing the IntelliVue MX40
1-3
MX40 Compatibility
The MX40 is compatible for use with IntelliVue Information Center Release
N. Limited compatibility is offered when used with IntelliVue Information
Center Release L or M. See the "Operating with Release L or M" chapter for
more information.
The MX40 is compatible for use with IntelliVue Patient Monitors Release G
or later when wirelessly connected.
The MX40 is compatible for use with IntelliVue Cableless Measurements
Release A.1.
ra
ft
op
The MX40 Patient Cable is compatible for use with IntelliVue Patient
Monitor platforms MP2/X2, MP5/MP5T/MP5SC, MP20/30 with MMS or X2,
MP40/50 with MMS or X2, MP60/70 with MMS or X2, MP80/90 with MMS
or X2, and MX800/700/600 with MMS or X2.
1-4
Introducing the IntelliVue MX40
2.
Product Safety
This section consolidates the general safety warnings associated with the
IntelliVue MX40. These warnings are repeated throughout the book in
context where relevant.
Safety symbols and other markings on the MX40 are also described here.
General Safety ............................................................................................ 2-2
ra
ft
op
Safety Symbols & Other Marks ............................................................... 2-4
Product Safety
2-1
General Safety
Warnings
The IntelliVue MX40 should not be used for primary monitoring in
applications where the momentary loss of the ECG is unacceptable at
the Information Center.
For continued safe use of this equipment, it is necessary that the listed
instructions are followed. Instructions in this manual in no way
supersede established medical procedures.
Do not touch the patient, or table, or instruments, during defibrillation.
The battery door must be closed during defibrillation. These steps
protect the clinician from high defibrillator voltage.
op
This device is not to be used in the vicinity of electrosurgical units
because such use may interrupt or interfere with the transmission of
signals from the MX40.
This equipment is not suitable for use in the presence of a flammable
anesthetic mixture with air, or with oxygen or nitrous oxide.
ft
This equipment is not suitable for use in an MRI environment.
Do not use patient cables with detachable lead wires that have exposed
male pins. Electrocution could result if these pins are plugged into AC
power.
ra
Do not use patient cables or accessory cables and sensors if prior visual
inspection reveals cable damage or the presence of liquid, lint or dust
inside.
The system is not completely immune from radio interference although
it is designed to minimize interference. Sources of interference that may
be a problem include failing fluorescent lights and construction
equipment. See "Electromagnetic Compatibility p. 13-6". The product
should not be used next to or stacked with other equipment. If you
must stack the product, you must check that normal operation is
possible in the necessary configuration before the product is used on
patients.
Do not rely exclusively on the audible alarm system for patient
monitoring. Adjustment of alarm volume to a low level during patient
monitoring may result in patient danger. Remember that the most
reliable method of patient monitoring combines close personal
surveillance with correct operation of monitoring equipment.
2-2
Product Safety
If the MX40 enters a continuous "boot-up" cycle, or the main display
does not appear or update, remove the device from service and contact
your service personnel.
Place the MX40 in a pouch or over clothing, or both, during patient use.
The device should not touch the patient’s skin during use.
Patients should be instructed not to open the battery compartment
while the MX40 is in use.
Failure on the part of the responsible individual hospital or institution
employing the use of this equipment to implement satisfactory
maintenance as needed may cause undue equipment failure and
possible health hazards.
op
Because the coverage range of Access Points can sometimes overlap,
including different floor levels, the IntelliVue Device Location feature is
not intended for use when attempting to locate a patient.
ra
ft
Short-range radio connections are subject to interruption due to
interference from other radio sources in the vicinity, including
microwaves, bluetooth devices, and DECT phones. Outside the
frequency band and 5% above and below, i.e. the exclusion band
according to IEC 60601-1-2, the short-range radio connection is immune
up to 3V/m in the frequency range from 80MHz to 2.5 GHz. Depending
on the strength and duration of the interference, the interruption may
occur for an extended period. Any interruption of the signal due to
interference, moving out of range, or for other reasons is indicated with
a Tele Disconnected INOP message on the IntelliVue Patient Monitor.
Caution
Philips recommends that when using a pouch to attach the MX40 to your
patient that you consider your patient's condition and are careful about
placement of the straps as the straps could present a strangulation hazard.
Product Safety
2-3
Safety Symbols & Other Marks
The table below describes the safety symbols and other markings present on the MX40 and the
lithium-ion battery.
Label
Definition
FCC ID:
Federal Communications
Commission (FCC) ID
IC:
Canadian ID
op
Federal Communications
Commission (FCC)
Grant of Equipment Authorization
CE Mark (MX40)
ft
Compliance to Council
Directive
93/42/EEC (Medical
Device Directive)
Class 2 Radio Equipment
Identifier (1999/5/EC)
CE Mark (Rechargeable Lithium-ion
Battery)
ra
Compliance to Council Directive
2004/108/EC (EMC Directive)
Non-Ionizing Radiation
Interference to electronic equipment
may occur in the vicinity of devices
marked with this symbol.
Disposal
Dispose of in accordance with the
local country’s requirements.
Follow operating instructions.
2-4
Product Safety
Label
Definition
Prescription Device
Canadian and American standards
compliance
Complies with applicable Canadian
and American safety standards.
Defibrillation Proof
op
Patient connections are protected
against defibrillation
(DEFIBRILLATION-PROOF) and are a
TYPE CF APPLIED PART.
Product Number
ra
ft
Serial Number
Used to identify the equipment during
a call to the Philips Healthcare
(Service).
MAC Address
Date of Manufacture
Battery Polarity
IPX Waterproof Rating
2D Barcode
Underwriter's Laboratories Listed
Component
Product Safety
2-5
Label
Definition
Service Identification Number
Used to identify the equipment during
a call to the Philips Healthcare
(Service).
ra
ft
op
Attention! See Instructions for Use.
2-6
Product Safety
3.
Basic Operation
This section gives you an overview of the IntelliVue MX40 and its
functions. It tells you how to perform tasks that are common to all
measurements, such as turning a measurement on and off, adjusting wave
size and information in preparation for use.
op
Familiarize yourself with all instructions including warnings and cautions
before starting to monitor patients. Read and keep the Instructions for Use
that come with any accessories as these contain additional important
information.
Controls, Indicators and Connectors ...................................................... 3-2
Operating and Navigating ....................................................................... 3-7
ft
Understanding Settings .......................................................................... 3-10
Battery Information ................................................................................. 3-12
Pouch Use ................................................................................................. 3-19
Telemetry Mode Use ............................................................................... 3-23
Monitoring Mode Use ............................................................................. 3-24
ra
Briefing the Patient .................................................................................. 3-25
Basic Operation
3-1
Controls, Indicators and Connectors
This section describes the clinical controls of the IntelliVue MX40. These
controls include buttons, display icons, visual and auditory indicators,
ports, and safety labeling located on the front and back of the device.
MX40 Controls and Indicators
1. Patient Cable
2. Patient Information Area
op
3. Active Alarms Area
4. INOP Area
5. Measurement Area 1
6. Measurement Area 2
ra
ft
7. Waveform 1
3-2
Basic Operation
8. Waveform 2
9. Radio/Network/Battery Status
Area
10. Leads Off Status Area
11. Silence Alarms Button
12. SmartKeys Button
13. Main Screen Button
14. Multi-Function Button
Multi-Function Button
Button
Function
Depending on configuration at the Information
Center:
generates a Nurse Call;
Initiates a Delayed Recording;
Both, or;
None
Note — the Multi-Function Button does not operate
Silence Alarm Button
Button
op
when paired with an IntelliVue Patient Monitor via
the short-range radio connection.
Function
ft
Initiates a local silence/acknowledgment of
all active alarms when enabled.
Silences the "Find Device" sound.
Note — Alarms at the MX40 can be silenced
ra
from the Information Center.
SmartKeys Button
Button
Function
Displays the SmartKey Menu on the touch
screen.
Basic Operation
3-3
Main Screen Button
Button
Function
Activates the Touch Display if touched for two
seconds.
Cycles through the display screens if touched
repeatedly.
Resumes from Standby.
SmartKeys
op
The following table lists the SmartKeys available on the display of the
MX40.
Note—gray text on a SmartKey signifies that the item is unavailable.
SmartKey
Function
Start SpO2
Starts a manual SpO2 measurement.
ft
Note — This
ra
SmartKey is
unavailable
when SpO2
mode is
continuous.
3-4
Basic Operation
Delay Record
Starts a delayed recording at the
Information Center.
Alarms
Review of up to 50 previous alarm
conditions. Pause Alarms for
configured time period (if enabled at
the Information Center).
Mode:
Telemetry /
Mode: Monitor
Toggles between modes. In
Telemetry Mode, display and audio
are off; in Monitor Mode, display and
audio are always on.
Function
Standby
Puts the device into standby locally
and at the Information Center.
Displays purchased/enabled product
options.
Add/Remove
Displays available monitors and
IntelliVue Cableless Measurements
to assign to via the short-range radio.
Print Reports
Prints the pre-configured report as
designated at the Information Center.
Vitals Trends
(Optional)
View up to 24 hours of tabular trend
data.
Screen Setup
Determines time period that the
display remains active after user
interaction.
op
SmartKey
Locks/Unlocks the display.
Op Mode
Selects either Monitoring, Demo,
Config or Service modes.
ft
Lock/Unlock
Alarms Area
ra
The Alarm Area of the MX40 displays
physiological alarms and technical alarms.
A multiple alarm indicator (down arrow) is
displayed when multiple alarm conditions
are present.
A check mark in front of the alarm text
signifies that the alarm has been
acknowledged by touching the Silence
Alarms button.
Alarm Indicators display in the Patient
Information Area in place of the time clock
when alarm/INOP conditions are present
but have not been acknowledged.
Touching the Alarms Area displays a list of
all active alarms.
The alarms paused icon communicates
whether the alarm system is on/off.
Local Alarm Audio is off when the alarm
volume symbol
is present.
Basic Operation
3-5
Patient Information Area
Touching the Patient Information Area displays the following information:
Bed Label
Patient Name (up to 15 characters will display)
Paced Status (see Paced Status below)
Time
Gender/Type (Male/Female and Adult/Pediatric)
op
MRN (Lifetime ID, Encounter ID)
Note — If you use an alternative ID, it will display at the Information Center and on
printed reports. It will not display at the MX40.
1. Pacing algorithm is on.
2. Pacing algorithm is off.
ra
ft
Paced Status
Display Lock
The Lock symbol appears in the lower left of the display when
the MX40 is in a locked state after five minutes of non-use.
Locking the display provides additional protection against
accidental patient access. The display is unlocked using the
SmartKeys menu.
Status Area
The status area of the MX40 displays short-range radio
connection (optional) and system wireless connection
status. You can also view battery strength for the type
of battery used in the device, AA or rechargeable
Li-on.
3-6
Basic Operation
Operating and Navigating
The principle method of operating your MX40 is via the Touch Display.
Almost every element on the is interactive. Display elements include
measurement numerics, information fields, alarm fields, waveforms,
SmartKeys and menus.
Power-On Self Test
op
Once battery power is supplied, the MX40 performs a power-on self test to
check operational status prior to start-up. Should a failure be detected, an
INOP tone will sound and if possible, the appropriate INOP message for
the failure will be communicated to the Information Center and displayed
locally.
A successful power-on self test will then transition the MX40 to the start-up
screen. Selectable background colors can be configured and display on the
screen for assistance with device identification. This can be helpful when
devices are in a pooled use setting.
ft
If the MX40 enters a continuous "boot-up" cycle or the main display does
not appear or update, ensure that you are using a freshly charged
lithium-ion battery or new disposable batteries. If the batteries are fresh and
the device reboots or does not update, remove the device from service and
contact your service personnel.
ra
You must visually check that a waveform is present on the display. You can
access further status information is by touching the status area on the
display.
Navigating
Touching the Navigation Bar on the right of the display will scroll through
additional display items. Solid downward arrows indicate there are
additional elements that are not currently displayed. The arrows briefly
illuminate when touched. Your selection from the menu also illuminates
when touched.
Basic Operation
3-7
Selecting Display Elements
Touch a display element to get to the actions linked to that element. For
example, touch the Patient Information element to call up the Patient Info
window, or touch the HR numeric to call up the Setup ECG menu. Touch
the ECG waveform to call up the wave selection menu.
Locking the Display
op
To provide additional protection against accidental patient access to the
MX40, the display can be locked using the Lock SmartKey. When Lock is
selected, the SmartKey menu automatically changes to the Main Screen.
When Unlock is selected, you must close the SmartKey menu to return to
the Main Screen.
The display automatically locks when there is no interaction for five
minutes.
Function
Display
Display
Locked/Active Locked/Inactive
Display
Unlocked/Active
Display
Unlocked/Inactive
Display Touch
No
Yes
No
Main Screen
Button
No
Yes
Yes
Yes
No
Yes
No
No
Yes
No
No
ra
Silence Button
ft
SmartKeys Button Yes
No
Measurement Area
The measurement area of the MX40 display is optimized to show available
parameter numerics, waveforms, and alarm limits. Each element is a touch
object and when you select it, further controls and menus become available.
Measurement Area Display Configurations
The display of your MX40 is configured/can operate in one of four available
orientations:
Portrait - One Waveform and four Numerics
Portrait - Two Waveforms and two Numerics
Landscape - Two Waveforms and three Numerics
3-8
Basic Operation
Portrait - Viewable Chest Diagram and two Numerics
Connecting/Disconnecting the Patient Cable
ft
op
The patient cable is connected to the MX40 as shown in the illustration
below.
When connecting to the MX40, there is a slight clicking sound that signifies
the the cable is securely connected.
ra
Disconnect the patient cable as shown below.
Caution
Never disconnect the patient cable by pulling on the leadwires, as this may
damage wires over time.
Basic Operation
3-9
Understanding Settings
Each aspect of how the MX40 works and looks is defined by a setting. There
are a number of different categories of settings, including:
Screen Settings - to define the selection and appearance of elements on
each individual display screen.
Measurement Settings - to define setting unique to each measurement,
e.g. high and low alarm limits.
Monitor Settings -including settings that affect more than one
measurement or display screen, for example alarm volume and alarm
pause time.
op
You must be aware that, although many settings can be changed during
use, permanent changes to settings can only be done in Configuration
Mode. All settings are restored to their default setting when the patient is
discharged or the MX40 is powered off.
ft
Changing Measurement Settings
Each measurement has a setup menu in which you can adjust all of its
settings. You enter the setup menu by selecting the measurement numeric.
ra
ECG Settings at the MX40
3-10
Setting
Description
Alarm Limits
Heart Rate alarm limits can be viewed locally
at the MX40. Limits set at the Information
Center (Release N or later) are reflected at
the MX40 when connected on the network.
Primary
(used for arrhythmia analysis only)
I,II, III, aVR, aVL, aVF, V1-V9, MCL, V3R,
V4R, V5R. Available waveforms are based
on lead set type. Lead II is the default.
Secondary
(used for arrhythmia analysis only)
I,II, III, aVR, aVL, aVF, V1-V9, MCL, V3R,
V4R, V5R. Available waveforms are based
on lead set type. Lead V is the default.
Paced Mode
Yes, No
Adjust Size
Set ECG gain to x1/2, x1, x2, x4
Arrhythmia
Initiate an Arrhythmia Relearn; View
Arrhythmia Alarm Limits; Turn Arrhythmia
Annotation On/Off.
Lead Placement
Set EASI, Standard
Basic Operation
Description
ECG
Set ECG On/Off
New Lead Setup
When IntelliVue Patient Monitor lead sets are
in use, selects 3-wire, or 5-wire.
Va Lead
Shows position of Va, Vb or C1, C2
electrodes. Choices are V1-V9, v3R, V4R,
V5R.
Vb Lead
Shows position of Va, Vb or C1, C2
electrodes. Choices are V1-V9, v3R, V4R,
V5R.
Change Numeric
Selects parameter numeric to display in
place of current HR numeric.
op
Setting
Waveform Settings at the MX40
Setting
Description
ra
Wave 2
Primary, Secondary, I, II, III, aVR, aVL, aVF,
V1-V9, MCL, V3R, V4R, V5R. Available
waveforms are based on patient cable type.
Lead II is the default. If Primary or Secondary
are selected, then the waveform displayed is
the waveform configured as primary or
secondary for arrhythmia analysis.
ft
Wave 1
Primary, Secondary, I,II, III, aVR, aVL, aVF,
V1-V9, MCL, V3R, V4R, V5R, Pleth (if SpO2
is available). Available waveforms are based
on patient cable type. Lead V is the default.Iif
Primary or Secondary are selected, then the
waveform displayed is the waveform
configured as primary or secondary for
arrhythmia analysis.
Primary or secondary waveform configuration changes made at the
Information Center change the MX40.
Basic Operation
3-11
Battery Information
Battery Safety Information
Warnings
The battery compartment door must be closed during defibrillation.
Use the Philips Rechargeable Lithium-ion Battery or 3 Duracell Alkaline
batteries, size AA, MN 1500, 1.5V, to ensure specified performance and
correct battery gauge reporting. Outdated, mismatched, or poor-quality
batteries can give unacceptable performance (e.g., insufficient
Battery-Low warning time). If you are using disposable batteries, the
use of fresh high-quality alkaline batteries is strongly recommended.
op
Certain failure conditions, such as short circuits, can cause a battery to
overheat during use. High temperatures can cause burns to the patient
and/or user. If the MX40 becomes hot to the touch, remove it from the
patient and place it aside until it cools. Then remove the batteries and
discard them. Have the MX40 checked by your service provider to
identify the cause of overheating.
ft
If you receive a BATTERY LOW or REPLACE BATTERY alarm, the
batteries must be promptly replaced. If these conditions are not
corrected, they will result in a device shutdown and cessation of
monitoring.
ra
Disposable batteries should be removed from the MX40 at the end of
the battery’s useful life to prevent leakage.
If battery leakage should occur, use caution in removing the battery.
The leaked substance may cause eye or skin irritation. Avoid contact
with skin. Clean the battery compartment according to the instructions
in the Maintenance section. Wash hands.
To eliminate the risk of electrical shock or burn, do not carry loose
batteries on your person, e.g. in clothing pockets.
Caution
Use of AA Lithium batteries or batteries with terminal voltage >1.6V may
cause damage to the device.
3-12
Basic Operation
Lithium-ion Rechargeable Battery Care
Care of the rechargeable battery begins when you receive a new battery for
use and continues throughout the life of the battery. The table below lists
battery care activities and when they should be performed.
When to Perform
Perform a visual inspection.
Before inserting a battery in the
MX40.
Charge the battery.
Upon receipt, after use, or if a low
battery state is indicated. To optimize
performance, a fully (or almost fully)
discharged battery should be charged
as soon as possible.
Clean the battery
At each patient discharge, or in cases
when the battery is exposed to
contaminants.
op
Activity
When not in use for an extended
period of time.
Decommission the battery
When any of the following INOPs are
displayed on the MX40:
ft
Charge stored batteries to at least
40% of their capacity every six
months.
TELE SERVICE BATTERY
TELE CHECK BATT TEMP
TELE REMOVE BATT
ra
Rechargeable batteries are charged using the IntelliVue CL Charging
Station. For information on charging station use, see Charging Li-ion
Rechargeable Batteries p. 12-7 .
Lithium-ion Rechargeable Battery Handling Precautions
Lithium-ion batteries store a large amount of energy in a small package.
Use caution when handling the batteries; misuse or abuse could cause
bodily injury and/or equipment damage.
Do not short circuit - take care that the terminals do not contact metal
(e.g. coins) or other conductive materials during transport and storage.
Do not crush, drop or puncture - mechanical abuse can lead to internal
damage and internal short circuits that may not be visible externally.
Do not apply reverse polarity.
Do not incinerate batteries or expose them to temperatures above 60oC
(140oF).
Basic Operation
3-13
If a battery has been dropped or banged against a hard surface, whether
damage is visible externally or not:
discontinue use.
dispose of the battery in accordance with the disposal instructions.
Lithium-ion Rechargeable Battery Storage
When storing rechargeable batteries, make sure that the battery terminals
do not come into contact with metallic objects or other conductive
materials.
op
If batteries are stored for an extended period of time, they should be stored
in a cool, dry place, ideally at 15oC (60oF), with a state of charge of 20% to
40%. Storing batteries in a cool place slows the aging process.
The batteries should not be stored at a temperature outside the range of
-20oC (-4oF) to 50oC (122oF).
ft
Stored batteries should be should be charged to at least 40% of their
capacity every 6 months.". They should be charged to full capacity prior to
use.
ra
Note — Storing batteries at temperatures above 38oC (100oF) for extended
periods of time could significantly reduce the batteries' life expectancy.
Inserting/Removing Batteries
Warning
Arrhythmia relearning is initiated whenever the MX40 is powered down
for one minute or longer. Be sure to check your patient’s arrhythmia
annotation for accuracy whenever relearn has occurred.
Caution
Remove the batteries before storing the MX40 for an extended period of
time.
3-14
Basic Operation
The battery compartment is located on the back of the MX40, accessible by
opening the compartment door from the bottom. It accommodates three
AA 1.5V Alkaline batteries or the Philips Rechargeable Lithium-ion battery.
Only these batteries should be used.
Note— Lithium-ion batteries should be fully charged prior to first use.
Important— Do not use other rechargeable batteries. Use of this type of
battery will adversely affect:
Battery gauge performance
Battery low warnings
Battery life performance
op
Inserting Batteries
 Insert batteries into the MX40 using the following
procedure.
Open the battery compartment by lifting up on both bottom sides of the
compartment door.
Insert the AA battery tray if not already present.
Insert three AA 1.5V Alkaline batteries, matching the polarity with the
+/- indications inside the compartment.
ft
ra
Note—all batteries are inserted with the + polarity in the same direction.
Basic Operation
3-15
If using the rechargeable lithium-ion battery, remove the AA battery
tray if present.
Insert the battery pack so that the raised tab is aligned with the cutout
in the base of the battery compartment. Close the battery compartment
door.
ra
ft
op
Watch for the start-up screen on the front of the MX40 to illuminate
briefly.
Removing the Batteries
Batteries should be removed when the MX40 is not in use or is being stored.
To remove the batteries, open the battery compartment door and push from
the opening at the bottom of the compartment to pop the batteries out.
Device settings (patient cable type, SpO2 mode, volume, etc.) are retained
when the batteries are removed.
3-16
Basic Operation
If you remove good AA batteries to turn off the MX40, keep them together
as a set for later re-use so that all batteries will have the same level of power
remaining.
Important— Do not "store" disposable AA batteries by leaving them in the
incorrect polarity position in the MX40.
Be careful not to short circuit the batteries. Batteries can get hot when
shorted. Short circuits are caused when a piece of metal touches both the
positive and negative terminals simultaneously. More than a momentary
short circuit will generally reduce the battery life. In case of a short circuit,
discard the batteries, or just the shorted one if the batteries are new.
Disposal of Batteries
op
When disposing of batteries, follow local laws for proper disposal. Dispose
of batteries in approved containers. If local regulations require you to
recycle batteries, recycle batteries in accordance with those regulations.
Battery Charge Status
ft
The battery charge indicator displays in the Status Area and communicates
the remaining battery charge time when using both AA batteries or the
rechargeable lithium-ion battery.
ra
When the MX40 is initially powered-on, it takes approximately 25 seconds
for the indicator to populate. During this time, the indicator displays a ? in
the battery icon.
In order to guarantee overall device performance, certain functionality is
disabled when the battery charge reaches critical levels. See the tables
below for additional information about battery status.
Lithium-ion Rechargeable Battery Charge Status
Approximate
Battery Life
Remaining
Approximate
Time
Remaining
(ECG only)
Approximate
Time
Remaining
(ECG & Spo2
Continuous)
Functionality Battery
Indicator
Disabled
LCD
Segments
100%
> 25 hours
> 9 hours
None
5 Green
75%
< 19 hours
< 7 hours
None
4 Green
50%
< 13 hours
< 5 hours
None
3 Green
25%
< 6 hours
< 2 hours
None
2 Green
10%
< 3 hours
< 1 hours
None
1 Green
Basic Operation
3-17
Approximate
Time
Remaining
(ECG only)
Approximate
Time
Remaining
(ECG & Spo2
Continuous)
Functionality Battery
Indicator
Disabled
LCD
Segments
Low battery
< 30 minutes
level to
replace/charg
e battery level
< 30 minutes
SpO2 and
short-range
radio are
disabled.
Display is at
half
brightness
1 Red
Red Battery
Icon
Audio
Replace/char
ge battery
level
< 10 minutes
Device
shutdown
1 Red
Red Battery
Icon
< 10 minutes
AA Battery Charge Status
Approximate
Time
Remaining
(ECG & Spo2
Continuous)
Functionality Battery
Indicator
Disabled
LCD
Segments
> 24 hours
> 9 hours
None
5 Green
< 18 hours
< 7 hours
None
4 Green
< 12 hours
< 5 hours
None
3 Green
< 6 hours
< 2 hours
None
2 Green
10%
< 2 hours
< 1 hours
None
1 Green
Low battery
level to
replace/charge
battery level
< 30 minutes
< 30 minutes
SpO2 and
short-range
radio are
disabled.
Display is at
half
brightness.
1 Red
Red Battery
Icon
Audio
Replace/charg
e battery level
< 10 minutes
< 10 minutes
Device
shutdown
1 Red
Red Battery
Icon
100%
75%
50%
ra
25%
Approximate
Time
Remaining
(ECG only)
ft
Approximate
Battery Life
Remaining
op
Approximate
Battery Life
Remaining
3-18
Basic Operation
Pouch Use
The MX40 is not intended for direct contact with the patient’s skin. During
normal use, the MX40 should be worn over clothing, in a pocket or,
preferably, in a pouch. The Waterproof Carry Pouch with clear front is an
appropriate means for holding the MX40. See Appendix A, "Accessories"
for ordering information.
Securing the Pouch
See the Carry Pouch, Waterproof, Instructions for Use, P/N 453564267571,
for more information.
Insert the MX40 into the pouch with lead wires and SpO2 sensor cable, if
used, exiting from the side opening of the pouch. Pinch the velcro
enclosures together to close the pouch around the cables.
ra
ft
op
Basic Operation
3-19
Seal the pouch.
Secure the pouch on the patient with the ties around the patient’s
shoulder and under the arm.
ra
ft
op
Check that the patient is comfortable wearing the pouch with the MX40.
Warning
To avoid the risk of strangulation, do not tie a pouch solely around the
patient’s neck.
3-20
Basic Operation
Showering
Warning
When the patient is showering, signal quality and leads off detection may
be compromised due to significant movement. Appropriate clinical
precautions must be taken.
Caution
Because the touchscreen display is sensitive to water impact, the display
should be locked when showering.
op
The MX40 can be used to monitor a patient in the shower, but only when
placed inside a Philips carrying pouch and secured on the patient as
described above. The combination of the MX40 and pouch will withstand
showering for up to 10 minutes.
ft
Drying the MX40 after Showering
After showering, perform the following steps to continue monitoring:
Remove the battery.
Pat dry the patient cable connections at the electrodes.
Wipe the lead wires with care.
If wet, dry the outside of the MX40 with a non-lint producing cloth.
If wet, wipe dry the inside of the battery compartment. Dry the
batteries.
If wet, disconnect the patient cable and shake out any water. Dry the
connector pin area with a cotton swab.
Re-insert the battery.
ra
Caution
The MX40 should not be used for monitoring if the battery compartment is
wet. Remove the batteries and wipe the compartment dry before continued
monitoring use.
Basic Operation
3-21
Accidental Liquid Exposure
ra
ft
op
If the MX40 is accidentally immersed in liquid, no damage to the device
and no electrical safety issues for the patient will result. Remove the device,
dry it off, and follow the procedure for cleaning/sterilization under
"Cleaning and Sterilization" as needed.
3-22
Basic Operation
Telemetry Mode Use
ra
ft
op
To minimize patient disruption, the MX40 operates in Telemetry Mode
when connected to the Information Center. In Telemetry Mode, the local
volume is set to zero and the display is off. You can activate the display at
any time by touching the Main Screen button for two seconds. All active
alarms can be viewed when the display is on. Regardless of the display
status, all measurement data is being sent to the Information Center.
Telemetry Mode is only available when connected to the Information
Center.
Basic Operation
3-23
Monitoring Mode Use
You may find the use of Monitoring Mode helpful when spending extended
time directly with your patient, e.g. during transport, showering, dressing
change. The display is always on for easy viewing and should an alarm
condition occur, it will be announced locally at the MX40 and at the
Information Center if networked connected. If the MX40 is not network
connected, the alarm is only announced locally.
 To use Monitor Mode:
Press the SmartKeys Button.
Press the Mode: Telemetry / Mode: Monitor SmartKey and choose
Mode: Monitor.
ra
ft
op
3-24
Basic Operation
Briefing the Patient
Warning
Patients should be instructed not to interact with the with display of the
device and to not open the battery compartment while the MX40 is in use.
Note — Pausing alarms at the Information Center activates the MX40
display. Patients should be notified that this is normal operation and not
cause for any concern.
op
If the Multi-Function button has been configured to generate a Nurse Call
alarm, recording at the Information Center, or both, instruct the patient to
use the button when needed.
ra
ft
If desired, you can turn off patient use of the Multi-Function button at the
Information Center. For more information see Patient Configurable Settings
in Telemetry Setup p. 9-7.
Basic Operation
3-25
op
ft
ra
3-26
Basic Operation
4.
Alarms
The section provides alarm information that applies to all measurements.
Measurement-specific alarm information is discussed in the sections on
individual measurements.
Alarms Overview ...................................................................................... 4-2
Physiologic Alarms ................................................................................. 4-10
ra
ft
op
Technical Alarms (INOPs) ..................................................................... 4-14
Alarms
4-1
Alarms Overview
The MX40 has two different types of alarms: physiological alarms and
INOPs. For MX40 devices operating with IntelliVue Information Center
Release L and M, physiological alarms are not available locally on the
MX40. INOPs are displayed as described here.
For MX40 devices operating with IntelliVue Information Center Release N,
physiological alarms are available locally on the MX40 when network
connected to the Information Center, and as configured by the Information
Center. Changes to physiological alarm settings can only be made at the
Information Center.
Physiological Alarms
INOPs
ft
op
Physiological alarms are red and yellow alarms. A red alarm indicates a
high priority patient alarm such as a potentially life threatening situation
(for example, asystole). A yellow alarm indicates a lower priority patient
alarm (for example, a low SpO2 alarm limit violation). Additionally there
are short yellow alarms, most of which are specific to arrhythmia-related
patient conditions (for example, ventricular bigeminy).
ra
INOPs are technical alarms, they indicate that the monitor cannot measure
or detect alarm conditions reliably. If an INOP interrupts monitoring and
alarm detection (for example, LEADS OFF), the monitor places a question
mark in place of the measurement numeric and an audible indicator tone
will be sounded. INOPs without this audible indicator indicate that there
may be a problem with the reliability of the data, but that monitoring is not
interrupted.
Most INOPs are light blue, however there are a small number of INOPs
which are always yellow or red to indicate a severity corresponding to red
and yellow alarms. The following INOPs can also be configured as red or
yellow INOPs to provide a severity indication:
ECG LEADS OFF
REPLACE BATTERY (when using disposable batteries)
TELE BATT EMPTY (when using the rechargeable battery pack)
All monitors in a unit should have the same severity configured for these
INOPs.
4-2
Alarms
The MX40 is designed to achieve visual alarm notification at a distance of
up to one meter, which is consistent with its intended use model as a
wearable monitor.
Alarms are indicated after the alarm delay time. This is made up of the
system delay time plus the trigger delay time for the individual
measurement. For more information see ECG Performance
Disclosure/Specifications p. 13-22 .
If more than one alarm is active, the highest priority alarm is shown. A
downward facing arrow symbol next to the alarm message informs you
that more than one message is active. The monitor sounds an audible
indicator for the highest priority alarm.
Warning
op
Visual Alarm Indicators
ft
The MX40 display is inactive for a majority of the time because it is
operating in Telemetry Mode. You must activate the screen to view any
alarms locally. The alarm message text is displayed, however, the alarm
volume setting is at zero.
Alarm Message
ra
An alarm message text appears in the alarm status area at the top of the
screen indicating the source of the alarm. If more than one alarm is
present,there is a downward facing arrow symbol at the right side. The
background color of the alarm message matches the alarm priority: red for
red alarms, yellow for yellow alarms, light blue for standard INOPs, red for
red INOPs and yellow for yellow INOPs. The asterisk symbols (*) beside
the alarm message match the alarm priority: *** for red alarms, ** for yellow
alarms, * for short yellow alarms. Standard INOPs do not have a symbol,
red and yellow INOPs have exclamation marks beside the alarm message:
!!! for red INOPs and !! for yellow INOPs.
Alarm limit violation messages are displayed in text form, for example **
SpO2 LOW.
Alarms
4-3
Alarm Indicator
An Alarm Indicator on the MX40 main display communicates alarm/INOP
conditions that have not been acknowledged. The alarm indicator is
divided into two sections and appears in the upper right hand corner
normally occupied by the time display. The right section flashes for a
physiological alarm, except for short yellow alarms where the indicator will
light for approximately six seconds. The color is yellow or red
corresponding to the highest priority alarm currently present.
op
An unacknowledged physiological alarm and INOP appears as (portrait
view):
ft
An acknowledged physiological alarm and INOP with an additional
unacknowledged physiological alarm appears as (landscape view):
ra
The left section lights continuously for a standard INOP and flashes for
INOPs configured as red or yellow alarms as follows:
INOP Color
On
Off
Yellow
1.0 seconds
1.0 seconds
Red
0.25 seconds
0.25 seconds
If only patient alarms are present, and no INOPs, the patient alarms will
use both left and right sections to flash (for red and yellow alarms) or light
for approximately six seconds (for short yellow alarms). If only INOPs are
present, and no patient alarms, red and yellow INOPs will use both left and
right sections to flash, but standard INOPs will always light continuously in
the left section only.
Once all alarm/INOP conditions are acknowledged, the time display
reappears.
Flashing Numeric
The numeric of the measurement in alarm flashes.
4-4
Alarms
Audible Alarm Indicators when in Monitoring Mode
The audible alarm indicators configured for your monitor depend on which
alarm standard applies in your hospital. Audible alarm indicator patterns
are repeated until you acknowledge the alarm by switching it off or
pausing it, or until the alarm condition ceases (if audible alarm indication is
set to non-latching).
Warning
op
Do not rely exclusively on the audible alarm system for patient
monitoring. Adjustment of alarm volume to a low level or off during
patient monitoring may result in patient danger. Remember that the
most reliable method of patient monitoring combines close personal
surveillance with correct operation of monitoring equipment.
ft
No audible alarm indicators are available when the MX40's volume
setting is zero or when operating in Telemetry Mode. Audible alarm
indicators become active as soon as the MX40 is no longer connected to
the Information Center.
Traditional Audible Alarms (HP/Agilent/Philips/Carenet)
Red alarms and red INOPs: A high pitched sound is repeated once a
second.
ra
Two-star yellow alarms and yellow INOPs: A lower pitched sound is
repeated every two seconds.
One-star yellow alarms (short yellow alarms): The audible indicator is
the same as for yellow alarms, but of shorter duration.
Standard INOPs: an INOP tone is repeated every two seconds.
ISO/IEC Standard Audible Alarms
Red alarms and red INOPs: A high pitched tone is repeated five times,
followed by a pause.
Two-star yellow alarms and yellow INOPs: A lower pitched tone is
repeated three times, followed by a pause.
One-star yellow alarms (short yellow alarms): The audible indicator is
the same as for yellow alarms, but of shorter duration.
Standard INOPs: a lower pitched tone is repeated twice, followed by a
pause.
Alarms
4-5
Acknowledging Alarms
To acknowledge all active alarms and INOPs, touch the Silence Alarm
button. This switches off the audible alarm indicators, if present, and alarm
messages.
A check mark beside the alarm message indicates that the alarm has been
acknowledged .
If the condition that triggered the alarm is still present after the alarm has
been acknowledged, the alarm message stays on the screen with a check
mark symbol beside it, except for NBP alarms and alarms from other
intermittent measurements. When such an alarm is acknowledged the
alarm message disappears.
op
If the alarm condition is no longer present, all alarm indicators stop and the
alarm is reset.
Switching off the alarms for the measurement in alarm, or switching off the
measurement itself, also stops alarm indication.
ft
Pausing or Switching Off Alarms
ra
If you want to temporarily prevent alarms from sounding, for example
while you are moving a patient, you can pause alarms, if configured.
Depending on your MX40 configuration, alarms are paused for one, two or
three minutes.
To Pause All Alarms
Select the Alarms SmartKey and select Pause Alarms. A timer on the
display shows the remaining pause time.
To Switch Individual Measurement Alarms On or Off
Select the measurement numeric to enter its setup menu.
Select Alarms to switch between on and off
The alarms off symbol is shown beside the measurement numeric.
While Alarms are Paused
In the alarm field, the monitor displays the message ALARMS PAUSED
1:28 or ALARMS OFF, together with the alarms paused symbol or the
alarms off symbol.
4-6
Alarms
No alarms are sounded and no alarm messages are shown.
INOP messages are shown but no INOP tones are sounded.
The only exceptions are the INOPs CUFF NOT DEFLATED, NBP CUFF
OVERPRESS and INOPs relating to empty, missing and malfunctioning
batteries.
These INOPs switch the alarms on, and the INOP tones are sounded,
even if alarms are paused or off. You need to remove the INOP
condition first before you can switch the alarm tones off again.
Restarting Paused Alarms
Alarm Limits
op
To manually switch on alarm indication again after a pause, select Pause
Alarms.
ft
The alarm limits you set determine the conditions that trigger yellow and
red limit alarms. For some measurements (for example, SpO2), where the
value ranges from 100 to 0, setting the high alarm limit to 100 switches the
high alarm off, or setting the low alarm limit to 0 switches it off. In these
cases, the alarms off symbol is not displayed.
ra
Warning
Be aware that the monitors in your care area may each have different alarm
settings, to suit different patients. Always check that the alarm settings are
appropriate for your patient before you start monitoring.
Viewing Individual Alarm Limits
You can see the alarm limits set for each measurement next to the
measurement numeric on the main screen.
Alarms
4-7
Changing Alarm Limits
 To change individual measurement alarm limits using
the measurement's Setup Menu:
In the measurement's setup menu, select the alarm limit you want to
change. This calls up a list of available values for the alarm limit.
Select a value from the list to adjust the alarm limit.
Reviewing Alarms
You can see which alarms and INOPs are currently active in the respective
alarms and INOPs fields at the top of the screen.
op
To see the currently active alarms and INOPs listed in one place, touch the
Alarms area.
ft
All alarms and INOPs are erased from the Alarm Messages window when
you discharge a patient, or if you change to Demonstration Mode.
Review Alarms Window
ra
The Review Alarms window contains a list of the 50 most recent alarms and
INOPs with date and time information.
The Review Alarms window also shows when alarms are paused or
silenced.
Note — Alarms that occur during an alarm suspend period will appear in
the Review Alarm window, however, they are not communicated to the
Information Center.
Latching Alarms
The alarm latching setting for your MX40 defines how the alarm indicators
behave when you do not acknowledge them. When alarms are set to
non-latching, their indicators end when the alarm condition ends.
Switching alarm latching on means that visual and/or audible alarm
indications are still displayed or announced by the monitor after the alarm
condition ends. The indication lasts until you acknowledge the alarm by
touching the Alarm Silence button.
4-8
Alarms
Alarm Latching Behavior
Red & Yellow Measurement Alarms
Alarm has not been
acknowledged.
Visual and
Audible Latching
Alarm condition still Alarm tone on. Alarm Alarm tone on.
message. Flashing
Alarm message.
present.
numerics.
Flashing numerics.
Alarm condition no
longer present.
All audible and visual Alarm tone on.
alarm indicators
Alarm message .
automatically stop.
Flashing numerics.
Alarm condition still Alarm tone off. Alarm
message with check
present.
mark. Flashing
numerics. Audible
alarm reminder (if
configured)
Alarm tone off.
Alarm message
with check mark.
Flashing numerics.
Audible alarm
reminder (if
configured)
Alarm condition no
longer present.
Audible and visual
alarm indicators
automatically stop.
op
Alarm has been
acknowledged.
Non-latching
Alarms
ft
Audible and visual
alarm indicators
automatically stop.
Alarm Behavior at Power On
ra
If the MX40 is powered off for longer than one minute and then powered
on again (or after a loss of power lasting longer than one minute, or when a
patient is discharged), the device restores the alarm settings from the
monitor's configured default settings.
If power is lost for less than one minute, the alarm on/off condition prior to
the power loss is restored.
Alarms
4-9
Physiologic Alarms
Physiologic alarms indicate a life-threatening situation or a less urgent
situation such as heart rate beyond limits.
Warning
Do not rely exclusively on the audible alarm system for patient
monitoring. Adjustment of alarm volume to a low level during patient
monitoring may result in patient danger. Remember that the most
reliable method of patient monitoring combines close personal
surveillance with correct operation of monitoring equipment.
op
ST and QT related alarm messages appear at the Information Center
only.
ft
Arrhythmia alarm chaining and customizing arrhythmia alarm settings are
described in the ECG and Arrhythmia Monitoring chapter. There are two
levels of arrhythmia analysis available: Basic and Enhanced. Enhanced
analysis includes Basic alarms.
The MX40 provides physiological alarms based on the settings at the
Information Center, Release N or later. Alarming is not active on the MX40
until it is configured via an active association with the Information Center.
ra
In the following table, Red (***) alarms are listed alphabetically, followed by
the Yellow (**) alarms, and the Yellow (*) alarms.
Alarm Text
Priority
Condition
Source
*** ASYSTOLE
Red
Asystole.
No QRS for 4 consecutive seconds
ST/AR
Basic &
Enhanced
Arrhythmia
*** BRADY yyy < xxx
Red
Extreme Bradycardia.
Heart Rate (yyy) less than Extreme
Brady limit (xxx)
ST/AR
Basic &
Enhanced
Arrhythmia
*** DESAT
Red
Very Low SpO2 Saturation.
SpO2 value below Desaturation limit
SpO2
Note— Desat limit is set 10 points
below low limit.
4-10
Alarms
Priority
Condition
*** TACHY yyy > xxx
Red
Extreme Tachycardia.
ST/AR
Heart Rate (yyy) greater than Extreme Basic &
Enhanced
Tachy limit
Arrhythmia
*** V-FIB/TACH
Red
Ventricular Fibrillation.
Fibrillatory wave (sinusoidal wave
between 2-10 Hz) for 4 consecutive
seconds
ST/AR
Basic &
Enhanced
Arrhythmia
*** V-TACH
Red
Ventricular Tachycardia.
Consecutive PVCs greater than or
equal to V-Tach Run limit and Heart
Rate greater than V-Tach limit (xxx)
ST/AR
Basic &
Enhanced
Arrhythmia
*/**AFIB
Yellow
Atrial fibrillation waveform detected
ST/AR
Enhanced
Arrhythmia
**NBP High
Yellow
**NBP Low
Yellow
** SpO2T yyy > xxx
Yellow
** SpO2T yyy < xxxx
Yellow
op
Alarm Text
High limit has been exceeded for high
pressure limit
NBP
Low limit has been exceeded for low
pressure limit
NBP
High SpO2.
SpO2 value (yyy) greater than high
SpO2 limit (xxx).
SpO2
Low SpO2.
SpO2
ft
ra
* HR yyy > xxx
* HR yyy < xxx
Yellow
Yellow
Source
SpO2 value (yyy) less than low SpO2
limit (xxx).
Heart Rate (yyy) greater than the
upper Heart rate limit (xxx).
ST/AR
Basic &
Enhanced
Arrhythmia
Heart Rate (yyy) lower than the lower
Heart Rate limit (xxx).
ST/AR
Basic &
Enhanced
Arrhythmia
* IRREGULAR HR
Yellow
Consistently irregular rhythm (irregular ST/AR
R-R intervals).
Enhanced
Arrhythmia
* MISSED BEAT
Yellow
No beat detected for 1.75 x average
R-R interval for Heart Rate greater
than 120, or no beat for 1 second with
Heart Rate greater than 120
(non-paced patient only).
ST/AR
Enhanced
Arrhythmia
Alarms
4-11
Alarm Text
Priority
Condition
Source
* MULTIFORM PVCs
Yellow
The occurrence of two differently
shaped Vs, each occurring at least
twice within the last 300 beats as well
as each occurring at least once within
the last 60 beats.
ST/AR
Enhanced
A run of Vs having a ventricular Heart
Rate greater than V-Tach limit but
lasting for less than the V-Tach Run
limit.
ST/AR
Enhanced
* NON-SUSTAIN VT
Yellow
Yellow
The patient has pressed the
Multi-Function Button on the MX40.
* PACER NOT CAPT
Yellow
No QRS for 1.75 x the average R-R
interval with Pace Pulse (paced
patient only).
* PAIR PVCs
Yellow
Yellow
ra
* PAUSE
Yellow
* PVCs >xxx/MIN
* R-ON-T PVCs
* RUN PVCs
No QRS and Pace Pulse for 1.75 x
the average R-R interval (paced
patient only).
ft
* PACER NOT PACE
op
*Nurse Call
Yellow
Yellow
Yellow
Two consecutive PVCs between
non-PVCs.
No QRS detected for x seconds.
Choices of >1.5 to 2.5 seconds.
Arrhythmia
Arrhythmia
ST/AR
Basic &
Enhanced
Arrhythmia
ST/AR
Basic &
Enhanced
Arrhythmia
ST/AR
Enhanced
Arrhythmia
ST/AR
Enhanced
Arrhythmia
PVCs within one minute exceed by
the PVCs/min limit (xxx).
ST/AR
Basic &
Enhanced
Arrhythmia
For Heart Rate less than 100, a PVC
with R-R interval less than 1/3 the
average interval followed by a
compensatory pause of 1.25 x
average R-R interval, or 2 such Vs
without a compensatory pause
occurring within 5 minutes of each
other. (When Heart Rate is greater
than 100, 1/3 R-R interval is too short
for detection.)
ST/AR
Enhanced
Run of PVCs greater than or equal to
2.
ST/AR
Enhanced
Arrhythmia
Arrhythmia
4-12
Alarms
Alarm Text
Priority
Condition
Source
* SVT
Yellow
Run of SVPBs greater than or equal
to SVT Run limit and with SVT Heart
Rate greater than the SVT Heart Rate
limit.
ST/AR
Enhanced
Arrhythmia
* VENT BIGEMINY
Yellow
A dominant rhythm of N, V, N, V
(where N= supraventricular beat,
V=ventricular beat).
ST/AR
Enhanced
A dominant rhythm of adjacent Vs
greater than Vent Rhythm limit and
ventricular Heart Rate less than
V-Tach limit.
ST/AR
Enhanced
A dominant rhythm of N, N, V, N, N, V
(where N=supraventricular beat,
V=ventricular beat).
ST/AR
Enhanced
* VENT RHYTHM
Yellow
Yellow
Arrhythmia
Arrhythmia
ra
ft
op
* VENT TRIGEMINY
Arrhythmia
Alarms
4-13
Technical Alarms (INOPs)
Technical Alarms, or INOPs (inoperative conditions), are sourced at the
MX40, the ST/AR algorithm running at the Information Center, or the
IntelliVue Patient Monitor. They identify inoperative conditions (that is
conditions where the system is not operating properly and therefore cannot
measure or detect alarm conditions reliably). There are four levels of
Technical Alarms:
Severe - Monitoring and alarm generation are disabled. Visual alarm
indicator on the MX40. Audible tone at the Information Center. Must be
acknowledged by a clinician.
op
Hard - Monitoring and alarm generation are disabled. Visual alarm
indicator on the MX40. Audible tone at the Information Center.
If the hard INOP is "latched", the sound will be silenced, but the
message will remain on the display until resolution of the offending
condition.
ft
Soft - Monitoring and alarms remain active. Visual alarm indicator on
the MX40 and at the Information Center. No audible tones are
generated at the Information Center
ra
Red/Yellow - Replace Battery and ECG Leads Off INOPs may be
configured to display as either Red or Yellow Technical Alarms.
Note - The ECG Leads Off INOP will initially display as a cyan
technical alarm until a valid ECG signal is obtained.
In the following table, technical alarms are listed alphabetically.
Alarm Text
Priority
BATTERY LOW T
Soft
Source - MX40
4-14
Alarms
Condition
What to do
There is less than
15 minutes of
monitoring time
remaining (AA
batteries).
Replace batteries
promptly to avoid
shutdown and cessation of
monitoring.
Lithium-ion battery
level is < 10% or
has <30 minutes
remaining time.
Insert a charged
lithium-ion battery pack.
Alarm Text
Priority
Condition
What to do
CANNOT ANALYZE
ECG
Hard
Arrhythmia algorithm
cannot reliably analyze
the ECG data on any
monitored leads.
Assess the lead selections,
initiate relearn, and validate
analyzed rhythm. Check
other INOPs for possible
source of problem.
CHECK ECG SETTINGS Hard
Synchronization of
ECG settings between
the monitor and the
Information Center has
failed.
Check that the ECG settings
from the ECG source are
appropriate.
Source - MX40 and
Information Center
Source - MX40
Note — When transitioning
CHECK PAIRING
Yellow
Technical
Alarm
There is a problem
with device pairing.
Check that the bedside
monitor is correctly paired.
When the MX40 is
wirelessly paired
with an X2 patient
monitor (no label)
docked with a larger
networked MP
series monitor, and
the network
connection is lost.
Select the correct device
to be paired.
ra
ft
Source - MX40
op
between networked and
non-networked monitoring,
this INOP will display.
Pressing the Silence button
on the monitor will dismiss
the INOP.
cl NBP Batt Low
Hard
CL NBP Pod weak
battery condition.
Charge battery.
Severe
CL NBP Pod empty
battery condition.
Charge battery. Monitoring is
not possible.
Source - Cableless
Measurement Device
cl NBP Batt Empty
Source - Cableless
Measurement Device
Alarms
4-15
Alarm Text
Priority
Condition
cl NBP DISCONNECT
Hard
CL NBP Pod is not
connected with the
MX40.
Source - Cableless
Measurement Device
cl SpO2 Batt Low
What to do
Resolve interference
condition.
Reduce range between
CL NBP Pod and MX40.
Hard
CL SpO2 Pod weak
battery condition.
Charge battery.
Severe
CL SpO2 Pod empty
battery condition.
Charge battery. Monitoring is
not possible.
Hard
CL SpO2 Pod is not
connected with the
MX40.
Source - Cableless
Measurement Device
cl SpO2 Batt Empty
Source - Cableless
Measurement Device
ECG/ARRH ALARM
OFF
Soft
ECG is turned off.
ra
Source - MX40
ft
cl SpO2 DISCONNECT
op
Source - Cableless
Measurement Device
ECG LEADS OFF
Note This INOP may
also be configured to
display as a Red or
Yellow Technical Alarm.
Red or
Yellow or
Hard
Technical
Alarm
Multiple leads are
off.
Resolve interference
condition.
Reduce range between
CL SpO2 Pod and MX40.
Turn on ECG.
Re-attach ECG leads to
patient..
Source - MX40
 LEAD OFF
Source - MX40
4-16
Alarms
Hard
Single lead is off.
If primary lead is MCL,
lead will be identified
as V/C in INOP text.
Re-attach ECG leads to
patient.
Alarm Text
Priority
LEADSET UNPLUGGED Hard
Source - MX40
LOCAL AUDIO OFF
Soft
Source - MX40
Condition
What to do
Leadset has been
unplugged from the
MX40.
Re-attach the ECG leadset.
There is no alarm
audio notification when
operating in Telemetry
Mode.
Change to Monitor Mode.
Note — This is normal
operation in Telemetry
Mode.
Hard
ft
Source - MX40
NO ALARM DISPLAY
Soft
ra
Source - MX40
NO CENTRAL
MONITOR
(appears at MX40 only)
Source - Patient
Monitor
The paired
MX40/bedside monitor
is out of short-range
radio range or there is
excessive radio
interference.
Reduce the distance
between the devices.
op
MONIT. DISCONNECT
Hard
When operating with
Information Center
Release L Or M, there
is no local alarming at
the MX40, networked
or non-networked.
The MX40 is out of
range of the
network.
Patient Sector at the
Information Center
is in Standby.
Identify and remove
interference source.
Condition is not present when
operating with Information
Center Release N or later
(unless specifically
configured to operate in this
way).
Return the MX40 to the
coverage area.
Select Resume at the
Information Center.
Alarms
4-17
Alarm Text
Priority
NO SIGNAL
(appears at the
Information Center only)
Hard,
Latched
Condition
The MX40 is outside
the coverage area,
or
No batteries in the
MX40, or
Source - Information
Center
The MX40 has
failed.
Source - MX40
Note — This INOP may
Dead battery. No
monitoring is
occurring.
Replace the MX40 if
Power On Self Test fails.
Put bed in Standby.
Replace batteries.
When operating
wirelessly, the
patient monitor is no
longer providing
power to the MX40,
and battery capacity
is now depleted.
Source - Information
Center
ft
also be configured to
display as a Red or
Yellow Technical
Alarm.
Red or
Yellow or
Hard
Technical
Alarm,
Latched
Make sure that the MX40
is within the coverage
area and has good
batteries.
op
REPLACE BATTERY T
What to do
%SpO2T EQUIP MALF
Hard
Malfunction in the SpO2 Contact Service.
equipment
Hard
Erratic SpO2
measurements, often
due to a faulty sensor
or invalid SpO2
measurements, or
incorrect transducer
position
Repeat measurement,
reposition sensor on patient,
or finally, replace sensor.
The update period of
displayed values is
extended due to an
NBP measurement on
the same limb or an
excessively noisy
signal.
If NBP is not active, check
the sensor placement.
Reposition the sensor on
patient, or replace sensor.
Soft
Some yellow
For information only.
arrhythmia alarms have
been turned off for this
patient.
ra
SOME ECG ALARMS
OFF
Source - MX40
%SpO2T ERRATIC
Source - MX40
%SpO2T EXTD UPDATE Soft
Numeric is replaced by a
-?-.
Source - MX40
4-18
Alarms
Alarm Text
Priority
Condition
%SpO2T
INTERFERENCE
Hard
Level of ambient light
Reduce ambient light to
or level of electrical
sensor or electrical noise
interference are so
sources.
high that the SpO2
sensor cannot measure
SpO2 and pulse rate.
Soft
Accuracy may be
reduced due to low
perfusion. Data
displayed with ?.
Increase perfusion. Change
sensor site. Avoid site distal
to BP cuff or intra-arterial
line. Warm the site.
Hard
No sensor attached to
SpO2 device
Attach SpO2 sensor.
Source - MX40
%SpO2T LOW PERF
Source - Monitor
%SpO2T NO SENSOR
What to do
technical alarm turns off
the SpO2 measurement
on the MX40 only (not at
the Information Center).
Source - MX40
Source - MX40
Hard
Excessive patient
movements or
electrical interference
are causing irregular
pulse patterns
ft
%SpO2T NOISY SIGN
op
Note — Silencing this
%SpO2T NON-PULSAT
Hard
Note — When paired
ra
directly with an IntelliVue
MP5 Patient Monitor, the
INOP will display as
SpO2T SENSOR OFF.
Reduce movement or
electrical noise sources.
Pulse is too weak or
not detectable
Check connection to
patient.
Sensor has fallen off
at patient
Change sensor site. Avoid
site distal to BP cuff or
intra-arterial line.
Source - MX40
%SpO2T SEARCHING
Soft
The patient signal is
Wait for the measurement to
analyzed, but a valid
complete.
numeric is not available
yet.
%SpO2T SENSOR
MALF
Hard
Malfunction of the
SpO2 sensor/adapter
cable
Replace sensor.
Soft
Lithium-ion battery
level is < 20% or has
<30 remaining time.
Insert a charged lithium-ion
battery pack.
Source - MX40
TELE BATTERY LOW
Source - MX40
Alarms
4-19
Alarm Text
Priority
Condition
What to do
TELE BATT EMPTY
Hard,
Latched
Lithium-ion battery
level is critically low. A
10-minute countdown
begins. The MX40 will
shutdown if the
condition is not
cleared.
Insert a charged lithium-ion
battery pack.
Note — This INOP may
also be configured to
display as a Red or
Yellow Technical Alarm.
Source - MX40
Note — For
Information Center
Release L or M, this
INOP will appear as
"REPLACE BATTERY
T".
TELE BATTERY TEMP Hard
Replace the lithium-ion
battery.
op
Source - MX40
The temperature of the
lithium-ion battery is
above 55 C or below
-5 C.
Note — For
TELE CHECK BATT
Soft
Lithium-ion battery has
< 25 charge cycles
remaining before
reaching the charge
cycle maximum limit.
ra
Source - MX40
ft
Information Center
Release L or M, this
INOP will appear as
"REPLACE BATTERY
T"
TELE INCOMPATIBLE
Hard
MX40s and bedside
monitors equipped with
short-range radio
capability are not
supported with this
revision of the
Information Center
Contact Service. The
Information Center needs to
be upgraded to support this
functionality.
Hard
MX40 malfunction or
self-test failure.
Contact Service to replace
the MX40.
Hard
RF Auto Shutoff after
10 minutes of all leads
off and no SpO2 sensor
connected.
Source - Monitor
TELE MALFUNCTION
Be aware that the Lithium-ion
battery pack will soon need
replacement.
Source - MX40
TRANSMITTER OFF
Source - MX40
4-20
Alarms
Reattach ECG leads to
patient.
Reattach SpO2 sensor.
Alarm Text
Priority
Condition
What to do
TELE REMOVE BATT
Hard,
Latched
The temperature of the
lithium-ion battery is
>60 C and the battery
must be removed.
Replace the lithium-ion
battery.
Source - Monitor
Note — For
Information Center
Release L or M, this
INOP will appear as
"REPLACE BATTERY
T".
Hard
The lithium-ion battery
has exceeded the
maximum charge cycle
limit.
Soft
Patient is at outer
range of the radio
coverage area.
Source - Monitor
TELE WEAK SIGNAL
Source - MX40
Replace the lithium-ion
battery.
Return patient to the
coverage area.
op
TELE SERVICE BATT
ft
The MX40 is
receiving a weak
signal with high data
loss from the AP.
The AP covering the
specific area is suspect.
Contact Service.
ra
Condition exists for
multiple devices in a
specific area
If patient is in close
proximity to AP, replace
the MX40. Contact
service.
Alarms
4-21
op
ft
ra
4-22
Alarms
5.
ECG and Arrhythmia
Monitoring
This section covers the specifics of ECG measurement and the ST/AR
Arrhythmia, ST, and QT algorithms used for arrhythmia monitoring.
ECG Safety Information ........................................................................... 5-2
op
Measuring ECG ......................................................................................... 5-5
Connecting and Positioning ECG Electrodes ........................................ 5-6
Selecting the Primary and Secondary ECG Leads ................................ 5-7
Checking Paced Status .............................................................................. 5-8
Understanding the ECG Display............................................................. 5-9
ft
Monitoring Paced Patients ..................................................................... 5-10
Changing the Size of the ECG Wave .................................................... 5-11
Selecting Positions of Va and Vb Chest Leads .................................... 5-12
Choosing EASI or Standard Lead Placement ...................................... 5-13
ra
ECG Configuration.................................................................................. 5-14
ECG Leads Monitored ............................................................................ 5-15
Reconstructed Leads ............................................................................... 5-17
3-Wire Placement..................................................................................... 5-18
5-Wire Placement (Standard Mode)...................................................... 5-19
5-Wire Placement (EASI Mode) ............................................................. 5-20
6-Wire Placement..................................................................................... 5-21
Chest Electrode Placement ..................................................................... 5-22
Monitoring during Leads Off ................................................................ 5-23
ST/AR Arrhythmia Monitoring ............................................................. 5-25
ST/AR ST Analysis Algorithm ............................................................... 5-32
QT Interval Monitoring .......................................................................... 5-35
ECG and Arrhythmia Monitoring
5-1
ECG Safety Information
Warnings
Always confirm MX40 and Information Center observations with
clinical observation of the patient before administering interventions.
To avoid patient injury, assure that the patient cable is not positioned
where leads could become entangled around the patient, or cause
choking, strangulation, or inhibit circulation in extremities.
Every lead must be secured to an electrode on the patient. Conductive
parts of electrodes must not contact earth or other conductive parts.
op
EASI derived 12-lead ECGs and their measurements are
approximations to conventional 12-lead ECGs. As the 12-lead ECG
derived with EASI is not exactly identical to the 12-lead conventional
ECG obtained from an electrocardiograph, it should not be used for
diagnostic interpretations.
EASI lead placement is supported for adult patients only.
ft
Ensure that the patient cable is properly connected to the MX40.
Do not mix and match electrodes of different types. In particular, do not
use electrodes of dissimilar metals. This helps ensure optimal signal
quality.
ra
Non-manufacturer supplied accessories and supplies can corrupt the
performance of the equipment. Use only AAMI EC-12 compliant
electrodes with this device. Use of electrodes that are non-compliant
may provide erroneous results.
During complete heart block or pacemaker failure (to pace or capture),
tall P-waves (greater than 1/5 of the average R-wave height) can be
erroneously counted by the arrhythmia algorithm, resulting in missed
detection of cardiac arrest.
Caution
To protect the MX40 from damage during defibrillation, to ensure
accurate ECG information, and to provide protection against signal
noise and other interference, use only ECG electrodes and cables
specified by Philips.
Philips recommends that you change the lead label only to reflect the
physical placement of electrodes. This will ensure a match between the
monitored lead and the label, and prevent any possible confusion.
5-2
ECG and Arrhythmia Monitoring
Note— When switching from EASI to standard monitoring, there is a
momentary loss of data.
For Paced Patients
Warnings
The output power of the MX40 and other sources of radio frequency
energy, when used in the proximity of a pacemaker, can be sufficient to
interfere with pacemaker performance. Due to the shielding effects of
the body, internal pacemakers are somewhat less vulnerable than
external pacemakers. However, caution should be exercised when
monitoring any paced patient.
op
In order to minimize the possibility of interference, position electrodes,
electrode wires, and the MX40 as far away from the pacemaker as
possible.
ft
Consult the pacemaker manufacturer for information on the RF
susceptibility of their products and the use of their products with the
IntelliVue Telemetry System. See the IntelliVue Information Center
Instructions for Use for additional information on monitoring paced
patients.
ra
When an external pacemaker is being used on a patient, arrhythmia
monitoring is severely compromised due to the high energy level in the
pacer pulse. This may result in the arrhythmia algorithm's failure to
detect pacemaker non-capture or asystole.
Pacemakers that create fusion beats (pace pulse on top of the QRS
complex) cannot be detected by the monitor's QRS detector.
For paced patients who exhibit only intrinsic rhythm, the monitor can
erroneously count pace pulses as QRS complexes when the algorithm
first encounters them, resulting in missed detection of cardiac arrest.
The risk of missing cardiac arrest can be reduced by monitoring these
patients with the low heart rate limit at or slightly above the
basic/demand pacemaker rate. A low heart rate alarm notifies you when
the patient begins pacing. Proper detection and classification of the
paced rhythm can then be determined.
ECG and Arrhythmia Monitoring
5-3
D
ra
ft
op
Note— During defibrillation, monitoring may be temporarily interrupted
or distorted. It may take several seconds for the ECG trace to reappear on
the screen. After defibrillation, the device will continue to monitor as
before; the device settings will not be affected.
5-4
ECG and Arrhythmia Monitoring
Measuring ECG
The electrocardiogram (ECG) measures the electrical activity of the heart
and displays it on the MX40 and the Information Center as a waveform and
a numeric.
In order to compare measured ECG signals, the electrodes (or patient
cables) are placed in standardized positions, forming "leads". To obtain
ECG signals optimized for use in diagnosis and patient management in
different care environments, different leadsets in varying lead placements
are used. Both standard lead and EASI lead placements can be used with
the MX40.
ra
ft
op
The Heart Rate calculation resides in the arrhythmia algorithm on the MX40
and at the Information Center. Arrhythmia analysis is always turned on for
telemetry patients. Arrhythmia analysis is either Basic or Enhanced,
depending on the product configuration.
ECG and Arrhythmia Monitoring
5-5
Connecting and Positioning ECG Electrodes
Correct lead placement is always important for accurate diagnosis.
Especially in the precordial leads, which are close the heart, QRS
morphology can be greatly altered if an electrode is moved away from its
correct location. Each electrode is color-coded. Use the placement diagrams
available on the display of the MX40 and in this section for guidance.
Additional lead placement information is available in the Online Help at the
IntelliVue Information Center.
When placing electrodes on the patient, choose a flat, non-muscular site
where the signal will not be impacted by either movement or bones.
Philips recommends that electrodes be changed every 24 hours.
op
In addition to correct positioning of the electrodes, optimal skin preparation
prior to electrode placement will help ensure a clear signal for diagnosis.
Prepare the patient’s skin. Good electrode-to-skin contact is important
for a good ECG signal, as the skin is a poor conductor of electricity.
ft
Select sites with intact skin, without impairment of any kind.
Clip or shave hair from the site as necessary.
Wash site with soap and water, leaving no soap residue.
ra
Note— Philips does not recommend using ether or pure alcohol,
because they dry the skin and increase the resistance.
Dry thoroughly.
Use ECG skin preparation paper (abrasive) to remove dead skin
cells and to improve the conductivity of the electrode site.
Check electrodes for moist gel, and attach to the clips. If you are not
using pre-gelled electrodes, apply electrode gel to the electrodes before
placement.
Note— Gel must be moist to provide a good signal.
5-6
Place the electrodes on the patient according to the lead placement you
have chosen (see the electrode placement diagrams following). Place the
edge down, then "roll down" the rest of the pad. Press firmly around the
adhesive edge toward the center.
Attach the patient cable to the MX40. An ECG waveform and numeric
appear on the monitor display.
ECG and Arrhythmia Monitoring
Selecting the Primary and Secondary ECG Leads
The MX40 uses the primary and secondary lead selected at the Information
Center to compute HR and to analyze and detect cardiac arrhythmias. They
are also available for recordings and for display on the Information Center.
The secondary lead is used if your device is configured for multi-lead
(instead of single-lead) arrhythmia analysis.
You should choose a lead as primary or secondary lead at the Information
Center that has the following characteristics:
the QRS complex should be either completely above or below the
baseline and it should not be biphasic
op
the QRS complex should be tall and narrow
ra
ft
the P-waves and T-waves should be less than 0.2 mV
ECG and Arrhythmia Monitoring
5-7
Checking Paced Status
It is important to set the paced status correctly when you start monitoring
ECG.
When Paced is set to Yes:
Pacer Algorithm is switched on. This means that pacemaker pulses are
not counted as extra QRS complexes.
The pacer spikes are shown in white.
The paced symbol is displayed.
op
When Paced is set to No and your patient has a pacemaker, pace pulses
may be counted as regular QRS complexes, which could prevent an
asystole event from being detected.
Warning
ft
Pace pulse rejection must be switched on for paced patients by setting
Paced to Yes. Switching pace pulse rejection off for paced patients may
result in pace pulses being counted as regular QRS complexes, which
could prevent an asystole event from being detected. At
admission/discharge, always check that paced status is correct for the
patient.
ra
Some pace pulses can be difficult to reject. When this happens, the
pulses are counted as a QRS complex, and could result in an incorrect
HR and failure to detect cardiac arrest or some arrhythmias. Make sure
that pace pulses are detected correctly by checking the pace pulse
markers on the display. Keep pacemaker patients under close
observation.
5-8
ECG and Arrhythmia Monitoring
Understanding the ECG Display
op
Your display may be configured to look slightly different.
1. Lead label of the displayed wave
4. Current heart rate
2. 1 mV calibration bar
5. Current heart rate alarm limits
3. Pacer spikes
6. EASI lead placement label (located here
when active)
ft
ECG HR numeric: This is the heart rate derived from the monitored ECG.
ra
Pacer Spikes: The pacer spikes are shown in white.
ECG and Arrhythmia Monitoring
5-9
Monitoring Paced Patients
An ECG optimized for monitoring a paced patient should look like this:
1. Normal Beats
2. Pace
Pulses/Beats
You should choose a lead as primary or secondary lead that has these
characteristics:
op
the normal QRS complex should be either completely above or below
the baseline and it should not be biphasic. For paced patients, the QRS
complexes should be at least twice the height of pace pulses.
the QRS complex should be tall and narrow
ft
the P-waves and the T-waves should be less than 0.2 mV.
Avoiding Pace Pulse Repolarization Tails
ra
Some unipolar pacemakers display pace pulses with repolarization tails.
These tails may be counted as QRSs in the event of cardiac arrest or other
arrhythmias.
If you note a visible repolarization tail, choose a lead that decreases the size
of the repolarization tail.
5-10
ECG and Arrhythmia Monitoring
1. Repolarization tail
(note width)
Changing the Size of the ECG Wave
If any of the displayed ECG waves is too small or clipped, you can change
the size of the ECG waves on the screen.
Changing the adjustment factor only changes the visual appearance of the
ECG wave on the MX40. It does not affect the ECG signal analyzed by the
algorithm.
Comparing the wave size to the 1 mV calibration bar on the ECG wave
segment can help you to get an idea of the true ECG signal strength.
To change the size of the ECG waves on the screen by a fixed adjustment
factor:
In the Setup ECG menu, select Adjust Size.
Select the required adjustment factor from the line of pop-up keys.
op
Size X1/2 to halve the wave size
ft
Size X1 to display the wave without zoom
Size X2 to double the wave size
ra
Size X4 to multiply the wave size by four
ECG and Arrhythmia Monitoring
5-11
Selecting Positions of Va and Vb Chest Leads
ra
ft
op
The two chest leads for the 6-lead placement can be positioned at any two
of the V1 to V9 and V3R, V4R and V5R positions. Select the positions you
have used in the Patient Window at the Information Center, so that the
chest leads will be correctly labeled.
5-12
ECG and Arrhythmia Monitoring
Choosing EASI or Standard Lead Placement
Choose either standard lead placement or EASI lead placement:
In the Setup ECG menu, select Lead Placement to toggle between
Standard or EASI.
Select Standard or EASI.
Note — When changing lead placement, the patient cable must be attached
to the MX40.
EASI is shown beside the 1 mV calibration bar on the ECG wave on the
display, and EASI is marked on any recorder strips and printouts.
ra
ft
op
See the sections on Lead Placement for electrode placement diagrams.
ECG and Arrhythmia Monitoring
5-13
ECG Configuration
The MX40 supports 3-, 5-, and 6-wire patient cables. The 5-wire patient
cable can be used for either standard or EASI electrode configurations. The
MX40 detects the patient cable type attached and automatically determines
the ECG measurement and transmitted leads.
Note—The labels and colors of the ECG electrodes differ according to the
standards that apply for your hospital. The electrode placement references
and illustrations in this chapter use the AAMI labels and colors. See the
table below for additional label and color information.
Electrode Colors
AAMI
EASI
IEC
AAMI
IEC
RA
White
Red
LA
Black
Yellow
LL
Red
Green
RL
Green
Black
V/Va
C/Ca
Brown
White
Cb
Brown/White
White/Blue
ft
op
Electrode Labels
ra
Vb
5-14
ECG and Arrhythmia Monitoring
ECG Leads Monitored
Depending on the patient cable connected to the MX40, a different set of
viewable leads are available at the MX40 and the Information Center. The
MX40 can source up to four raw ECG waves to the Information Center.
If you are using ...
these leads can be selected at the MX40
and the Information Center
3-wire
I, II, III
Sourced (raw) waves are received as:
Channel 1 = I, II, or III
Default is II.
5-wire (Standard mode)
I, II, III, aVR, aVL, aVF, MCL and V
op
Sourced (raw) waves are received as:
Channel 1 = II
Channel 2 = III
Channel 3 = MCL
Defaults are II, V, III.
I, II, III, aVR, aVL, aVF, V1, V2, V3, V4, V5,
V6
ft
5-wire (EASI mode)
In EASI mode, the sourced (raw) waves
are received as:
Channel 1 = Vector 1 (A-I)
ra
Channel 2 = Vector 2 (A-S)
Channel 3 = Vector 3 (E-S)
Defaults are II, V2, III, V5.
Arrhythmia monitoring is performed only on
the primary and secondary leads selected
at the Information Center, although you can
view and perform ST analysis on all 12
EASI derived leads.
ECG and Arrhythmia Monitoring
5-15
If you are using ...
6-wire
these leads can be selected at the MX40
and the Information Center
I, II, III, aVR, aVL, aVF, V1, V2, V3, V4, V5,
V6, V7, V8, V9, V3R, V4R, V5R.
Sourced (raw) waves are received as:
Channel 1 = II
Channel 2 = III
Channel 3 = Va
Channel 4 = Vb
Defaults are II, Va = V2, III,Vb = V5.
op
The two chest leads, Va and Vb, can be
placed on the patient in any of the V lead
positions (V1 through V9, V3R, V4R, V5R).
Lead assignment is available at the
Information Center. When unassigned, the
chest leads use the defaults.
Note— The lead label assigned to Vb
cannot be selected for Va even though Vb
does not appear to be used.
ra
ft
When display of the pleth wave is enabled
at the Information Center, the second chest
lead (Vb) is not available for monitoring.
5-16
ECG and Arrhythmia Monitoring
Reconstructed Leads
Reconstruction of leads from the sourced wave is defined by the
calculations in the following table. EASI reconstructed leads are a linear
combination of all three raw EASI leads
3-wire
5-wire
Standard
6-wire
Clinical Calculations
in terms of
electrodes
LA-RA
II
(default)
II (default) II
(default)
III
III
(default)
MCL
III
(default)
LL-LA
V-LA, where V=C
aVR
aVR
RA-(LA+LL)/2
aVL
aVL
LA-(RA+LL)/2
aVF
aVF
LL-(LA+RA)/2
V (default)
ft
ra
LL-RA
op
ECG Lead
V-(RA+LA+LL)/3,
where V=C
Va
Va-(RA+LA+LL)/3,
where Va=V2 (default)
position
Vb
Vb-(RA+LA+LL)/3,
where Vb =V5
(default) position
ECG and Arrhythmia Monitoring
5-17
3-Wire Placement
1. RA - directly below the clavicle
and near the right shoulder
2. LA -directly below the clavicle
and near the left shoulder
ra
ft
op
3. LL - on the left lower abdomen
5-18
ECG and Arrhythmia Monitoring
5-Wire Placement (Standard Mode)
1. RA directly below the clavicle and near
the right shoulder
2. LA directly below the clavicle and near
the left shoulder
3. RL on the left lower abdomen
4. LL on the right lower abdomen
op
5. V on the chest, the position depends
on your required lead selection. The
typical position is V1, although this
may vary according based on your
hospital’s protocol.
V1 on the fourth intercostal space at the
right sternal border
ra
ft
V2 on the fourth intercostal space at the
left sternal border
V3 midway between the V2 and V4
electrode positions
V4 on the fifth intercostal space at the
left midclavicular line
V5 on the left anterior axillary line,
horizontal with the V4 electrode position
V6 on the left midaxillary line, horizontal
with the V4 electrode position
ECG and Arrhythmia Monitoring
5-19
5-Wire Placement (EASI Mode)
1. E (V) on the lower sternum at the level of
the fifth intercostal space
2. A (LL) on the left midaxillary line at the
same level as the E electrode
3. S (LA) on the upper sternum
4. I (RA) on the right midaxillary line at the
same level as the E electrode
ft
op
5. N (Reference) can be anywhere, usually
below the sixth rib on the right hip
ra
Make sure that the S and E electrodes line up vertically on
the sternum, and that the I, E and A electrodes align
horizontally.
5-20
ECG and Arrhythmia Monitoring
6-Wire Placement
6-lead placement uses the same positions from as the 5-lead standard
placement described above , along with two precordial leads - referred to as
Va and Vb.
The default position of Va - the brown lead - is at the V2 position.
The default position for Vb - the brown/white lead - is at the V5 position.
ra
ft
op
The lead placement for the Va and Vb lead labels must be appropriate. If
your unit uses other precordial leads for Va and Vb, they may be assigned
in Unit Settings at the Information Center as defaults for your whole unit,
or you may need to assign the new positions on a per-patient basis in the
Patient Window at the Information Center.
ECG and Arrhythmia Monitoring
5-21
Chest Electrode Placement
V1 on the fourth intercostal space at the
right sternal border
V2 on the fourth intercostal space at the
left sternal border
V3 midway between the V2 and V4
electrode positions
V4 on the fifth intercostal space at the left
midclavicular line
V5 on the left anterior axillary line,
horizontal with the V4 electrode position
V6 on the left midaxillary line, horizontal
with the V4 electrode position
op
V3R-V6R on the right side of the chest in
positions corresponding to those on the
left
VE over the xiphoid process
V7 on posterior chest at the left posterior
axillary line in the fifth intercostal space
ft
V7R on posterior chest at the right
posterior axillary line in the fifth intercostal
space
For accurate chest electrode placement and measurement, it is important to
locate the fourth intercostal space.
ra
 To locate the fourth intercostal space:
5-22
Locate the second intercostal space by first palpating the Angle of Lewis
(the little bony protuberance where the body of the sternum joins the
manubrium). This rise in the sternum is where the second rib is
attached, and the space below this is the second intercostal space.
Palpate and count down the chest until you locate the fourth intercostal
space.
ECG and Arrhythmia Monitoring
Monitoring during Leads Off
ECG Fallback and Extended monitoring states are supported for the MX40
when the primary and/or secondary leads are in a "Leads Off" INOP
condition. Both of these states are entered into after 10 seconds of "Leads
Off" in an attempt to maintain monitoring and arrhythmia analysis.
ECG Fallback
ECG Fallback occurs when the primary lead is in "Leads Off" for 10 seconds
and a secondary lead is available.
Multilead Analysis
op
If there is a "Leads Off" technical alarm in the primary lead for > 10 seconds,
the active secondary lead becomes the primary lead. The arrhythmia
algorithm switches the leads on the display, but relearn does not occur.
When the "Leads Off" condition is corrected, the leads are switched back to
their original state.
ft
Single Lead Analysis
For single lead analysis, if there are two leads available, the secondary lead
is made the primary lead until the "Leads Off" condition is corrected. The
arrhythmia algorithm performs a relearn using the available lead.
Fallback for EASI
ra
If one of the derived EASI leads is in a technical alarm condition, a flat line
is displayed. After 10 seconds, the directly acquired EASI AS, EA, or AI
lead, depending on which is available, is displayed. Arrhythmia relearn is
performed with transition to or from EASI Fallback monitoring using the
available lead(s).
Relearning
Whenever there is a "Leads Off" condition for more than 60 seconds, the
arrhythmia algorithm performs a Relearn using the available leads.
Warning
Since Relearn happens automatically, if learning takes place during
ventricular rhythm, the ectopics can be incorrectly learned as the normal
QRS complex. This can result in missed detection of subsequent events of
V-Tach and V-Fib. For this reason, you should:
Respond promptly to any technical alarm.
ECG and Arrhythmia Monitoring
5-23
Ensure that the arrhythmia algorithm is labeling beats correctly.
ra
ft
op
5-24
ECG and Arrhythmia Monitoring
ST/AR Arrhythmia Monitoring
ST/AR Arrhythmia Algorithm
Indications for Use
The ST/AR Arrhythmia Algorithm is indicated for use in instances where
the clinician decides to monitor cardiac arrhythmias of adult and pediatric
patients and/or the ST segment of adult patients to gain information for
treatment, monitor the adequacy of treatment, or to exclude causes of
symptoms.
How the ST/AR Algorithm Works
op
ST/AR multi-lead analysis is performed on the user-selected primary and
secondary leads. If only one lead is available for multilead, ST/AR analysis
is performed on the single available lead.
Arrhythmia analysis consists of several steps:
The ECG signal is pre-processed to filter out baseline wander, muscle
artifact, and signal irregularities. In addition, if the Patient Paced status
= Yes, pace pulses are detected then rejected from the processing to
avoid seeing them as QRS beats.
Beat detection to locate the QRS complexes for further analysis.
ra
ft
Feature measurement such as R-wave height, width, and timing.
Beats classification. Templates are created and are matched to incoming
beats, and the appropriate beat label is determined.
Rhythm and alarm detection. Beat labels are used to produce the values
and events needed to generate rhythms and alarms.
Working in parallel with beat detection and classification, a separate
detector examines continuously for ventricular fibrillation, asystole, and
noise.
The quality of the ECG signal is important for accurate arrhythmia analysis.
The section below provides guidelines for optimizing signals for
arrhythmia analysis.
For additional information on the ST/AR Algorithm, refer to the
Arrhythmia Monitoring ST/AR Algorithm Application Note,
#453564115631.
ECG and Arrhythmia Monitoring
5-25
Aberrantly-Conducted Beats
As P-waves are not analyzed, it is difficult and sometimes impossible for
the monitor to distinguish between an aberrantly-conducted
supraventricular beat and a ventricular beat. If the aberrant beat resembles
a ventricular beat, it is classified as ventricular. You should always select a
lead where the aberrantly-conducted beats have an R-wave that is as
narrow as possible to minimize incorrect calls. Ventricular beats should
look different from these 'normal beats'. Instead of trying to select two leads
with a narrow R-wave, it may be easier to just select one lead and use single
lead arrhythmia monitoring. Extra vigilance is required by the clinician for
this type of patient.
Intermittent Bundle Branch Block
ft
op
Bundle branch and the other fascicular blocks create a challenge for the
arrhythmia algorithm. If the QRS during the block changes considerably
from the learned normal, the blocked beat may be incorrectly classified as
ventricular, causing false PVC alarms. You should always select a lead
where the bundle branch block beats have an R-wave that is as narrow as
possible to minimize incorrect calls. Ventricular beats should look different
from these 'normal beats'. Instead of trying to select two leads with a
narrow R-wave, it may be easier to just select one lead and use single lead
arrhythmia monitoring. Extra vigilance is required by the clinician for this
type of patient.
ra
ECG and Arrhythmia Alarm Overview
The ECG and arrhythmia alarms available depend on which measurements
are switched on, and the arrhythmia option enabled for your MX40.
Basic arrhythmia alarms are available when Arrhythmia is switched on
Enhanced arrhythmia alarms are available when the Enhanced Arrhythmia
option has been enabled for your device. To check your enabled settings,
view the Standby screen.
5-26
Alarms with Basic Arrhythmia
Option
Additional Alarms with Enhanced
Arrhythmia Option
***Asystole
**Afib
***Ventricular
Fibrillation/Tachycardia
**Supraventricular Tach
***Extreme Bradycardia
**Missed Beat
***Extreme Tachycardia
**Pause
ECG and Arrhythmia Monitoring
Alarms with Basic Arrhythmia
Option
Additional Alarms with Enhanced
Arrhythmia Option
***Ventricular Tachycardia
**Irregular HR
**High heart rate
**Ventricular Rhythm
**Low heart rate
**Run PVCs High
**Pacer Not Capture (if Pacing
set to Yes)
**Pair PVCs
**Pacer Not Pacing (If Pacing set
to Yes)
**R-on-T PVCs
**PVCs/min HIGH (PVC >
limit/min)
**Ventricular bigeminy
**Ventricular trigeminy
op
**Non-sustain VT
**Multiform PVCs
ft
Using ECG Alarms
ra
ECG alarms can be switched on and off and the high and low alarm limits
changed just like other measurement alarms, as described in the Alarms
chapter. Special alarm features which apply only to ECG are described
here.
Extreme Alarm Limits for Heart Rate
The extreme rate alarms, Extreme Tachy and Extreme Brady, are set at the
Information Center by adding a set value (the D value) to the high and low
alarm limits.
1. Extreme Brady Limit
2. Low Limit
3. High Limit
4. Extreme Tachy Limit
5. Extreme Brady (D value)
6. Extreme Tachy (D value)
You need to know which value has been configured for your monitor.
Changing the high and low alarm limits automatically changes the extreme
alarm limits within the allowed range.
ECG and Arrhythmia Monitoring
5-27
Arrhythmia Alarm Settings
Some arrhythmia alarms can be turned off at the Information Center. They
are:
Non-Sustain, Vent Rhythm, Run PVCs, Pair PVCs, R-On-T PVCs,
V.Bigeminy, V.Trigeminy, Multif.PVCs, Pause, SVT, Irregular HR,
Missed Beat, PVCs/min and Afib.
It is also possible to turn all yellow arrhythmia alarms off at the Information
Center.
Yellow Arrhythmia Alarms
op
Alarms that have been turned off at the Information Center will appear as
off in the Arrhythmia menu of the MX40, but they are not accessible, nor
can you change limits locally.
ra
Warning
ft
Yellow arrhythmia alarms are short yellow alarms specific to
arrhythmia-related patient conditions. Depending on your monitor and
Information Center configuration, they may be shown with one or two
stars. The heart rate alarms (High HR and Low HR) can be configured as
short yellow or standard yellow alarms. When they are standard yellow
alarms they exist independently of the other arrhythmia alarms and no
timeout periods apply.
When arrhythmia analysis is on, all yellow ECG and arrhythmia alarms are
short yellow alarms (one-star). This means that the alarm tones (if volume
is on) are active for six seconds only, after which the blinking numeric and
the alarm message remain for up to three minutes. The only exception to
this are the HR High and Low alarms which can be configured as standard
yellow alarms. Red alarms behave as usual.
Viewing Arrhythmia Waves
 To review arrhythmia beat labels:
5-28
Go to the Setup ECG menu.
Select Arrhythmia.
Change Annotate Arrhy from Off to On. Beat labels will be annotated
above the ECG wave and Delayed will appear beside it.
ECG and Arrhythmia Monitoring
 To return to the normal ECG primary lead display:
Select Annotate Arrhy.
Change to Off.
Exit from the Setup ECG menu.
Arrhythmia Beat Labels
Arrhythmia beat labels tell you how the monitor is classifying beats.
N = Normal
op
V = Ventricular Ectopic
S = Supra-ventricular Premature
P = Paced
' = Pacer spike
ft
" = Biventricular Pacer Spike
L = Learning patient's ECG
A = Artifact (noisy episode)
ra
? = Insufficient information to classify beats
Learning
The arrhythmia system’s goal is to learn the patient’s normal complexes so
it can differentiate abnormal beats. This "learning" process uses the 15 first
valid beats (for example, free from noise) encountered during the learning
phase.
While the system is learning the complex, the delayed arrhythmia wave
displays the beat label "L".
Learning Phase
A learning phase involves the system learning the patient’s dominant
complexes. During a learning phase:
Alarm timeout periods are cleared.
Stored arrhythmia templates are cleared.
ECG and Arrhythmia Monitoring
5-29
Asystole, Vfib, and HR alarms (when there are enough beats to
compute the HR) are active.
All other alarms are not active.
Single Lead Analysis
If single lead analysis is selected, the arrhythmia system begins alearning
whenever:
ECG monitoring is initiated.
The Relearn key is activated (see Initiating Arrhythmia Relearning
Manually p. 5-31).
The ECG Lead or Lead Label is changed manually, or when Fallback
occurs (see ECG Fallback p. 5-23).
Multilead Analysis
op
A Leads Off INOP condition (that has been active for >60 seconds) ends.
If multilead analysis is selected, the arrhythmia system begins a learning on
both leads whenever:
ft
ECG monitoring is initiated.
The Relearn key is activated (see Initiating Arrhythmia Relearning
Manually p. 5-31).
ra
There has been a Leads Off INOP condition (that has been active for >60
seconds) for both leads, and the condition ends in either lead.
Multilead Analysis With Changes in One Lead
Since the arrhythmia system uses more than one lead for analysis, if there is
a change in one lead, the system does a relearn only on the affected lead.
This happens whenever:
An ECG lead or label is changed.
A Leads Off INOP condition (that has been active for >60 seconds) ends.
Note— During this learning phase the system will continue monitoring
using the operative lead. Therefore, the delayed arrhythmia wave is not
labeled"L". In addition:
Alarm timeout periods are maintained.
Stored arrhythmia templates are maintained for the operative lead.
All alarms turned on are active.
5-30
ECG and Arrhythmia Monitoring
EASI ECG Monitoring
Whenever there is an INOP condition, the arrhythmia algorithm performs a
Relearn, using the available lead.
Warning
Since Relearn happens automatically, if learning takes place during
ventricular rhythm, the ectopics may be incorrectly learned as the normal
QRS complex. This may result in missed detection of subsequent events of
V-Tach and V-Fib. For this reason, you should:
Respond to the INOP message (for example, re-connect the electrode(s).
Ensure that the arrhythmia algorithm is labeling beats correctly.
op
Initiating Arrhythmia Relearning Manually
ft
To initiate relearning manually, in the Setup ECG menu, select Relearn
Arrhy.
While the monitor is learning, if annotate arrhythmia is On, the delayed
arrhythmia wave displays the beat label L.
Next, the monitor determines the dominant rhythm. The beats are
labeled N.
ra
After relearning is complete, you should check the delayed arrhythmia
wave to ensure that the algorithm is labeling the beats correctly.
If beats are still not classified correctly, check that the ECG is optimized for
arrhythmia monitoring. You may need to select a different lead or change
the electrodes or electrode positions if there is excessive noise, unstable
voltage, low amplitude, or large P- or T-waves.
ECG and Arrhythmia Monitoring
5-31
ST/AR ST Analysis Algorithm
Intended Use
The intended use of the ST/AR ST Analysis algorithm is to monitor an adult
patient’s ECG for ST segment elevation or depression and produce
events/alarms for all possible ECG leads. The ST Analysis algorithm is
capable of monitoring paced and non-paced adult patients.
Note—The ST Analysis algorithm does not analyze ventricularly paced or
ventricular ectopic beats.
Warning
op
This device provides ST level change information; the clinical significance
of the ST level change information needs to be determined by a physician.
ft
The ST/AR ST algorithm at the Information Center monitors ST segment
elevation or depression for each available telemetry ECG lead and produces
events/alarms simultaneously. ST values update with every measurement
period and enunciate, depending upon the severity of the change, events
and alarms as they are detected.
ra
The ST/AR ST algorithm is approved for use only with non-paced and
atrially-paced adult telemetry-monitored patients. With EASI monitoring,
ST analysis is performed on up to 12 leads, and an additional value of ST
index is calculated and displayed. Assessment of EASI-derived 12-lead ST
measurement is recommended for adult patients that meet the following
parameters:
Ages: 33-82 years
Heights: 147 to 185 cm (58 to 73 in)
Weights: 53 to 118 kg (117 to 261 lbs)
Height to Weight Ratios: 1.41 to 2.99 cm/kg (0.25 to 0.54 in/lb)
All ST analysis and ST alarms for telemetry patients are performed by the
Information Center.
For additional information on ST monitoring, refer to the following
documentation:
ST/AR Algorithm - ST Segment Monitoring Application Note,
#452296220161
IntelliVue Information Center Instructions for Use and Online Help
5-32
ECG and Arrhythmia Monitoring
The Measurement
ft
op
The ST measurement for each beat complex is the vertical difference between
two measurement points. The isoelectric point provides the baseline for
the measurement and the ST point provides the other measurement point.
It is positioned with reference to the J-point.
Algorithm Processing
ra
ST analysis analyzes ECG signals to classify the heart beats. Only beats
classified as normal or Supraventricular (atrially paced) are used to
calculate ST elevations and depressions.
The ST/AR ST Analysis algorithm processing includes special ST filtering,
beat selection and statistical analysis, calculation of ST segment elevations
and depressions, and lead reconstruction and wave generation.
When ST analysis is being performed on two leads, the averaged derived
and reconstructed ST waves and associated ST segment values are given for
up to six leads, depending on the type of patient cable:
3-wire: one lead
5-wire: up to two leads if monitoring a chest and a limb lead
5-wire: up to six leads if monitoring two limb leads
5-wire: up to 12 leads if monitoring using EASI
6-wire: up to 8 leads if monitoring two limb leads and two chest leads
Note—No ST analysis is done on a patient if an electrode falls off.
ECG and Arrhythmia Monitoring
5-33
Displayed ST Data
ST data displays as values in the Patient Sector and Patient Window at the
Information Center. A positive value indicates ST segment elevation; a
negative value indicates ST segment depression. You can view ST data in
ST Review, Trend Review, and Event Review windows.
Note — ST data and alarms are not displayed at the MX40.
EASI ST Analysis
anterior lead V2
lateral lead V5
ft
inferior lead aVF
op
The Information Center generated ST values presented in the patient sector
and Patient Window for EASI derived leads is STindx (ST Index). STindx is
a summation of three ST segment measurements, using the leads that can
indicate ST segment changes in the different locations of the heart:
Turning ST Monitoring On/Off
The ST Setup Window at the Information Center allows you to turn ST
monitoring on or off for all available ECG leads.
ra
You would turn ST monitoring off if:
You are unable to get any lead that is not noisy.
Arrhythmias such as atrial fib/flutter cause irregular baseline.
The patient is continuously ventricularly paced.
The patient has left bundle branch block.
5-34
ECG and Arrhythmia Monitoring
QT Interval Monitoring
Of special concern for QT monitoring is the administration of QT
prolonging drugs to patients identified with risk factors for Torsade de
Pointe. Females, older patients and patients with bradycardia, impaired left
ventricular function (ischemia, left ventricular hypertrophy), hypokalemia
and hypomagnesemia are in this increased risk category.
ra
ft
op
QT interval monitoring can assist in the detection of prolonged QT interval
syndrome.The QT interval in an ECG lead is the time interval from the
onset of the earliest deflection in the QRS complex to the end of the T wave.
For patients being monitored by the MX40, the Information Center
measures the QT interval once every minute during startup, during the
learning phase and on lead mode change. After that the Information Center
updates the QT values every five minutes.
The QT interval has an inverse relationship to heart rate. Faster heart rates
shorten the QT interval and slower heart rates prolong the QT interval. To
correct the QT interval for heart rate the Information Center uses the Bazett
correction formula by default. Your system, however, may be set up to use
the Fridericia correction formula as an alternative. The heart rate corrected
QT interval is abbreviated as QTc.
Note — QT Data is not displayed at the MX40.
ECG and Arrhythmia Monitoring
5-35
Intended Use
The intended use of the ST/AR QT/QTc analysis is for use by the physician
in the risk assessment process indicated for pediatric and adult patients
with and without symptoms of arrhythmia. QT measurement is intended to
be used by qualified health professionals in hospital or clinical
environments. Composite QT (single or multi-lead derived) measures the
interval only and is not intended to produce any interpretation or diagnosis
of those measurements. Additional information regarding QT monitoring
can be found in the QT/QTc Interval Monitoring Application Note,
#4522962215621
Warning
op
The device provides QT and QTc interval change information; the clinical
significance of the QT and QTc interval change information should be
determined by a clinician.
ft
How the QT Analysis Algorithm Works
ra
The Information Center measures the QT values once every minute during
startup. Subsequently, the Information Center updates the QT values every
five minutes. Normal or atrial paced beats and beats with a similar
morphology are averaged to form a representative waveform for further
processing. Normal beats followed by a premature QRS will be excluded
from the measurements to prevent the premature beat from obscuring the
end of the T-wave. If the algorithm cannot form a representative waveform,
for example because the morphology of the beats is too varied, the
Information Center generates a Cannot Analyze QT INOP when it detects
two consecutive invalid 5 minute values. This is also the case if normal
beats have been falsely labeled so that the algorithm does not have enough
valid beats to make QT measurements. No QT value is calculated if the
QT-HR is >150 bpm (Adult) or >180 bpm (Pedi/Neo).
Because of the different algorithm approaches, a QT/QTc measurement
from a diagnostic 12-lead program may differ from the realtime
measurement.
For QT interval monitoring to be effective, basic or enhanced arrhythmia
monitoring must be on.
5-36
ECG and Arrhythmia Monitoring
Adjusting QT Settings
For patients being monitored by the MX40, you can adjust QT settings in
the QT Setup window at the Information Center.
Turn QT analysis on by clicking in the QT Analysis On check box. QT
analysis is on when a checkmark displays in the check box. When the QT
measurement is on, a QT status message is displayed in the QT Setup
window, along with the current values for QT, QTc, dQTc and QT-HR. The
lead labels indicating the leads used to calculate the baseline and current
values also appear.
op
Note—Turning QT analysis off does not clear the baseline value. This
allows you to turn QT analysis off during prolonged arrhythmias, such as
bigeminy, without losing the baseline.
Limitations for QT Monitoring
ft
Some conditions may make it difficult to achieve reliable QT monitoring.
When this occurs the CANNOT ANALYZE QT INOP message displays at
the Information Center, along with a QT STATUS message. Some
conditions that may make reliable QT monitoring difficult include:
T-Wave Detection Limitations.
ra
Flat T-wave, atrial Fibrillation or atrial Flutter and prominent U-waves
can make QT monitoring difficult. For these cases you should select All
as the QT Lead on the QT window. The Information Center will use the
lead or leads that have a T-wave with sufficient amplitude and can be
detected. Alternatively select a single lead with a good T- wave
amplitude and no visible flutter activity and without a predominant
U-wave or P-wave.
QRS Changes
QRS changes such as widened QRS can affect QT monitoring. If a long
QTc is observed verify that is not caused by QRS widening.
Rhythm and Rate Limitations
Rhythm and rate limitations such as high heart rate (> 150 beats/min for
adults patients or > 180 beats/min for pediatric or neonatal patients),
paced rhythm and bigeminy rhythm can make reliable QT monitoring
difficult. If rhythm is sustained you may want to consider turning QT
interval monitoring off.
ECG and Arrhythmia Monitoring
5-37
op
ft
ra
5-38
ECG and Arrhythmia Monitoring
6.
Monitoring Pulse Rate
This section provides an introduction to the Pulse measurement and its
application.
Pulse Rate Measurement .......................................................................... 6-2
ra
ft
op
Displaying the Pulse Rate Measurement at the MX40 ......................... 6-3
Monitoring Pulse Rate
6-1
Pulse Rate Measurement
The pulse rate measurement counts the arterial pulsations that result from
the mechanical activity of the heart in beats per minute (bpm). The pulse
rate is derived from the SpO2 measurement. Displayed results can range
from 30 to 300 bpm. There is no alarm function for pulse rate.
ra
ft
op
The pulse numeric is displayed at the Information Center only when SpO2
is being measured continuously. Manual measurements are displayed at
the MX40 with a time stamp. There are no alarms associated with the pulse
measurement. Pulse is turned on in the Telemetry Setup window at the
Information Center.
6-2
Monitoring Pulse Rate
Displaying the Pulse Rate Measurement at the
MX40
 To display the pulse rate measurement at the MX40:
If not already selected, press the Main Screen button and select the 1
waveform with 4 numerics display.
If pulse is not already displayed, touch a numeric.
Select Change Numeric.
Select Pulse.
ra
ft
op
Monitoring Pulse Rate
6-3
op
ft
ra
6-4
Monitoring Pulse Rate
7.
SpO2 Monitoring
This section provides an introduction to the SpO2 measurement and its
application.
SpO2 Safety Information ........................................................................... 7-2
ra
ft
op
Pulse Oximetry Measurement ................................................................. 7-5
SpO2 Monitoring
7-1
SpO2 Safety Information
Warnings
Always confirm monitor observations with clinical observation of the
patient before administering interventions.
op
Prolonged, continuous monitoring can increase the risk of changes in
skin characteristics, such as irritation, reddening, blistering or pressure
necrosis, particularly on patients with impaired perfusion and varying
or immature skin morphology. Specific attention must be given to
sensor site inspection for changes in skin quality, proper optical path
alignment and attachment. Check the application site at regular
intervals and change the site if any compromise in skin quality should
occur. More frequent checking can be required due to an individual
patient's condition.
Injected dyes such as methylene blue or intravascular dyshemoglobins
such as methemoglobin and carboxyhemoglobin can lead to inaccurate
(over-estimated) measurements.
ft
Interference leading to inaccurate measurements can be caused by:
High levels of ambient light (Hint: cover application site with
opaque material)
Electromagnetic interference
ra
Excessive patient movement and vibration.
This equipment is not suitable for use in the presence of a flammable
anesthetic mixture or oxygen concentrations greater than 25% (or partial
pressures greater than 27,5 kPa /206.27 mmHg).
Disposable SpO2 sensors can be damaged and lead to patient harm if
they become wet. Wet sensors must be replaced immediately.
To avoid venous pulsation, obstructed circulation, pressure marks,
pressure necrosis, artifacts and inaccurate measurements, make sure
that the sensor is not too tight. If the sensor is too tight, because the
application site is too large or becomes too large due to edema,
excessive pressure may be applied. This can result in venous congestion
distal from the application site, leading to interstitial edema, hypoxia
and tissue malnutrition.
Inspect the sensor application site every 2 to 3 hours to ensure skin
integrity, correct optical alignment, and circulation distal to the sensor
site. Move the sensor application site every four hours, or more often if
circulation or skin integrity is compromised.
7-2
SpO2 Monitoring
At elevated ambient temperatures, be careful with measurement sites
that are not well perfused, because this can cause severe burns after
prolonged application. All listed sensors operate without risk of
exceeding 41o C on the skin if the initial skin temperature does not
exceed 37o C.
Avoid placing the sensor on extremities with an arterial catheter or
intravascular venous infusion line.
Sensors connected to the MX40 but not applied to the patient, can
produce an error measurement. To avoid misdiagnosis, ensure the
sensor is properly applied to the patient.
Cautions
op
If you measure SpO2 on a limb that has a inflated NBP cuff, a
non-pulsatile SpO2 INOP (SpO2T NO PULSE) can occur. If the monitor
is configured to suppress this alarm, there may be a delay of up to 60
seconds in indicating critical patient status, such as sudden pulse loss or
hypoxia.
ft
Do not use OxiCliq disposable sensors in a high humidity environment,
such as an incubator, or in the presence of fluids, which may
contaminate sensor and electrical connections causing unreliable or
intermittent measurements. Do not use disposable sensors on patients
who have allergic reactions to the adhesive.
ra
Do not use more than one extension cable (M1941A). See Appendix A,
Accessories, for information on which sensors cannot be used with an
extension cable.
Position the sensor cable away from power cables to avoid electrical
interference.
SpO2 Information for the User
The pulse oximeter is calibrated to indicate functional oxygen saturation
(fractional oxyhemoglobin), and displayed results can range from 0 to
100%.
A 10 second averaging filter is used in the calculation of the result.
Displayed results are typically updated every second, but the update
period can be automatically delayed by up to 30 seconds in the presence of
noise.
SpO2 Monitoring
7-3
Physiological SpO2 alarm signals will be generated. For adult patients, the
SpO2 low limit can be set between 50 and 99% inclusive, in 1% increments,
and the SpO2 high alarm limit can be set between 51 and 100% inclusive, in
1% increments. For pediatric patients, the SpO2 low limit can be set between
30 and 99% inclusive, in 1% increments, and the high alarm limit can be set
between 31 and 100% inclusive, in 1% increments. The maximum delay
between the physiological alarm condition and alarm signal generation is
25 seconds.
Pulse rate is also derived from the pulsatile SpO2 measurement, and
displayed results can range from 30 to 300 bpm. There is no alarm function
for pulse rate.
ra
ft
op
The pleth wave is auto-scaled to maximum display size. It decreases only
when the signal quality becomes marginal. Pleth wave size is NOT directly
proportional to the pulse volume.
7-4
SpO2 Monitoring
Pulse Oximetry Measurement
The MX40 supports an SpO2 sensor connection using Fourier Artifact
Suppression Technology (FAST). The FAST algorithm overcomes many of
the issues associated with traditional pulse oximetry such as sensitivity to
patient movement and intense ambient light. The algorithm offers
improved motion artifact rejection as well as performance improvements
for patients with low perfusion. SpO2 can be measured continuously, where
a value is sent to the Information Center every second, or as a single,
individual Manual measurement. The Manual measurement will be
removed from the Information Center display after 1 hour.
op
The SpO2 parameter measures the arterial oxygen saturation, that is, the
percentage of oxygenated hemoglobin in relation to the total hemoglobin.
ft
If, for example, a total of 97% of the hemoglobin molecules in the red blood
cells of the arterial blood combine with oxygen, then the blood has an
oxygen saturation of 97%. The SpO2 numeric that appears on the monitor
will read 97%. The SpO2 numeric indicates the percentage of hemoglobin
molecules which have combined with oxygen molecules to form
oxyhemoglobin.
ra
The oxygen saturation is measured using the pulse oximetry method.
This is a noninvasive method of measuring the arterial hemoglobin
oxygen saturation. It measures how much light, sent from light sources
on one side of the sensor, travels through patient tissue (such as a finger
or an ear), to a receiver on the other side of the sensor.
The amount of light passing through depends on many factors, most of
which are constant, such as tissue or venous blood. However one of the
factors, the blood flow in the arterioles, varies with time because it is
pulsatile.
This measurement principle is used to derive the SpO2 measurement. The
numeric that is displayed is the oxygen saturation of the arterial blood - the
measurement of light absorption during a pulsation. Correct placement of
the sensor is essential for accurate measurements.
Note—Because pulse oximeter equipment measurements are statistically
distributed, only about two-thirds of pulse oximeter equipment
measurements can be expected to fall with ± Arms of the value measured
by a CO-oximeter.
SpO2 Monitoring
7-5
SpO2 Sensors
Familiarize yourself with the instructions for use supplied with your sensor
before using it. In particular, check that the sensor being used is
appropriate for your patient category and application site. See Appendix A,
Accessories, for a complete listing of supported sensors for the MX40.
Selecting an SpO2 Sensor
Warning
op
Use only Philips-approved accessories. Use of product accessories
(patient cables, SpO2 sensors, etc.) other than those specified in this
manual may lead to patient injury or result in increased electromagnetic
emissions or decreased immunity of the product.
Reuse: Never reuse disposable sensors, accessories and so forth that are
intended for single use, or single patient use only.
Packaging: Do not use a sterilized accessory if the packaging is
damaged.
ft
Do not use disposable sensors on patients who exhibit allergic reactions
to the adhesive.
ra
When the specified Nellcor® sensors are used, the application must be
consistent with the sensor manufacturer's own guidelines.
Philips reusable sensors in adult, pediatric and infant models can be used,
as well as Philips and Nellcor® disposable sensors.
Caution
Do not use OxiCliq disposable sensors in a high humidity environment, or
in the presence of fluids. These can contaminate sensor and electrical
connections, and thereby cause unreliable or intermittent measurements.
The following table will help you in selecting the correct sensor type.
7-6
SpO2 Monitoring
Sensor Type
When to Use
Reusable
You can use reusable sensors on different
patients after cleaning and disinfecting
them. For care and cleaning instructions,
see the instructions accompanying the
sensors. Reusable sensors should be
changed to another site every four hours or
in accordance with your clinical practice
guidelines.
See the Directions for Use supplied by
Nellcor® Incorporated for instructions on
preparation and application of reusable
sensors.
Use disposable sensors only once and
then discard. However, you can relocate
them to a different patient-site if the first
location does not give the desired results.
Do not reuse disposable sensors on
different patients.
op
Disposable
Note — See the Instructions for Use
ft
supplied by Nellcor® Incorporated for
instructions on preparation and application
of disposable sensors.
Sensor Application Safety Information
ra
Warning
Failure to apply a sensor properly can reduce the accuracy of the SpO2
measurement.
Loose/Tight sensor: If a sensor is too loose, it can compromise the
optical alignment or fall off. If it is too tight, for example because the
application site is too large or becomes too large due to edema,
excessive pressure can be applied. This can result in venous congestion
distal from the application site, leading to interstitial edema, hypoxia
and tissue malnutrition.
Skin irritations or ulcerations can occur as a result of the sensor being
attached to one location for too long. To avoid skin irritations and
ulcerations, inspect the sensor application site every 2-3 hours, and
change the application site at least every 4 hours or according to clinical
practice guidelines.
SpO2 Monitoring
7-7
Venous Pulsation: Do not apply sensor too tightly as this results in
venous pulsation, which can severely obstruct circulation and lead to
inaccurate measurements.
Ambient Temperature: Never apply an SpO2 sensor at ambient
temperatures above 37 oC (99 oF) because this can cause severe burns
after prolonged application.
Extremities to Avoid: Avoid sites distal to NBP cuff, intra-arterial line,
or intravascular venous infusion line.
Applying the Sensor
Follow the SpO2 sensor's Instructions for Use, adhering to all warnings
and cautions.
If necessary, remove colored nail polish from the application site.
Apply the sensor to the patient. The application site should match the
sensor size so that the sensor can neither fall off, nor apply excessive
pressure.
Check that the light emitter and the photodetector are directly opposite
each other. All light from the emitter must pass through the patient's
tissue.
ft
op
ra
Connecting SpO2 Cables
The sensor cable is either directly connected to the blue SpO2 connector on
the MX40 patient cable or is connected to an adapter cable that is then
connected to the MX40 SpO2 connector.
Tone Modulation Indication
The pulse signal tone is controlled by the setting in the SpO2 Tone
Modulation menu.
Signal Quality Indicator
The SpO2 numeric is displayed together with a signal quality indicator
which gives an indication of the reliability of the current values.
7-8
SpO2 Monitoring
The level to which the triangle is filled shows the quality of the signal. The
signal quality is at a maximum when the triangle is completely filled.
Measuring SpO2
Warning
Removal of the SpO2 sensor from the MX40 patient cable during
Continuous SpO2 monitoring results in a "No Sensor" technical alarm.
Silencing this alarm turns the SpO2 measurement off, however the SpO2
module is still operating in the background and consuming battery
power. If you do not intend to resume continuous SpO2 monitoring,
change to Manual mode.There is no technical alarm for a "No Sensor"
condition in Manual mode.
ft
op
If you measure SpO2 on a limb that has an inflated NBP cuff, a
non-pulsatile SpO2 technical alarm can occur. If the monitor is
configured to suppress this alarm, there can be a delay of up to 60
seconds in indicating critical patient status, such as sudden pulse loss or
hypoxia.
ra
SpO2 measurements can be made manually on an as-needed basis in
Manual mode, or continuously in Continuous mode, depending on your
MX40 configuration. While operating in Continuous mode, you can also
measure pulse, and display the pleth wave on the MX40 and at the
Information Center. The SpO2 parameter is turned on/off at the MX40 or by
a control from the Information Center. SpO2 monitoring consumes
considerable electrical energy. The battery power must be at least 10% full
in order to make SpO2 measurements.
To resume the SpO2 measurement after it has been turned off, touch the
blank measurement area and select SpO2 to turn it back on.
Note — Before disabling SpO2 at the Information Center, acknowledge any
active alarms at the MX40.
Setting the mode to Manual or Continuous can be done at the Information
Center or at the MX40.
 To select the measurement mode at the MX40:
In Spo2 Setup, select Mode.
Select Continuous or Manual mode.
SpO2 Monitoring
7-9
Understanding SpO2 Alarms
SpO2 monitoring offers high and low limit alarms, and a high priority (red
level) oxygen desaturation alarm. For adult patients, the SpO2 low limit can
be set between 50 and 99% inclusive, in 1% increments. For pediatric
patients, the SpO2 low limit can be set between 30 and 99% inclusive, in 1%
increments. The desaturation limit is set automatically at 10 below the Low
Limit. You cannot set the low limit below the desaturation limit. The SpO2
high alarm limit can be set between 51 and 100% inclusive, in 1%
increments for adult patients and set for pediatric patients between 31 and
100% inclusive, in 1% increments.
op
The delay between the physiologic alarm condition and alarm annunciation
at the MX40 is <16 seconds. This means that the MX40 will generate an
alarm if the averaged numeric value on the display exists beyond the alarm
limit for more than a maximum of 16 seconds.
Setting the high SpO2 alarm limit to 100% is equivalent to switching off the
high alarm. Therefore the upper alarm limit for oxygen saturation must be
carefully selected in accordance with accepted clinical practices.
ft
The default setting for SpO2 yellow alarms is latched. That is, when an SpO2
limit is exceeded, you will need to acknowledge it at the Information
Center. The sound will be silenced but the message will remain on the
display until the condition is resolved.
ra
See the Alarms chapter for a list of the SpO2 alarms.
7-10
SpO2 Monitoring
8.
Monitoring with other
Assigned Devices
This section provides information about the use of the MX40 when it is
assigned to other monitoring devices. The MX40 can be assigned to
IntelliVue Patient Monitors or IntelliVue Cableless Measurements for SpO2
and NBP. The connection to these other devices is done by pairing
networked devices or using the integrated short-range radio of the MX40.
Warning
op
For additional information on IntelliVue Patient Monitor or IntelliVue
Cableless Measurements operation, consult the Instructions for Use that
accompanied the device.
ft
Assignment of the MX40 to IntelliVue Patient Monitors is only supported
when the patient monitor (MP5,MP5T,MP5SC, MP2 or X2 only) is equipped
with a short-range radio. Monitors that have this equipment will display
the short-range radio symbol
on the label.
ra
Note — Assignment of the MX40 to IntelliVue Patient Monitors is not
available with patient monitors connected to the M3140 Information Center.
Note — The MP5T and MP5SC are non-networked device as it does not
support a connection to the Information Center.
Assigning Devices ..................................................................................... 8-2
Controls Available when Assigned to IntelliVue Cableless
Measurements ............................................................................................ 8-5
Controls Available when Assigned to IntelliVue Patient Monitors ... 8-6
MX40 Display when Wirelessly Connected to a Patient Monitor ...... 8-7
Monitoring with other Assigned Devices
8-1
Assigning Devices
Device Assignment at the Information Center
You can assign an MX40 to a patient monitor at the Information Center. The
data from the MX40 automatically displays as a permanent overview
session in the Telemetry Data window on the patient monitor.
At the Information Center the MX40 data and the patient monitor data are
integrated in the patient sector.
Warning
op
All data presented in the Telemetry Data window are delayed for several
seconds. If you need realtime data, e.g. for defibrillation, always use the
ECG from the patient monitor.
Device Assignment at the MX40
ft
 To assign an MX40 to an IntelliVue Cableless
Measurement device:
Press the SmartKey button.
Press the Add/Remove SmartKey.
ra
From the Add to menu, select the desired device and press Confirm.
The MX40 will attempt to complete the assignment for a 2-minute period. If
assignment fails or the MX40 is no longer in range of the other device, the
short-range radio turns off to save battery power. Repeat the procedure
above to retry or resume the assignment. You may also need to restart the
short-range radio at the cableless measurement device if it has entered its
power save mode. Touch and hold the left button on the device to restart
the short-range radio.
 To assign an MX40 to an IntelliVue Patient Monitor:
Press the Smartkey button.
Press the Add/Remove Smartkey. The measurement selection key on
the monitor will change to show the "assign telemetry" icon
8-2
In the Assign Telemetry Device menu, select the correct equipment label
for the device.
Monitoring with other Assigned Devices
When connected the
icon appears at the Information Center.
The MX40 is assigned to the monitor. A "Tele Device Assigned" message
appears on the monitor. If the ECG wave now appears on the monitor, the
signal from the MX40 is successfully transmitting to the monitor. To
confirm that the correct MX40 has been assigned, open the ECG Setup
menu by touching the ECG waveform or HR numeric. The title of the menu
contains the equipment label of the MX40. Check that this is the correct
label.
op
When assigned to the monitor, the display of the MX40 appears as shown
below:
The display is primarily inactive, and there is no viewable patient data
displayed, however, battery status information is available.
ft
If a monitor is already paired to another device, you cannot assign an MX40
to that monitor.
If the MX40 goes out-of-range or loses the short-range radio connection, it
will switch over to standard telemetry transmission to the Information
Center. In this case, the telemetry data is displayed in the Telemetry Data
Window.
ra
If the devices are unassigned, the short-range radio connection is ended
 To remove an assigned device from the MX40:
Press the Smartkey button.
Press the Add/Remove Smartkey.
From the Remove from menu, select the desired device and press
Confirm.
Device Assignment at the Patient Monitor
At the patient monitor, you can assign an MX40 to the patient monitor
using the Telemetry menu on the patient monitor.
Monitoring with other Assigned Devices
8-3
D
ra
ft
op
When the devices are networked, all data is sent to the Information Center.
When non-networked, only the additional parameters measured at the
patient monitor (NBP, SpO2, and predictive temperature) are sent to the
Information Center. The Telemetry Data window is not displayed when
devices are non-networked.
8-4
Monitoring with other Assigned Devices
Controls Available when Assigned to IntelliVue
Cableless Measurements
At the
MX40
At the IntelliVue
At the IIC
Cableless
Measurement Device
Start SpO2
Yes
Yes
Yes
Change SpO2 Mode
Yes
Yes
Yes
Select SpO2 Repetition
Time
No
Yes
No
Assign SpO2 Pod
Yes
Yes
No
Remove SpO2 Pod
Yes
Yes
Yes
Change Alarm Limits
No
No
Yes
Place Device in Standby
No
No
No
Alarm Silence
Yes
(local only)
No
Yes
Yes
No
(if enabled)
Yes
Start/Stop/Stat NBP
Yes
Yes
Yes
Change NBP Mode
Yes
Yes
No
Change NBP Repetition
Time
No
Yes
No
Change Alarm Limits
No
No
Yes
Assign NBP Pod
Yes
Yes
No
Remove NBP Pod
Yes
Yes
Yes
Place Device in Standby
No
No
No
Alarm Silence
Yes
(local only)
No
Yes
Alarm Off/Pause
Yes
No
(if enabled)
Yes
Action
ft
op
SpO2
Alarm Off/Pause
ra
NBP
Monitoring with other Assigned Devices
8-5
Controls Available when Assigned to IntelliVue
Patient Monitors
At the
MX40
At the IntelliVue
Patient Monitor
At the IIC
Start SpO2
Yes
Yes
Yes
Change SpO2 Mode
Yes
Yes
Yes
Select SpO2 Repetition
Time
No
Yes
No
Assign SpO2 Pod
Yes
Yes
No
Remove SpO2 Pod
Yes
Yes
Yes
Action
Change Alarm Limits
No
Yes
Yes
No
No
No
Yes
(local only)
Yes
Yes
Yes
Yes
(if enabled)
Yes
Start/Stop/Stat NBP
Yes
Yes
Yes
Change NBP Mode
Yes
Yes
No
Change NBP Repetition
Time
No
Yes
No
Change Alarm Limits
No
Yes
Yes
Assign NBP Pod
Yes
Yes
No
Remove NBP Pod
Yes
Yes
Yes
Place Device in Standby
No
No
No
Alarm Silence
Yes
(local only)
Yes
Yes
Alarm Off/Pause
Yes
Yes
(if enabled)
Yes
Place Device in Standby
Alarm Silence
ra
NBP
ft
Alarm Off/Pause
8-6
op
SpO2
Monitoring with other Assigned Devices
MX40 Display when Wirelessly Connected to a
Patient Monitor
ra
ft
op
When the MX40 is wirelessly connected to a patient monitor via the
short-range radio, its display is primarily inactive. There is no viewable
patient data on the display, however, battery status information is available
if the display is turned on.
Monitoring with other Assigned Devices
8-7
op
ft
ra
8-8
Monitoring with other Assigned Devices
9.
Monitoring with the MX40 at
the Information Center
This section describes the behavior of the MX40 as it relates to what is
displayed at the Information Center.
MX40 Controls in the Patient Window .................................................. 9-2
op
Locating the MX40 (Find Device) ............................................................ 9-4
Viewing Device Location and Location History (optional)................. 9-5
Using the Device Location Client (optional) ......................................... 9-6
Patient Configurable Settings in Telemetry Setup ................................ 9-7
ra
ft
Unit Configurable Settings ..................................................................... 9-11
Monitoring with the MX40 at the Information Center
9-1
MX40 Controls in the Patient Window
The Patient Window at the Information Center (accessed from the Patient
Window control in the Patient Sector) includes controls for a number of
MX40 operations. For detailed instructions on these operations, see the
IntelliVue Information Center Instructions for Use or the Online Help.
 To View ECG or SpO2 Alarm Limits
Move the cursor over the HR or SpO2 label to display the current high
and low alarm limits.
 To Change ECG or SpO2 Alarm Limits
Move the cursor over the High or Low numeric to display up/down
arrow controls for adjusting the limit.
After adjusting the limit, move the cursor away from the area to dismiss
the limit controls.
op
 To Change ECG Waveform Size
Move the cursor over the ECG waveform to display the ECG Waveform
Size control.
Select the desired size from the list.
ft
ra
 To Select Lead
Move the cursor over the ECG waveform to display the Lead Selection
control.
Select the desired lead from the list.
Important — Do not set the primary and secondary channels to the same
lead.
 To Change Va and Vb Default Lead Settings (6-lead
only)
9-2
Move the cursor over the ECG waveform to display the Lead Selection
popup.
Select the label from the label list.
For Va or Vb, select Va or Vb, then select the lead to be assigned.
Assignment of the same V lead to both Va and Vb is not allowed.
Monitoring with the MX40 at the Information Center
Important — Do not set the primary and secondary channels to the same
lead.
 To Initiate a Spot Check (Manual) Spo2 Measurement
Move the cursor over the SpO2 label.
Click on the Spot Check (Manual) icon.
op
ra
ft
Monitoring with the MX40 at the Information Center
9-3
Locating the MX40 (Find Device)
The Find Device feature enables you to generate an alternating pitch
repeated tone at the MX40 to assist in locating a missing device. This
function is initiated in the Telemetry Setup Window. Find Device requires
that the MX40 has sufficient battery power and is within the coverage area.
 To locate an MX40:
From the Patient Window, select Telemetry Setup.
Select Find Device to generate a repeated tone at the MX40.
ra
ft
op
To silence this tone, touch the silence key on the MX40.
9-4
Monitoring with the MX40 at the Information Center
Viewing Device Location and Location History
(optional)
You can see the location of an MX40 in the Patient Window. The Device
Location information is identified in the Patient Window by a compass icon
followed by the location name of the access point that the MX40 is currently
connected to. If the location of the device changes, the Patient Window is
updated within 5 seconds of the location change.
Warning
op
You can view the location history for a particular MX40 in the Device
Location History field in the Telemetry Setup window. The field displays
the five most recent Device Location descriptions in ascending order and
updates every time there is a change in location for the device. The total
timespan of the log is 60 minutes.
ft
Because the coverage range of Access Points can sometimes overlap,
including different floor levels, the IntelliVue Device Location feature is not
intended for use when attempting to locate a patient.
ra
Note — If there is a change in location while viewing the Telemetry Setup
window, you must re-enter Telemetry Setup to see the change, as it does
not update automatically.
Monitoring with the MX40 at the Information Center
9-5
Using the Device Location Client (optional)
The Device Location Client application is an optional software application
that allows you to display and locate devices visually, using Floor Plans
associated with your hospital’s layout. Device location history is also
available. The application is accessible using a separate PC’s web browser.
For additional installation information, see the IntelliVue Device Location
Installation Guide.
Warning
op
Because the coverage range of Access Points can sometimes overlap,
including different floor levels, the IntelliVue Device Location feature is not
intended for use when attempting to locate a patient.
Displaying and Locating Devices
ft
The left side of the Client display screen contains a list of clinical units
associated with the current Floor Plan. Each unit contains a list of bed
labels. You view the beds listed within a unit by clicking on the plus sign
next to the unit name.
Note — The beds listed are only those equipped with traditional IntelliVue
telemetry devices or the MX40.
ra
To identify and locate the device associated with the bed, simply click on
the desired bed label. The floor plan and the status bar above the floor plan
image now display the location of the device. Additionally, the status bar
lists the Access Point the device is currently associated with.
Viewing Device Location History
The location history of a particular device is also available. Select a device
from the Device List box and then click on the down arrow in the status bar.
The last five known locations of the device are displayed.
9-6
Monitoring with the MX40 at the Information Center
Patient Configurable Settings in Telemetry Setup
The Telemetry Setup window enables you to configure the MX40 for
patient-specific settings. All patient-specific settings will be reset to the unit
defaults upon patient discharge. To access the window, from the Patient
Window click Telemetry Setup.
ra
ft
op
The following settings can be adjusted in this window:
Monitoring with the MX40 at the Information Center
9-7
Patient-Configurable Settings in Telemetry Setup
Control
Function
Telemetry/
Determines the
Multi-Function Information Center
Button
response when the
Multi-Function Button is
pressed.
Setting Choices
Nurse Call - generate nurse call
alarm that can be retrieved from
Alarm Review for later use.
Factory
Default
Nurse Call
Record - generate a recording
strip
Nurse Call and Record - generate
nurse call alarm and recording
strip
None
9-8
disable
disable
Note — this does not affect the
appearance of the pacer spikes
on the MX40.
enable
enable
disable
Spot Check (Manual)- Provides
manual measurements so the
clinician can check as needed.
Measurement can be initiated at
Note — Pulse Rate
the MX40 from the SmartKeys
and Pleth Wave are not
menu or the SpO2 Setup menu
available in Spot Check
and at the Information Center by
(Manual) mode.
selecting the Spot Check SpO2
icon in the Patient Window.
Determine the MX40
SpO2 measurement
behavior.
ra
SpO2 Mode
Enable/disable the
SpO2 measurement at
the Information Center
and the MX40.
enable
op
SpO2 Enabled
Sets the appearance of
the pacer spikes to a
fixed size as they
appear in the patient
window.
ft
Fixed Pacer
Amplitude
Continuous - Sends an SpO2
parameter value to the
Information Center every second.
If selected, Pulse Rate and Pleth
Wave may also be sent.
Monitoring with the MX40 at the Information Center
Spot Check
(Manual)
Patient-Configurable Settings in Telemetry Setup
Control
Function
Setting Choices
Factory
Default
Suppress
SpO2 INOPs
with NBP
Enable/disable the
SpO2 algorithm to
suppress sending
technical alarms from
the MX40 during an
NBP measurement for
60 seconds.
enable
enable
disable
Warning
Enable/disable the
transmission of the
Pleth wave (and its
subsequent display) to
the Information Center.
For Continuous SpO2
mode only.
ra
Pleth Wave
ft
op
If you measure SpO2
on a limb that has an
inflated NBP cuff, a
non-pulsatile SpO2
technical alarm can
occur. If the monitor is
configured to suppress
this alarm, there can be
a delay of up to 60
seconds in indicating
critical patient status,
such as sudden pulse
loss or hypoxia.
enable
disable
Note — When enabled, the Pleth
wave replaces the Vb wave in the
Patient Window during 6-lead
monitoring.
Pulse
Enable/disable display enable
of the Pulse rate at the disable
Information Center. For
Continuous SpO2 mode
only.
SpO2 Alarm
Turn SpO2 alarms
on/off at the
Information Center and
the MX40.
enable (on)
Change current
settings back to last
saved clinical unit
settings.
(none)
Unit Settings
disable
(Pleth is not
displayed.)
disable
(Pulse rate
is not
displayed.)
enable
disable (off)
Monitoring with the MX40 at the Information Center
9-9
op
ft
ra
9-10
Monitoring with the MX40 at the Information Center
Unit Configurable Settings
Unit Settings provide access to clinical configuration items that affect all
patients on an Information Center. Changes in unit settings take effect upon
discharge, except for Standby duration and SpO2 mode, which take effect
immediately.
ra
ft
op
Access to unit settings requires a password, and the displays are in English.
Telemetry specific settings are accessed through All Controls -> Unit
Settings -> Telemetry Setup. The setting for telemetry non-arrhythmia
yellow alarms and INOP severity is located in All Controls -> Unit Settings
-> Alarms. For all other information on unit settings, see IntelliVue
Information Center Instructions for Use.
Monitoring with the MX40 at the Information Center
9-11
Unit Settings - Telemetry Setup
Control
Function
Settings
Factory
Default
Patient Type
Set patient type used for
SpO2 and NBP alarm
limits.
Adult
Adult
Telemetry/
Determine the Information
Multi-Function Center response when
Button
Telemetry Button is
pressed.
Pediatric
Nurse Call - generate nurse
call alarm that can be
retrieved from Alarm Review
for later use.
Nurse Call
Record - generate a recording
strip
Both - generate nurse call
alarm and recording strip
Standby
Duration
op
None
Sets the standby duration
on the device.
Infinite
Infinite
10 minutes
20 minutes
30 minutes
ft
1 hour
2 hours
3 hours
4 hours
Enable/disable alarm
pause/suspend at the
MX40.
enable
Suspend
Duration
Sets the alarm suspend
duration time for each
assigned device on the
Information Center.
1, 2, or 3 minutes
2 minutes
enable
enable
(battery
gauge is
displayed)
ra
Enable
Remote
Suspend
Battery Gauge Display/disable a battery
on Information gauge for each assigned
Center
device on the Information
Center.
disable
disable
disable
Note — the
battery
gauge is
always
displayed on
the MX40.
9-12
Monitoring with the MX40 at the Information Center
Unit Settings - Telemetry Setup
Control
Function
Settings
RF Auto
Shutoff
Enable/disable RF
operation during an
extended situation of all
leads off for more than 10
minutes and the SpO2 is
not being measured
continuously.
enable
Fixed Pacer
Amplitude
Sets the appearance of
the pacer spikes to a fixed
size as they appear in the
patient window.
enable
Autopair
Enable/disable the
autopairing of the MX40
and the IntelliVue Patient
Monitor at the Information
Center.
enable
Enable/disable the SpO2
measurement at the
Information Center.
enable
op
enable
(MX40 will
shut off after
10 minutes
of Leads Off
condition
and SpO2 is
not being
measured
continuously
. Reconnect
the patient
cable to
resume
monitoring.)
disable
disable
ft
ra
Enable SpO2
disable
Factory
Default
enable
disable
enable
disable
Monitoring with the MX40 at the Information Center
9-13
Unit Settings - Telemetry Setup
Settings
Factory
Default
Control
Function
SpO2 Mode
Determine the MX40 SpO2 Spot Check (Manual)Spot Check
Provides manual
measurement behavior.
(Manual)
measurements
so
the
clinician
Note — Pulse Rate and
can check as needed.
Pleth Wave are not
Measurement can be initiated
available in Spot Check
from the SmartKeys menu, the
(Manual) mode.
SpO2 Setup menu or by
selecting the Spot Check
SpO2 icon in the Patient
Window.
Enable/disable the SpO2
algorithm to detect NBP
running and suppress
sending technical alarms
from the MX40 for 60
seconds.
enable
disable
ra
Suppress
SpO2 Inops
with NBP
ft
op
Continuous - Sends an SpO2
parameter value to the
Information Center every
second. If selected, Pulse
Rate and Pleth Wave may
also be sent.
Warning
If you measure SpO2 on a
limb that has an inflated
NBP cuff, a non-pulsatile
SpO2 technical alarm can
occur. If the monitor is
configured to suppress
this alarm, there can be a
delay of up to 60 seconds
in indicating critical patient
status, such as sudden
pulse loss or hypoxia.
9-14
Monitoring with the MX40 at the Information Center
enable
Unit Settings - Telemetry Setup
Factory
Default
Control
Function
Settings
Pleth Wave
Enable/disable the
transmission of the Pleth
wave and its subsequent
display to the Information
Center. For Continuous
mode only.
enable
Enable/disable the
transmission of the Pulse
rate and its subsequent
display to the Information
Center. For Continuous
mode only.
enable
Turn SpO2 alarms on/off
at the Information Center.
enable (on)
Increment/decrement
SpO2 high alarm limit by 1
(in %).
Limit maximum is 100. Limit
minimum is 51 (adult) or 31
(pediatric). High and low limit
must be at least 1% apart.
100 (adult,
pediatric)
Increment/decrement
SpO2 low alarm limit by 1
(in %).
Limit maximum is 99. Limit
minimum is 50 (adult) or 30
(pediatric). High and low limit
must be at least 1% apart.
90 (adult,
pediatric)
SpO2 Limits
High
ra
SpO2 Limits
Low
during 6-lead monitoring, the
Pleth wave will replace the Vb
wave in the Patient Window.
disable
op
SpO2 Alarm
Note — When enabled,
disable
(Pulse rate
is not
displayed.)
enable
disable (off)
ft
Pulse
disable
disable
(Pleth wave
is not
displayed.)
Monitoring with the MX40 at the Information Center
9-15
Unit Settings - Default Leads
Control
Function
Settings
Factory
Default
3-wire
Set the unit default lead.
I, II, III
II
5-wire, ECG1 Set the unit default lead.
I, II, III, MCL, AVR, AVL,
AVF, V
II
5-wire, ECG2 Set the unit default lead.
I, II, III, MCL, AVR, AVL,
AVF, V
5-wire, ECG3 Set the unit default lead.
I, II, III, MCL, AVR, AVL,
AVF, V
III
Set the unit default lead.
I, II, III, AVR, AVL, AVF, V1, II
V2, V3, V4, V5, V6
5-wire EASI,
ECG2
Set the unit default lead.
I, II, III, AVR, AVL, AVF, V1, V2
V2, V3, V4, V5, V6
5-wire EASI,
ECG3
Set the unit default lead.
5-wire EASI,
ECG4
Set the unit default lead.
op
5-wire EASI,
ECG1
I, II, III, AVR, AVL, AVF, V1, III
V2, V3, V4, V5, V6
ft
I, II, III, AVR, AVL, AVF, V1, V5
V2, V3, V4, V5, V6
I, II, III, MCL, AVR, AVL,
AVF, V1, V2, V3, V4, V5, V6,
V7, V8, V9, V3R, V4R, V5R
II
6-wire, ECG2 Set the unit default lead.
I, II, III, MCL, AVR, AVL,
AVF, V1, V2, V3, V4, V5, V6,
V7, V8, V9, V3R, V4R, V5R
V2; V lead
choice is
determined
by Va and
Vb settings
6-wire, ECG3 Set the unit default lead.
I, II, III, MCL, AVR, AVL,
AVF, V1, V2, V3, V4, V5, V6,
V7, V8, V9, V3R, V4R, V5R
III
6-wire, ECG4 Set the unit default lead.
I, II, III, MCL, AVR, AVL,
AVF, V1, V2, V3, V4, V5, V6,
V7, V8, V9, V3R, V4R, V5R
V5; V lead
choice is
determined
by Va and
Vb settings
ra
6-wire, ECG1 Set the unit default lead.
9-16
Monitoring with the MX40 at the Information Center
Unit Settings - NBP Setup
Settings
Factory
Default
Control
Function
Patient Type
Set patient type used for NBP Adult
alarm limits.
Pediatric
Adult
NBP Alarm
Set NBP alarm notification.
Systolic or
Diastolic
Systolic or Diastolic
Systolic
Diastolic
Mean
Off
Increment/decrement NBP
low alarm limit by 1.
Limit Maximum is 155
Limit Minimum is 28 (Adult)
ft
Systolic Low
Limit Maximum is 260
160 Adult
Limit Minimum is 160 (Adult) 120 Pediatric
Limit Maximum is 260
Limit Minimum is 75 (Ped.)
op
Systolic High Increment/decrement NBP
high alarm limit by 1.
90 Adult
70 Pediatric
Limit Maximum is 255
Limit Minimum is 28 (Ped.)
Increment/decrement NBP
high alarm limit by 1.
Diastolic Low Increment/decrement NBP
low alarm limit by 1.
Mean High
Limit Maximum is 260
Limit Minimum is 90 (Adult)
90 Adult
70 Pediatric
Limit Maximum is 260
Limit Minimum is 45 (Ped.)
ra
Diastolic
High
Limit Maximum is 85
Limit Minimum is 28 (Adult)
50 Adult
40 Pediatric
Limit Maximum is 40
Limit Minimum is 28 (Ped.)
Increment/decrement NBP
high alarm limit by 1.
Limit Maximum is 260
Limit Minimum is 65 (Adult)
110 Adult
90 Pediatric
Limit Maximum is 260
Limit Minimum is 55 (Ped.)
Mean Low
Increment/decrement NBP
low alarm limit by 1.
Limit Maximum is 60
Limit Minimum is 28 (Adult)
60 Adult
50 Pediatric
Limit Maximum is 50
Limit Minimum is 28 (Ped.)
Monitoring with the MX40 at the Information Center
9-17
Unit Settings - Alarms
Control
Function
Non-arrhythmia
Yellow Alarms
Set latched/non-latched Latched
status for SpO2, ST, and Non-latched
other non-arrhythmia
yellow alarms.
Latched
Leads Off
Adjust the severity level
of this technical alarm
(INOP).
Cyan
Cyan
Adjust the severity level
of this technical alarm
(INOP).
Cyan
Factory Default
Yellow
Red
Cyan
Yellow
Red
ra
ft
op
Replace Battery
Settings
9-18
Monitoring with the MX40 at the Information Center
10. Operating with Information
Center Release L or M
This section covers performance differences when operating the MX40 with
previous releases of the Information Center (Release L or M).
Display ...................................................................................................... 10-2
ra
ft
op
Alarms ....................................................................................................... 10-3
Operating with Information Center Release L or M
10-1
Display
ra
ft
op
An MX40 operating with either Release L or M of the Information Center
has a fixed display showing either one measurement waveform and four
numeric parameter values or the ECG lead placement chest diagram along
with two numeric parameter values, depending on configuration.
10-2
Operating with Information Center Release L or M
Alarms
An MX40 operating with Release L or M of the Information Center does not
have physiological alarm capability locally at the device (networked or
non-networked). A No Alarm Display message is present along with the
Alarms Paused icon.
Technical alarms (INOPs) are communicated and can be silenced using the
Alarm Silence button.
Technical alarms can be reviewed using the Alarms SmartKey.
op
Note — Not all rechargeable battery technical alarms are communicated via
the Alert Data Integration paging system. The following alarms are not
communicated:
TELE CHECK BATT
TELE SERVICE BATT
TELE BATTERY TEMP
ra
ft
However, these technical alarms are still transmitted to the Information
Center.
Operating with Information Center Release L or M
10-3
op
ft
ra
10-4
Operating with Information Center Release L or M
11. Trends (Optional)
This section covers the trend functionality of the MX40. Trends are patient
data collected over time and displayed in tabular form to give you a picture
of how your patient's condition is developing. Trend information is stored
in the MX40 for continuously-monitored measurements, such as ECG, as
well as for aperiodically-measured parameters, such as SpO2.
ra
ft
op
Viewing Vital Trend Information ......................................................... 11-2
Trends (Optional)
11-1
Viewing Vital Trend Information
 To view Vital Trend information:
Touch the SmartKeys button.
From the SmartKeys menu, select Vitals Trend.
 To change the time columns:
Touch the time column.
Select a different time period.
ra
ft
op
11-2
Trends (Optional)
12. Maintenance
This section provides procedures for maintaining the MX40 after
installation, including equipment label assignment, cleaning, and
troubleshooting information for common problems.
Cleaning .................................................................................................... 12-2
Label Assignment for Replacement MX40........................................... 12-5
ra
ft
op
Charging Lithium-ion Rechargeable Batteries .................................... 12-7
Maintenance
12-1
Cleaning
The procedure in this section keeps the MX40 and its accompanying patient
cable clean and provides protection against infectious agents and
bloodborne pathogens. Both the outside and the inside of the MX40 battery
compartment and the patient cable must be kept free of dirt, dust, and
debris.
Important — After exposure, the MX40 and the patient cable must be
cleaned as per the instructions contained herein. Sterilization of the MX40
has been qualified using the STERRAD 100NX System. For more
information and instruction on sterilizing the MX40, contact your service
personnel.
op
 Perform the following steps to clean the MX40 and the
patient cable of visible surface contamination.
Note — when cleaning, the use of protective gloves is encouraged.
Remove the batteries and disconnect the patient cable.
If using disposable AA batteries, remove the battery tray and clean
separately.
Wipe the MX40 and the patient cable clean by using a cloth dampened
modestly with one of the approved cleaning agents listed in the table
below.
ra
ft
Follow the manufacturer's instructions with regard to application
duration.
Wipe the M40 and inside the patient cable housing with distilled water
or alcohol to prevent residue build-up.
Allow to air-dry, or dry with a non-lint producing cloth.
Cleaning Materials for the MX40
Caution
Use of abrasive cleaning materials, or disinfectants or cleaning agents
not listed herein, on any part or component of the MX40 may damage
the components.
The Gore-tex patch in the battery compartment of the MX40 can be
damaged by the use of glutaraldehyde and anti-bacterial soap.
12-2
Maintenance
Sharp or pointed instruments should not be used to remove soil from
recessed areas on the MX40.
Approved Cleaners
Cleaner
Active Ingredient
Isopropyl Alcohol
based
Isopropyl Alcohol (>70%)
Hydrogen Peroxide
Hydrogen Peroxide (3%)
Chlorine Bleach
Sodium Hypochlorite (1:10 concentration,
mixed < 24 hours)
Caltech Dispatch
5200 Wipes
Sodium hydroxide (<0.2%)
op
Sodium metasilicate (<0.6%)
Sodium hypochlorite (<1.0%)
Incidin Liquid
Propanol-2 (20%)
Ethanol (10%)
Benzalkoniumchlorid (<1.0%)
Isopropyl alcohol (15-18%)
ft
Metrex CaviWipes
Sodium hydroxide (0.1%)
2-butoxyethanol (1-5%)
Isopropanol (70%)
Resert XL HLD
Hydrogen peroxide (1.4-2-3%)
ra
Viraguard
2-Fumic Acid (<2.5%)
Sporox II Sterilizing &
Disinfection Solution
Hydrogen peroxide (7.5%)
Sanicloth Plus
Germicidal Cloths
Isopropyl alcohol (55%)
WipesPlus
Disinfecting Wipes
Phenylphenol (0.28%),
TechSpray General
Purpose Cleaner
Isopropyl alcohol (70%)
Oxivir Tb Cleaner
Disinfectant
Hydrogen peroxide (2.5-3.5%)
Oxivir Tb Wipes
Hydrogen peroxide (3%)
Sanicloth HB
Quaternary ammonium (1%)
Phosphoric acid (0.85%)
Quaternary ammonium (0.5%)
Benzyl-p-chlorophenol (0.03%)
Maintenance
12-3
Cleaner
Active Ingredient
Sanicloth Plus
Quaternary ammonium (0.25%)
2-Butoxyethol (1-4%)
Isopropyl alcohol (14.85%)
Super Sanicloth
Quaternary ammonium (<1%)
Isopropyl alcohol (55%)
Carpe Diem TM/ MC
Tb Wipes
Hydrogen peroxide (0.5%)
Benzyl alcohol (3.1%)
ra
ft
op
Note —The cleaners listed above are also suitable for cleaning the patient
cable and the lithium-ion battery.
12-4
Maintenance
Label Assignment for Replacement MX40
During installation, an equipment label is assigned to each MX40 in a
clinical unit so that the device can be identified during operation within the
wireless system. If an MX40 is lost, the Assign Label function at the
Information Center enables you to unassign the label from a lost device,
and re-assign its label to a replacement device. Labels are limited to those
available in an individual clinical unit. The Label Assignment function
requires a password for access, and its controls are available in English
only.
Re-assigning an Equipment Label
op
 To re-assign an equipment label to a replacement
device:
At the Information Center, clear the sector that the original equipment
label was assigned to (Patient Window -> Sector Setup -> Clear
Sector -> OK).
ft
Note — Before clearing the sector, ensure that the equipment label of
the lost device is not actively assigned to a patient being monitored.
Select All Controls -> Label Assignment.
Enter password.
ra
Note — The remaining screens will be in English only.
Insert battery power into the MX40 and if attached, disconnect the
patient cable.
Select Refresh.
Select the MAC address of the replacement device from the New
Devices list. If the address does not appear, remove battery power and
re-insert. Select Refresh.
Note — The MAC address appears on the rear label of the MX40.
Select the equipment label that was assigned to the previous device
from the Equipment Label list.
Select Assign Label to initiate programming of the equipment label
into the replacement MX40.
When prompted, press Confirm on the MX40 to accept the assignment.
The confirmation must occur within 30 seconds of the prompt.
Maintenance
12-5
10 Wait for the new_device label to change to the selected equipment label.
ra
ft
op
11 In Sector Setup, select the Bed Label and Equipment Label and then
press OK.
12-6
Maintenance
Charging Lithium-ion Rechargeable Batteries
The li-ion rechargeable battery is recharged using the IntelliVue CL
Charging Station.
To charge a battery, place it onto a charger slot on the charging station. The
battery power indicators will supply information about the charge status.
Warning
Always use the supplied power cord with the grounded mains plug to
connect the charging station to a grounded AC mains socket. Never
adapt the mains plug from the power supply to fit an ungrounded AC
mains socket.
op
Do not use AC mains extension cords or multiple socket outlets. If a
multiple portable socket outlet without an approved isolation
transformer is used, the interruption of its protective grounding may
result in leakage currents equal to the sum of the individual ground
leakage currents, so exceeding allowable limits.
ft
Do not connect any devices that are not supported as part of the system.
Battery Power Indicators
ra
There are various indications which help you keep track of the battery
power status.
LEDs on the charging station slots
battery status information on both the MX40 and the charging station's
display
INOP messages
The indicators always show the remaining capacity in relation to the
battery's actual maximum capacity which may lessen as the battery ages.
Charging Station LEDs
The nine charger slot LEDs show the battery status of the device in their
slot and are switched off if no battery is inserted.
If a battery is put on a charging station slot, the corresponding LED will
flash yellow until the battery's current state has been identified. Then a
beep is issued and the LED reflects the battery status as described in the
table below.
Maintenance
12-7
Status
LED
no battery on charger slot
off
battery put on charger slot
flashing yellow
battery not properly recognized,
error
cyan
battery recognized, battery
charging
yellow
battery recognized, battery full
(>90%)
green
The AC Power / Error LED is
green when the charging station is connected to AC power
op
cyan during startup or to indicate a general charging station error
ft
Note — Wiping of battery contacts with an alcohol solution after cleaning is
recommended.
Battery Status on the Charging Station Display
ra
The IntelliVue CL Charging Station display provides a quick overview of
all the connected devices and their battery status. The screen is arranged in
the same layout as the charger slots.
Battery Lifetime Management
The lifetime of a li-ion battery depends on the frequency and duration of
use. When properly cared for, the useful life is approximately 4 years or 500
complete charge-discharge cycles, whichever comes first. In addition,
experience indicates that the incidence of failure may increase with battery
service life due to the accumulated stresses of daily use. We therefore
strongly recommend that li-ion batteries be replaced after 2 years or 500
complete charge-discharge cycles.
The age of a li-ion battery begins at the date of manufacture. The date of
manufacture is listed on the side of the battery.
12-8
Maintenance
 To check the number of charge-discharge cycles:
Touch the battery gauge on the display.
The number of cycles is listed as xx/500 on the Device Status menu.
Battery Disposal
ra
ft
op
Discharge the battery and insulate the terminals with tape before disposal.
Dispose of used batteries promptly and in accordance with local recycling
regulations.
Maintenance
12-9
op
ft
ra
12-10 Maintenance
13. Safety Standards &
Specifications
This section describes the regulatory standards that the IntelliVue MX40
complies with, along with product and measurement specifications.
Regulatory Information .......................................................................... 13-2
op
Electromagnetic Compatibility .............................................................. 13-6
Battery Specifications ............................................................................ 13-12
Lithium-ion Battery Charge Time ....................................................... 13-14
Physical Specifications .......................................................................... 13-15
MX40 1.4 GHz Radio............................................................................. 13-16
ft
MX40 2.4 GHz Radio............................................................................. 13-17
MX40 Short-Range Radio ..................................................................... 13-19
Environmental Specifications .............................................................. 13-20
ra
Measurement Specifications ................................................................ 13-21
Safety Standards & Specifications
13-1
Regulatory Information
Software Hazard Prevention
Potential hazards arising from errors in the software program have been
identified. Mitigations applied to reduce the associated risk of such hazards
are included as part of the Risk Management, Clinical Evaluation, and
Verification and Validation phases of the product’s development.
AC Power Source
op
The system is not intended for connection to the public mains as defined in
CISPR-11.
Industrie Canada Compliance (Canada)
This Class B ISM device complies with Canadian ICES-001.
ft
Cet ISM de la classe B est conforme à la norme NMB-001 du Canada.
Safety Standards
ra
The device complies with the following safety requirements for medical
electrical equipment:
EN 60601-1:1990 + A1:1993 + A2:1995 +A11:1993 +A12:1993 + A13:1996
General Requirements for Safety (with worldwide deviations, including
U.S. deviations)
CSA C22.2 #601.1:1992 Medical Electrical Equipment - General Safety
UL 60601-1 Medical Electrical Equipment - General Safety
UL 2054 Standards for Household and Commerical Batteries
EN 60601-1-1:2006 System Requirements
EN 60601-1-4:2000 Safety Requirements for Programmable Electronic
Medical Systems
EN 50371:2005 Low Power Electronic and Electronic Apparatus
Electromagnetic Exposure
EN ISO 9919:2005 Requirements for SpO2 Pulse Oximeters
EN ISO 10993-1:2003 Biocompatibility
EN ISO 10993-1:2003 Biocompatibility (for leadwires and pouch)
13-2
Safety Standards & Specifications
EN ISO 9919:2005 Pulse Oximeters
IEC 60601-1-2:2001 Electromagnetic Compliance
IEC 60601-1-4:1999 +A1 Requirements for Programmable Electrical
Medical Systems
IEC 60601-1-6:2006 General requirements for basic safety and essential
performance - Collateral standard: Usability
IEC 60601-1-8:2006 General Requirements for Safety for Alarm Systems
IEC 60601-2-49:2001 Particular Requirements for Safety for Patient
Monitoring Equipment
op
IEC 60601-2-27:2005 Particular Requirements for Safety for
Electrocardiograph Monitoring Equipment
IEC 62133:2002 Safety Requirements for Portable Sealed Secondary Cells
(alkaline, lithium-ion)
AAMI EC 13:2007 Performance Standard, Cardiac Monitors
ft
AAMI EC 53:1995 (R) 2001 ECG Cables/Leadwires (excluding 4.2.1)
Intended Use Statement
ra
Intended for monitoring and recording of and to generate alarms for,
multiple physiological parameters of adults and pediatrics in a hospital
environment and during patient transport inside hospitals. Not intended
for home use. Intended for use by health care professionals.
Indications for Use
Indicated for use by health care professionals whenever there is a need for
monitoring the physiological parameters of patients. Intended for
monitoring and recording of, and to generate alarms for, multiple
physiological parameters of adults and pediatrics in hospital environments
and during transport inside hospitals.
Safety Standards & Specifications
13-3
Intended Uses of MX40
The MX40 is to be used primarily as a traditional telemetry medical device.
It connects to the IntelliVue Information Center by way of a wireless
network. When the MX40 is connected the IntelliVue Information Center
the IntelliVue Information Center provides the primary patient monitoring
and alarming function. The MX40 does not automatically provide local
monitoring or alarming when connected to the Information Center.
The MX40 can provide time-limited local monitoring when it is not
connected to the wireless network.
op
Unlike a traditional bedside monitor which operates on AC power, the
MX40 is powered by battery and cannot provide continuous monitoring.
Authorized EU Representative
ft
Philips Medizin Systeme Deutschland
Hewlett-Packard-Strasse 2
D 71034, Boeblingen
Germany
Patient Population
ra
This device is not for use with infant or neonatal patients.
Use of the device is restricted to one patient at a time.
The components/accessories which come into contact with the patient’s skin
are in compliance with the relevant requirements of EN ISO 10993-1 for
Biocompatibility. The device is not designed for direct contact with the
patient’s skin. The accompanying pouch is the appropriate means for
holding the device.
Rx
Federal Law restricts this device to sale by or on the order of a physician.
13-4
Safety Standards & Specifications
Essential Performance
The IntelliVue MX40 provides Essential Performance (EP) under normal
operating conditions (includes EMC exposure) only as a complete Medical
Electrical System, consisting of the MX40, MPx companion monitor
(Optional), IntelliVue CL SpO2 and NBP Cableless Measurement
devices(Optional), IntelliVue Telemetry Network Infrastructure, and the
M3290 Information Center Software.
The System achieves its Essential Performance exclusively through alarm
generation at the M3140-55 IntelliVue Information Center and locally at the
MX40, based on configuration.
ra
ft
op
The IntelliVue MX40 protects the patient from unacceptable immediate
clinical risk by generating specific Physiological Alarms when appropriate.
If the system cannot generate Physiological Alarms, then relevant Severe or
Hard-Level Technical Alarms (Inops) are created.
Safety Standards & Specifications
13-5
Electromagnetic Compatibility
Medical electrical equipment can either generate or receive electromagnetic
interference. This product has been evaluated for electromagnetic
compatibility (EMC) with the appropriate accessories according to IEC
60601-1-2:2001, the international standard for EMC for medical electrical
equipment. This IEC standard has been adopted in the European Union as
the European Norm, EN 60601-1-2:2001.
Radio frequency (RF) interference from nearby transmitting devices can
degrade performance of the product. Electromagnetic compatibility with
surrounding devices should be assessed prior to using the product.
op
Fixed, portable, and mobile radio frequency communications equipment
can also affect the performance of medical equipment. See your service
provider for assistance with the minimum recommended separation
distance between RF communications equipment and the product.
Warnings
ft
The cables, sensors/transducers, and other accessories for which compliance
is claimed are listed in the Service and User documentation accompanying
the product.
ra
The use of accessories, transducers and cables other than those specified
in the product service and user documentation can result in increased
electromagnetic emissions or decreased immunity of the product.
Short-range radio connections are subject to interruption due to
interference from other radio sources in the vicinity, including
microwaves, bluetooth devices, and DECT phones. Outside the
frequency band and 5% above and below, i.e. the exclusion band
according to IEC 60601-1-2, the short-range radio connection is immune
up to 3V/m in the frequency range from 80MHz to 2.5 GHz. Depending
on the strength and duration of the interference, the interruption may
occur for an extended period. Any interruption of the signal due to
interference, moving out of range, or for other reasons is indicated with
a Tele Disconnected INOP message.
The product should not be used next to or stacked with other
equipment. If you must stack the product, you must check that normal
operation is possible in the necessary configuration before the product
is used on patients.
13-6
Safety Standards & Specifications
Reducing Electromagnetic Interference
The MX40 and associated accessories can be susceptible to interference
from other RF energy sources and continuous, repetitive, power line bursts.
Examples of other sources of RF interference are other medical electrical
devices, cellular products, information technology equipment, and
radio/television transmission. If interference is encountered, as
demonstrated by artifact on the ECG or dramatic variations in physiological
parameter measurement values, attempt to locate the source. Assess the
following:
Is the interference due to misplaced or poorly applied electrodes or
sensors? If so, re-apply electrodes and sensors correctly according to
directions in Chapter 6.
op
Is the interference intermittent or constant?
Does the interference occur only in certain locations?
Does the interference occur only when in close proximity to certain
medical electrical equipment?
ft
Once the source is located, attempt to attenuate the interference by
distancing the MX40 from the source as much as possible. If assistance is
needed, contact your local service representative.
ra
Restrictions for Use
Artifact on ECG and other physiological waveforms caused by
electromagnetic interference should be evaluated by a physician or
physician authorized personnel to determine if it will negatively impact
patient diagnosis or treatment.
Electromagnetic Compatibility (EMC) Specifications
Take special precautions regarding electromagnetic compatibility (EMC)
when using medical electrical equipment. You must operate your
monitoring equipment according to the EMC information provided in this
book. Portable and mobile radiofrequency (RF) communications equipment
can affect medical electrical equipment.
Accessories Compliant with EMC Standards
All accessories listed in the accessories section comply, in combination with
the MX40, with the requirements of IEC 60601-1-2:2001 + A1:2004.
Safety Standards & Specifications
13-7
Warning
Using accessories other than those specified may result in increased
electromagnetic emission or decreased electromagnetic immunity of the
monitoring equipment.
Electromagnetic Emissions
Compliance
Avoiding Electromagnetic
Interference
Radio Frequency
(RF) emissions
Group 1
TheMX40 uses RF energy only for
its internal function. Therefore, its RF
emissions are very low and are not
likely to cause any interference in
nearby electronic equipment.
RF emissions
CISPR 11
Class B
The MX40 is suitable for use in all
establishments.
Harmonized
emisssions
Not Applicable
Device is battery powered only
ft
op
Emissions Test
Not Applicable
ra
Voltage
fluctuations/Flicker
emissions
IEC 61000-3-3
Electromagnetic Immunity
The MX40 is suitable for use in the specified electromagnetic environment.
The user must ensure that it is used in the appropriate environment as
described below.
Immunity Test
IEC 60601-1-2 Test
Level
Compliance Level
Electromagnetic
Environment Guidance
Electrostatic
discharge (ESD)
±6 kV contact
±6 kV contact
±8 kV air
±8 kV air
Floors should be wood,
concrete, or ceramic tile. If
floors are covered with
synthetic material, the relative
humidity should be at least
30%.
IEC 61000-4-2
13-8
Safety Standards & Specifications
Immunity Test
IEC 60601-1-2 Test
Level
Compliance Level
Electromagnetic
Environment Guidance
Power frequency
(50/60 Hz) magnetic
field
3 A/m
3 A/m
Power frequency magnetic
fields should be a t levels
characteristic of a typical
location in a typical
commercial and/or hospital
environment
IEC 61000-4-8
Recommended Separation Distance
Warning
op
The MX40, equipped with a wireless network interface, intentionally
receives RF electromagnetic energy for the purpose of its operation.
Therefore, other equipment may cause interference, even if that other
equipment complies with CISPR emission requirements.
ft
In the following table, P is the maximum output power rating of the
transmitter in watts (W) according to the transmitter manufacturer and d is
the recommended separation distance in meters (m).
ra
Portable and mobile RF communications equipment should be used no
closer to any part of the MX40, including cables, than the recommended
separation distance calculated from the equation appropriate for the
frequency of the transmitter.
Field strengths from fixed RF transmitters, as determined by an
electromagnetic site survey, should be less than the compliance level in
each frequency range.
Interference may occur in the vicinity of equipment marked with this
symbol:
Immunity Test
IEC 60601-1-2 Test
Level
Compliance Level
Electromagnetic
Environment Guidance
Conducted RF
3 Vrms
3 VRMS
IEC 61000-4-6
150 kHz to 80 MHz
Recommended separation
distance:
d = 1.2√P
Safety Standards & Specifications
13-9
Immunity Test
IEC 60601-1-2 Test
Level
Compliance Level
Electromagnetic
Environment Guidance
Radiated RF IEC
61000-4-3
3 V/m
80 MHz to 2.5 GHz
3 V/m
Recommended separation
distance:
80 MHz to 800 MHz
d = 1.2√P
800 MHz to 2.5 GHz
d = 2.3√P
op
Field strengths from fixed transmitters, such as base stations for radio
(cellular, cordless) telephones and land mobile radios, amateur radio, AM
and FM radio broadcast and TV broadcast cannot be predicted theoretically
with accuracy. To assess the electromagnetic environment due to fixed RF
transmitters, an electromagnetic site survey should be considered. If the
measured field strength in the location in which the monitor is used
exceeds the applicable RF compliance level above, the MX40 should be
observed to verify normal operation. If abnormal performance is observed,
additional measures may be necessary, such as reorienting or relocating the
monitor.
ft
These guidelines may not apply in all situations. Electromagnetic
propagation is affected by absorption and reflection from structures,
objects, and people.
ra
The MX40 is intended for use in an electromagnetic environment in which
radiated RF disturbances are controlled. The customer or user of the
monitor can help prevent electromagnetic interference by maintaining a
minimum distance between portable and mobile RF communications
equipment and the monitor as recommended below, according to the
maximum output power of the communications equipment.
In the following table, P is the maximum output power rating of the
transmitter in watts (W) according to the transmitter manufacturer and d is
the recommended separation distance in meters (m).
Frequency of
Transmitter
150 kHz to 80 MHz
80 MHz to 800 MHz
800 MHz to 2.5 GHz
Equation
d = 1.2√P
d = 1.2√P
d = 2.3√P
Rated max. output
power of transmitter
Separation distance
Separation distance
Separation distance
0.01 W
0.1 m
0.1 m
0.2 m
0.1 W
0.4 m
0.4 m
0.7 m
1W
1.2 m
1.3 m
2.3 m
13-10 Safety Standards & Specifications
Frequency of
Transmitter
150 kHz to 80 MHz
80 MHz to 800 MHz
800 MHz to 2.5 GHz
10 W
3.8 m
3.8 m
7.3 m
100 W
12.0 m
12.0 m
23.0 m
Electrosurgery Interference/Defibrillation/Electrostatic
Discharge
Restart Time
op
The equipment returns to the previous operating mode within 10 seconds
without loss of any stored data. Measurement accuracy may be temporarily
decreased while performing electrosurgery or defibrillation. This does not
affect patient or equipment safety. Do not expose the equipment to x-ray or
strong magnetic fields (MRI).
ra
ft
After power interruption, an ECG wave will be shown on the display after
30 seconds maximum.
Safety Standards & Specifications
13-11
Battery Specifications
Battery Life
The battery life specifications listed below are based on the use of three
Duracell MN 1500 batteries. Battery life for other brands may differ.
Telemetry Mode
Networked
Battery Life
24.7 hours
ECG/SpO2 Continuous
(using legacy SpO2
cable/sensors. Only one
radio active.)
8.9 hours
ECG/SpO2 Manual
In this mode battery life is dependent on
the usage rate and will range between the
ECG Only battery life and the ECG/SpO2
Continuous battery life.
ft
Monitor Mode
Non-networked
op
ECG Only (only one
radio active)
Battery Life
7.3 hours
ECG/SpO2 Continuous
(using legacy SpO2
cable/sensors. Only one
radio active.)
4.6 hours
ra
ECG Only (only one
radio active)
The battery life specifications listed below are based on the use of the
Philips Rechargeable Lithium-ion battery.
Telemetry Mode
Networked
Battery Life
ECG Only (only one
radio active)
25.1 hours
ECG/SpO2 Continuous
(using legacy SpO2
cable/sensors. Only one
radio active.)
14.1 hours
ECG/SpO2 Manual
In this mode battery life is dependent on
the usage rate and will range between the
ECG Only battery life and the ECG/SpO2
Continuous battery life.
13-12 Safety Standards & Specifications
Monitor Mode
Non-networked
Battery Life
ECG Only (only one
radio active)
8.6 hours
ECG/SpO2 Continuous
(using legacy SpO2
cable/sensors. Only one
radio active.)
7.0 hours
ECG/SpO2 Manual
In this mode battery life is dependent on
the usage rate and will range between the
ECG Only battery life and the ECG/SpO2
Continuous battery life.
Nominal Current
Nominal Current
op
Operating Mode
67 mA @ 3.6V
ECG/SpO2 Continuous
(Display inactive)
136 mA @ 3.6V
ra
ft
ECG Only (Display
inactive)
Safety Standards & Specifications
13-13
Lithium-ion Battery Charge Time
Charging Method
Charge Time
Battery pack
charge time from
90% depletion
state
The Lithium-ion Battery Pack is
charged on a separate external
charging station. It must be removed
from the MX40 to charge.
6.5 hours
ra
ft
op
Definition
13-14 Safety Standards & Specifications
Physical Specifications
Parameter
Specification
Height
126.8 mm (4.99 in)
Width
69.9 mm (2.75 in)
Depth
31.5 mm (1.24 in)
Weight
Without batteries, includes
SpO2 and Short-range
radio
1.4 GHz - 240 g (8.5 oz)
With 3 AA batteries,
includes SpO2 and
Short-range radio
1.4 GHz - 298 g (10.5 oz)
With lithium-ion battery,
includes SpO2 and Short
-range radio
1.4 GHz - 279 g (9.8 oz)
ft
op
2.4 GHz - 215 g (7.6 oz)
2.4 GHz - 324 g (11.4 oz)
2.4 GHz - 305 g (10.8 oz)
Display
2.8" QVGA Color LCD
View Area
43.2mm x 57.6 mm (1.70" x 2.26")
Resolution
240 x 320
ra
Type
Backlight
White LED
ECG Display Sector Size
(height)
13.5mm (portrait), 9.9mm
(landscape)
ECG Display Sweep Speed
10mm/s with 4.32 sec of viewable
ecg data (portrait), 10mm/s with
5.76 sec of viewable ecg data
(landscape)
Safety Standards & Specifications
13-15
MX40 1.4 GHz Radio
Parameter
Specification
Frequency Ranges
Bands: 1395-1400 MHz and 1427-1432
MHz
Channel Spacing: 1.6 MHz
8 dBm +2/-1.5 dB (4.5 mW to 10 mW), into
antenna load
MX40 Frequency
Accuracy during normal
operation
<+60/-100 KHz relative to channel
frequency, includes temperature
compensation and aging effects
Antenna Gain
-3 dBi
Modulation Type
op
RF Output Power
(existing systems)
Out of Band Spurious
Emission Levels:
GFSK with Root Raised Cosine filtering
(1M60Q7D)
<-41 dBm in 1 MHz bandwidth for FCC
limit
ft
<= 1394 MHz, >= 1401
MHz
<= 1428 MHz, >= 1433
MHz
ra
Occupied bandwidth as
< +/- 800 KHz
defined by power in 99%
BW
1.4GHz WMTS (US only)
This device complies with Part 15 of the FCC Rules. Operation is subject to
the condition that this device does not cause harmful interference.
Operation of this equipment requires the prior coordination with a
frequency coordinator designated by the FCC for the Wireless Medical
Telemetry Service.
13-16 Safety Standards & Specifications
MX40 2.4 GHz Radio
Parameter
Specification
Frequency Range
ISM Band: 2400 - 2483.5 MHz
Channel Assignment
48 radio channels assigned from 2401.056
MHz - 2482.272 MHz
Channel Spacing: 1.728 MHz
RF Output Power
FCC: Channels 0-46 -17 dBm +/- 1 dB (40
mW to 63 mW, nominal 50 mW), into
antenna load. Channel 47 only - 14.5 dBm
+/- 1 dB.
ETSI: 12 dBm +/- 1 dB (13 mW to 20 mW,
nominal 16 mW), into antenna load
op
ARIB: 13.5 dBm +/- 1 dB (18 mW to 28
mW, nominal 22 mW), into antenna load
<+ 60 /- 100 KHz relative to channel
frequency, includes temperature
compensation and aging effects
Modulation Type
GFSK, Gaussian Frequency Shift keying
(1M40Q7D)
Modulation Bandwidth
Typically 1.4 MHz (20 dB Bandwidth)
ra
ft
Transceiver Frequency
Accuracy during normal
operation
Out of Band Spurious
Emission Levels
Typically 980 KHz (6 dB Bandwidth)
Meets ETSI, RS210, FCC, ARIB standards
2.4 GHz ISM
FCC and Industry Canada Radio Compliance: This device complies with
Part 15 of the FCC Rules and RSS-210 of Industry Canada. Operation is
subject to the following two conditions: (1) this device may not cause
harmful interference, and (2) this device must accept any interference
received, including interference that may cause undesired operation. Any
changes or modifications to this equipment not expressly approved by
Philips Medical Systems may cause harmful radio frequency interference
and void your authority to operate this equipment.
Safety Standards & Specifications
13-17
The radio device used in this product is in compliance with the essential
requirements and other relevant provisions of Directive 1999/5/EC (Radio
Equipment and Telecommunications Terminal Equipment Directive). Class
2 radio equipment. Member states may apply restrictions on putting this
device into service or placing it on the market. This product is intended to
be connected to the Publicly Available Interfaces (PAI) and used
throughout the EEA.
ra
ft
op
This ISM device complies with Candadian ICES-001. Cet appareil ISM est
conforme a la norme NMB-001 du Canada.
13-18 Safety Standards & Specifications
MX40 Short-Range Radio
Parameter
Specification
Frequency Ranges
ISM Band: 2400-2483.5MHz
Radio Channel
assignment
16 Radio Channel assigned, Fc= 2405
+5*(k-11)MHz, k=11,12,…,26
Frequency Control
Configured via the bedside monitor.
RF Output Power
MX40 Frequency
Accuracy during normal
operation
<+/-40ppm, includes temperature
compensation & aging effects
Modulation Type
Direct Sequence Spread Spectrum (DSSS),
O-QPSK with half sine pulse shaping
modulation (1M40Q7D)
1.5 to 4.5 dBm +0/-3dB (0.7 mW to 0.3 mW),
into Antenna load.
op
Modulation Bandwidth
>500KHz, typically +/-950KHz (6dB Bandwidth),
ra
ft
typically +/-1.4MHz (20dB Bandwidth)
Safety Standards & Specifications
13-19
Environmental Specifications
Parameter
Specification
Temperature
Operating 0 to 37o C (32 to 99o F)
Storage -30o C to 50o C (-22o F to 122o F) without batteries
Humidity
Operating < 95% RH at 37o C (98.6o F) non-condensing
Storage < 90% RH at 50o C (112o F) without batteries
Altitude
op
Operating & 3,000 m (9,842 ft)
Non-operating
ra
ft
Barometric 72kPa (537 mmHg)
Pressure
13-20 Safety Standards & Specifications
Measurement Specifications
ECG
Parameter
Specification
ECG channel
transmitted Leads
Channel #1 = I, II, or III
5 electrodes
Channel #1 = II
Channel #2 = III
Channel #3 = MCL
5 electrodes, EASI
Channel #1 = Va-i
Channel #2 = Va-s
Channel #3 = Ve-s
6 electrodes
Channel #1= II
Channel #2 = III
Channel #3 = Va
Channel #4 = Vb
5 V
ft
Resolution
op
3 electrodes
Differential, defibrillator protected against 360
joules discharge into a 100 ohm load
Input Impedance
> 5 megohms (@ 10 Hz
ra
ECG Input
Input Dynamic Range
+/- 9 mV
DC Offset Range
+/- 320 mV
CMRR
> 90 dB @ 50, 60 Hz
Bandwidth +/- 3 dB
0.05 to 40 Hz
Gain Accuracy
+/- 5% at 25 C (77 F)
Noise Referred to ECG AAMI: 30 V (as per AAMI EC 13)
Input (Peak-to-Peak)
Lead Wires
3, 5 or 6-wire patient cable compatible with
IntelliVue Patient Monitor, AAMI/IEC color
codes
Time to baseline
recovery from
Defibrillator
AAMI: 5 s max (until ECG wave is on display
but not yet centered, monitoring bandwidth)
Safety Standards & Specifications
13-21
Parameter
Specification
Pacer Rejection
Performance
Positive pacers
(Pace pulses with no
tails).
+2 to +700 mV
0.1, 0.2, 0.5 and 1.0 ms
+2 to +500 mV
1.5 ms
Amplitude
Width
+2 to +400 mV
Negative pacers
2 ms
Width
-2 to -700 mV
ms
0.1, 0.2, 0.5 and 1.0
-2 to -500 mV
1.5 ms
-2 to -400 mV
2 ms
op
Amplitude
Philips does not claim, verify, or validate
support for all available pacemakers.
Meets Essential Performance.
ft
EMC Performance
Limits, radiated
immunity
All ECG connections are patient safe within
750 msec of patient cable removal, with
patient leakage current <10
Exception:Leadset detection pins are
protected mechanically to prevent patient
contact.
ra
ECG Patient Cable
Disconnection Safety
ECG Performance Disclosure/Specifications
Characteristic
Performance Disclosure/Specification (in italics)
Heart Rate Averaging Method
Two different methods are used:
Normally, heart rate is computed by averaging the 12
most recent RR intervals.
If each of 3 consecutive RR intervals are greater
than 1200 milliseconds (i.e. rate less than 50 b/min)
for adult and pediatric patients, then the 4 most
recent RR intervals are averaged to compute the HR.
13-22 Safety Standards & Specifications
Characteristic
Performance Disclosure/Specification (in italics)
Heart Rate Meter Accuracy and
Response to Irregular Rhythm
Provides correct heart rates (80, 60, 120, 90 b/min)
using test waveforms as indicated in ANSI/AAMI EC13
Sec. 3. 1. 2. 1 (5).
Response Time of Heart Rate Meter to For a rate increase, the average time to reach the
specified heart rate using test waveforms as indicated in
Change in Heart Rate
ANSI/AAMI EC13 Sec. 3. 1. 2. 1 (6) is 8.6 seconds. For
a rate drop, the average time is 8.2 seconds.
The ranges of time to alarm using test waveforms as
indicated in ANSI/AAMI EC13 Sec. 3. 1. 2. 1 (7) are 6.4
to 9.3 seconds.
Pacemaker Pulse Rejection Capability
Rejects pace pulses using test waveforms as indicated
in ANSI/AAMI EC13 Sec. 3. 1. 4 (with amplitude from
+/- 2 to +/- 700 mV, width from 0.1 to 2.0 ms).
Range and Accuracy of Heart Rate
Meter
op
Time to Alarm for Tachycardia
Meets the ANSI/AAMI EC13 Section 3.2.7
recommended minimum range and accuracy.
Alarm Limit Range
ft
Heart rate range is 15 - 300 b/min with accuracy of
1% of the range for Adult and Pediatric patients. (Note:
for rates equal to or less than 15, the displayed heart
rate is 0).
Meets the ANSI/AAMI EC13 Section 3.2.8.1 standard.
Lower alarm limit is 15 -295. Upper alarm limit is 20 300.
Meets the ANSI/AAMI EC13 Section 3.2.8.2 standard.
The resolution is 5 b/min.
Alarm Limit Accuracy
Meets the ANSI/AAMI EC13 Section 3.2.8.3 standard.
ra
Resolution of Alarm Limit Settings
Error less than ± 10% or ± 5b/min
Time to Alarm for Cardiac Standstill
Meets the ANSI/AAMI EC13 Section 3.2.8.4 standard:
maximum alarm time <10 seconds, using the test
waveforms as indicated.
Time to Alarm for Low Heart Rate
Meets the ANSI/AAMI EC13 Section 3.2.8.5 standard:
maximum alarm time <10 seconds, using the test
waveforms as indicated.
Time to Alarm for High Heart Rate
Meets the ANSI/AAMI EC13 Section 3.2.8.6 standard:
maximum alarm time <10 seconds, using the test
waveforms as indicated.
Alarm Silencing
The time required for reactivation of a latched, silenced
alarm is 3 minutes
ECG Waveform Display Time Base
Accuracy
0.8%. Meets the ANSI/AAMI EC13 Section 3.2.9.6
standard: maximum error = +/-10%.
Safety Standards & Specifications
13-23
Characteristic
Performance Disclosure/Specification (in italics)
Channel Width
40 mm. Meets the ANSI/AAMI EC13 Section 3.2.9.7(a)
standard: minimum = 30mm.
Trace Width
0.3 mm. Meets the ANSI/AAMI EC13 Section 3.2.9.7(b)
standard: maximum = 1.0mm.
Aspect Ratio
0.4s/mV. Meets the ANSI/AAMI EC13 Section 3.2.9.7(f)
standard: 0.4s/mV.
Input Signal Reproduction Accuracy:
-2.9%. Meets the ANSI/AAMI EC13 Section 3.2.9.8(a)
standard: maximum = +/- 20%.
Overall Error
Frequency Response: Sinusoidal
0.67 to 40 Hz (3 db down). Meets the ANSI/AAMI EC13
Section 3.2.9.8(b) standard: 0.67 to 40 Hz
(3 db down).
0 to 25% reduction. Meets the ANSI/AAMI EC13
Section 3.2.9.8(b) standard: 0 to 25% reduction.
Impulse Response:
Displacement = 0.08 mV, slope = 0.11 mV/s. Meets the
ANSI/AAMI EC13 Section 3.2.9.8(c) standard:
displacement maximum = 0.1 mV; slope
(for waves marked with ST bandwidth)
op
Frequency Response: Triangular
maximum = 0.30 mV/s.
ra
FAST SpO2
Minimum = 0.2 mV RTI. Meets the ANSI/AAMI EC13
Section 3.2.9. 12 standard: minimum = 0.2 mV RTI.
ft
Pacemaker Pulse Display Capability
Parameter
Specification
SpO2 Measurement
Range (Calibration
and Display)
0 to 100%
SpO2 Accuracy
See table following.
SpO2 Resolution
1%
13-24 Safety Standards & Specifications
Parameter
Specification
SpO2 Numerics Averaging
5 - 20 seconds (default = 10 seconds)
Note—The update rate for the SpO2 pulse
oximetry value and pulse rate is typically 1
second. This can be extended to a max. 60 s
when NBP is measured on the same limb,
with a corresponding INOP message after a
max. of 30 s, indicating that the displayed
values are not current values.
The effect of SpO2 pulse oximetry on data
averaging is internally controllable by the
patient worn monitorMX40, with no user
controls.
SpO2 & Pulse
Numerics - Update
Rate
Transmitted once per second.
Pleth Wave- Sampling
Rate
125 sps
Technical Alarms
(INOPs)
Triggered if the sensor is disconnected, if a
pulse is not detected, if the signal is noisy, if
light interference is detected, if the sensor is
defective, if the measurement is erratic, or if
the module is malfunctioning
Note—The update rate for the SpO2 pulse
ra
ft
op
oximetry value and pulse rate is typically 1
second. This can be extended to a max. 60 s
when NBP is measured on the same limb,
with a corresponding INOP message after a
max. of 30 s, indicating that the displayed
values are not current values.
Wavelength Range
500 to 1000 nm
Note—Information about wavelength range
can be especially useful to clinicians (e.g.,
clinicians performing photodynamic therapy).
Pulse Rate
Measurement
Range: 30 to 300 bpm
(available only with
Continuous SpO2)
Resolution: 1 bpm
Accuracy: +/- 2%
Display of SpO2
numerics
SpO2 values are displayed as xxx % SpO2 to
meet ISO 9919.
Emitted Light Energy
< 15 mW
Safety Standards & Specifications
13-25
Type
Description
Model Number
Accuracy %
rms
(70-100%
Range)
Adult Finger, 2m cable
M1191B
2.0
Adult Finger, 3m cable
M1191BL
2.0
Adult Finger, 0.45m cable
M1191T
3.0
op
SpO2 Sensor Accuracy
Reusable Sensors
M1192A
2.0
Pediatric, Small Adult Finger, 0.45m
cable
M1192T
3.0
Adult &Pediatric Ear Clip, 1.5m cable
M1194A
3.0
Adult Finger Clip, 3m cable
M1196A
3.0
Adult Finger Clip, 2m cable
M1196S
3.0
Adult Finger Clip, 0.9m cable
M1196T
3.0
LNCS Adult Reusable Sensor
Masimo LNCS
DC-I
2.0
LNCS Pediatric Reusable Sensor
Masimo LNCS
DC-IP
2.0
LNCS Tip-Clip Ear Reusable Sensor
Masimo LNCS TC-I 3.5
LNOP Adult Reusable Sensor
Masimo
LNOP-DC-I
2.0
LNOP Pediatric Reusable Sensor
Masimo LNOP
DC-IP
2.0
LNOP Tip-Clip Reusable Sensor
Masimo LNOP
TC-I
3.5
ra
ft
Pediatric, Small Adult Finger, 1.5m
cable
13-26 Safety Standards & Specifications
Model Number
Accuracy %
rms
(70-100%
Range)
Adult Finger, > 40kg
M1901B
3.0
Pediatric 3-20kg
M11902B
3.0
Pediatric Finger, 10-50kg
M1903B
3.0
Adult Finger, >30kg
M1904B
3.0
Adult, Pediatric > 20kg
M1131A
3.0
Adult Finger, > 30kg
Nellcor OxiMax Max-A
3.0
Adult Finger, > 30kg
Nellcor OxiMax Max-AL
3.0
Adult Finger > 40kg
op
Type
Nellcor OxiMax Max-N
3.0
Nellcor OxiMax Max-P
3.0
Nellcor OxiMax Max-I
3.0
Nellcor Oxisensor II D-25
3.0
Nellcor Osixensor II N-25
3.0
Pedicatric Finger 10-50kg
Nellcor Oxisensor II D-20
3.0
Adult Finger
Nellcor OxiCliq A
3.0
Pediatric Finger
Nellcor OxiCliq P
3.0
Pediatric
Nellcor OxiCliq I
3.0
Adult Finger > 40kg
Nellcor OxiCliq N
3.0
Pediatric Adhesive
Masimo LNOP PDT
2.0
Pediatric Adhesive
Masimo LNOP PDTx
2.0
Adult Adhesive
Masimo LNOP ADT
2.0
Adult Adhesive
Masimo LNOP ADTx
2.0
Adult Adhesive
Masimo LNCS ADTx
2.0
Pediatric Adhesive
Masimo LNCS PDTx
2.0
Adult Adhesive
Masimo LNCS Neo-3
2.0
Description
Single Patient Use Sensors
Pediatric
Pediatric
Adult Finger > 30kg
ra
ft
Adult Finger > 40kg
Safety Standards & Specifications
13-27
op
ft
ra
13-28 Safety Standards & Specifications
A. Accessories
This section lists the accessories for use with the MX40. Accessories are
subject to change. Some accessories are not supplied by Philips.
You can order parts and accessories from Philips at
www.medical.philips.com or consult your local Philips representative for
details.
Warning
op
Use only Philips-approved accessories. Use of product accessories
(patient cables, SpO2 sensors, etc.) other than those specified in this
manual may lead to patient injury or result in increased electromagnetic
emissions or decreased immunity of the product.
ft
Reuse: Never reuse disposable transducers, sensors, accessories, etc.
that are intended for single use, or single patient use only. Reuse may
compromise device functionality and system performance and cause a
potential hazard.
Philips' approval: Use only Philips-approved accessories. Using
non-Philips-approved accessories may compromise device functionality
and system performance and cause a potential hazard.
ra
Packaging: Do not use a sterilized accessory if its packaging is
damaged.
Accessories
A-1
MX40 Accessories
Pouches
Description
989803174141
Carry Pouch, Waterproof, box of
50
989803174151
Carry Pouch, Waterproof, box of
200
9300-0768-050
Disp tele pouch w/snaps, 50/box
9300-0768-200
Disp tele pouch w/snaps, 200/box
Miscellaneous
Order Number
Protective caps, adapter cable,
MX40
989803176491
Protective caps, Reusable leads,
MX40
989803174131
MX40 Lithium-ion battery, pkg 3
989803176201
MX40 Lithium-ion battery, pkg 1
MX40 AA Battery adapter, pkg 3
989803174891
A-2
Description
ra
ft
989803176501
op
Order Number
Accessories
ECG Accessories
Electrodes
Description
M4612A
Solid gel ECG electrode 5/pouch
300/case
M4613A
Solid gel ECG electrode 30/pouch
300/case
40489E
Adult paper tape ECG electrode, disp.
300/case
40493D
Adult foam ECG electrode, disp.
300/case
40493E
Adult foam ECG electrode, disp.
300/case
M1935A
Disposable EEG/ECG snap electrode
100/case
989803148801
Small adult solid gel snap electrode
1500/case
ft
op
Order Number
Adult cloth ECG electrode, disp.
300/case
13942E
Adult plastic tape ECG electrode, disp.
300/case
13950B
Pediatric cloth ECG electrode, disp.
300/case
13951C
Neo/Pediatric solid gel electrode, disp.
300/case
13955C
Neo/Pedi snap electrode, square,
disp.300/case
ra
13941E
Leadsets and Patient Cables
MX40 Reusable Patient Cables
Order Number
Description
989803171801
ECG 3 lead grabber AAMI .85m (35")
989803171811
ECG 3 lead grabber AAMI + SpO2 .85m (35")
989803171821
ECG 5 lead snap AAMI .85m (35")
Accessories
A-3
Order Number
Description
989803171841
ECG 5 lead snap AAMI + SpO2 .85m (35")
989803171831
ECG 5 lead grabber AAMI .85m (35")
989803171851
ECG 5 lead grabber AAMI + SpO2 .85m (35")
989803171861
ECG 6 lead grabber AAMI .85m (35")
989803171871
ECG 6 lead grabber AAMI + SpO2 .85m (35")
MX40 Extender Cable, including Bed Sheet Clip, p/n 989803172241
Reusable Leadsets for Use with IntelliVue Patient Monitors
Description
989803151991
ECG 3 lead snap, gray, AAMI .85m (35")
989803151971
ECG 3 lead grabber, gray, AAMI .85m (35")
989803152071
ECG 5 lead snap, multi AAMI .85m (35")
989803152051
ECG 5 lead grabber, multi AAMI .85m (35")
989803152151
ECG 6 lead snap, multi AAMI .85m (35")
989803152131
ECG 6 lead grabber, multi AAMI .85m (35")
989803152001
ECG 3 lead snap, gray IEC .85m (35")
989803151981
ECG 3 lead grabber, gray IEC .85m (35")
989803152081
ECG 5 lead snap, multi IEC .85m (35")
989803152061
ECG 5 lead grabber, multi IEC .85m (35")
ra
ft
op
Order Number
All above leadsets require the MX40 to InvelliVue Adapater Cable, p/n
989803172211
A-4
Accessories
SpO2 Accessories
Philips/Nellcor Disposable Sensors
Description
989803105481 (A)
M1904B Adult Finger, >30 kg
989803128551
M1133A Neo/Infant/Adult, <3, 10-20 kg, >40
kg
989803164921
M1134A Adh.-free Neo/Infant/Adult, >40 kg
989803128531
M1131A Adult/Pedi, >20 kg
989803111561(A)
M1903B Pedi Finger, 10-50 kg
989803105471(A)
M1902B Infant, 3-20 kg
op
Order Number
989803105461(A)
M1901B Neonatal,<3 kg, >40 kg
989801190969 (B)
NellCor OxiMax Max-1, 3-20 kg
989801190966 (B)
Nellcor Oxisensor II D-20, 10-50 kg
Nellcor OxiMax D-25, >30 kg
ft
989801190967 (B)
989801190970 (B)
Nellcor OxiMax N-25, <3 kg, >40 kg
ra
Require M1943A/AL cable to connect to MX40. Sold in packages of 24. (A)
Only available from Philips in Europe and (B) Only avialable from Philips in
Japan.
Philips Reusable Sensors
Order Number
Description
989803144371 A, B
M1191B Adult Finger, >50 kg
989803103231 A, B
M1192APedi/Sm. Adult 1.5 m, 15-50 kg
989803103251 A, B
M1194A Adult/Pedi Ear 1.5m, >40 kg
989803144381 A
M1191A Adult Finger 3 m, >50 kg
989803128631 A
M1196A Adult Finger 3 m, >40 kg
989803128591 C, D
M1191T Adult Finger .45 m, >50 kg
989803128611 C, D
M1192T Pedi/Sm. Adults .45 m, 15-50 kg
989803128641 C, D
M1196T Adult Finger .9 m, >40 kg
989803174381
M1196S Adult Finger 2m, >40 kg
A, B
Accessories
A-5
Order Number
Description
All sold as one piece each.
A - Sensors plug directly into MX40.
B - Supports use of M1941A extension cable.
C - Not for use with M1941A extension cable.
D - Requires M1943A/AL adapter cable.
Order Number
Description
989803105691
M1943A Adapter Cable, 1. m
989803128651**
M1943AL Adapter Cable, 3 m
989803105681**
op
Adapter Cables
M1020-61100**
Massimo Adapter Cable for LNOP sensors,3.6
Massimo Adapter Cable for LNCS sensors, 3
ft
989803148221**
M11941A Extension Cable, 2 m
ra
**Not to be used with the MX40 extender cable, p/n 989803172241
A-6
Accessories
B. Default Settings
ra
ft
op
This section documents the most important default settings of your MX40
as it is delivered from the factory. For a comprehensive list and explanation
of default settings, see the IntelliVue Information Center Release N
Configuration Guide. The MX40's configuration settings can be changed
permanently in Configuration Mode.
Default Settings
B-1
Alarm Default Settings
Alarm Setting
Factory Default
Alarm Volume
On Network: 0
Off Network: 10
Tone Modulation
On
Alarm Sound
Traditional
Alarm Pause Time
2 min.
Alarm Reminder (Red, Yellow)
On
Alarm Reminder (INOP)
On
Reminder Time
3 min.
ECG Leads Off - Severity
Replace Battery - Severity
Alarms On
op
QRS Volume
Cyan
Cyan
Information Center Release L/M: Disabled
ra
ft
Information Center Release N: Enabled
B-2
Default Settings
ECG, Arrhythmia, ST and QT Default Settings
ECG Settings
Factory Defaults
Adult
On
Primary Lead
II
Secondary Lead
6-lead: V2
5-lead (Standard): V
5-lead (EASI): V2
Default ECG Size
x1
Lead Placement
Standard
Leadset Type
AAMI
Analysis Mode
High Limit
Low Limit
op
ECG
Pedi
Multi-lead
120 bpm
160 bpm
50 bpm
75 bpm
4.0 sec
Arrhythmia Settings
Factory Defaults
ft
Asystole Threshold
ra
Adult
Arrhythmia
On
Pause Threshold
2.0 sec
VTach HR
100 bpm
VTach Run
Vent Rhythm
14
SVT HR
180 bpm
SVT Run
PVCs/min
10
Non-Sustained VT
On
Run PVCs
On
Pair PVCs
On
Pedi
120 bpm
200
Default Settings
B-3
Arrhythmia Settings
Factory Defaults
Adult
On
V.Bigeminy
On
V.Trigeminy
On
PVCs/min
On
Multif. PVCs
On
Pacer N. Cap
On
Pacer N. Pac
On
Pause
On
Missed Beat
SVT
op
R-On-T PVCs
On
On
Afib
On
On
ra
ft
Irregular HR
B-4
Default Settings
Pedi
Configuration Default Settings at the MX40
Setting
Factory Default
Touch Tone Volme
0 - 10
Default Screen
1 Wave (Portrait)
2 Waves (Portrait)
2 Waves (Landscape)
Chest Diagram
Screen Color
Blue
Gray
Green
Pink*
Purple*
Yellow*
(*only display in Standby Mode)
op
Alarm Sounds
Traditional
ISO
Confirm to restore to unit default settings
ra
ft
Unit Defaults
Default Settings
B-5
op
ft
ra
B-6
Default Settings
C. MX40 2.4GHz WLAN Radio
The MX40 2.4GHz WLAN Radio conforms to the 802.11 b/g standard,
operating in the 2.4GHz ISM band.
The Radio characteristics are defined below.
WLAN Radio RF Specs
Specification
802.11b
2.4 to 2.483GHz
Transmitter Power
14 to 17 dBm into antenna
load
op
Frequency Range
Spectrum Mans (relative to
max power spectral density)
<-30 dBr @ +/-11MHz offset
Modulation Type
CCK modulation
<-50 dBr @ +/-22MHz offset
ft
802.11g
2.4 to 2.483GHz
Transmitter Power
12 to 15 dBm into antenna
load
Spectrum Mans (relative to
max power spectral density)
<-20 dBr @ +/-11MHz offset
ra
Frequency Range
Modulation Type
<-28 dBr @ +/-20MHz offset
<-40 dBr @ +/-30MHz offset
OFDM modulation
ISM Radio
FCC and Industry Canada Radio Compliance: This device complies with
Part 15 of the FCC Rules and RSS-210 of Industry Canada. Operation is
subject to the following two conditions: (1) this device may not cause
harmful interference, and (2) this device must accept any interference
received, including interference that may cause undesired operation. Any
changes or modifications to this equipment not expressly approved by
Philips Medical Systems may cause harmful radio frequency interference
and void your authority to operate this equipment.
MX40 2.4GHz WLAN Radio
C-1
op
ft
ra
C-2
MX40 2.4GHz WLAN Radio
D. Sales and Support Offices
Please call your local Philips Healthcare sales office listed in your telephone
directory or a Philips Healthcare regional office listed below for the location
of your nearest sales office.
On the web
www.healthcare.philips.com
By fax
+31 40 27 64 887
op
Via email
healthcare@philips.com
ft
By postal service
Philips Healthcare
Global Information Center
P.O. Box 1168
5602 BD Eindhoven
The Netherlands
Asia
Tel: +842 2821 5888
ra
Europe, Middle East, Africa
Tel: +31 40 27 63005
Latin America
Tel: +55 11 2125 0764
North America
Tel: +1 800 229 6417
Sales and Support Offices
D-1
op
ft
ra
D-2
Sales and Support Offices
Index
Accessories
ECG • A-3
MX40 • A-2
SpO2 • A-5
Charging Lithium-ion Rechargeable Batteries • 3-13
alarms • B-2
ecg, arrhythmia, ST and QT • B-3
ft
ECG Fallback • 5-30
ECG Performance Disclosure/Specifications • 4-3
Electromagnetic Compatibility • 2-2
Initiating Arrhythmia Relearning Manually • 5-30
op
Default Settings • B-1
ra
Patient Configurable Settings in Telemetry Setup •
3-25
D
ra
op
ft
D
ra
op
ft
op
ft
ra
Part Number 453 564 242 441
Printed in USA June 2011
First Edition
453 564 242 441

---

Source Exif Data:

File Type                       : PDF
File Type Extension             : pdf
MIME Type                       : application/pdf
PDF Version                     : 1.5
Linearized                      : Yes
Tagged PDF                      : Yes
XMP Toolkit                     : Adobe XMP Core 4.0-c321 44.398116, Tue Aug 04 2009 14:24:39
Create Date                     : 2011:07:12 15:40:27-04:00
Creator Tool                    : Microsoft® Word 2010
Modify Date                     : 2011:07:20 10:55:36-04:00
Metadata Date                   : 2011:07:20 10:55:36-04:00
Producer                        : Microsoft® Word 2010
Format                          : application/pdf
Title                           : MX40 IFU - 453564242441
Document ID                     : uuid:70cdef31-9bd0-4908-bb05-12d193b1ac99
Instance ID                     : uuid:0d4bb2bc-8076-4152-8621-274cf8d9eab1
Has XFA                         : No
Page Count                      : 210
Language                        : en-US
Creator                         : Microsoft® Word 2010

EXIF Metadata provided by EXIF.tools